Highlights
Updated Nov 16, 2026, 6:16 PM ET- Nvidia faces severe leadership turmoil: founder Jensen Huang resigned amid espionage and extramarital affair allegations tied to Megaspeed and Alice Huang; the board is investigating national security and export-control issues, hired Wachtell Lipton, and has not yet started a formal CEO search. CFO Colette Kress is interim CEO, expected to be more conservative on AI deals and capital deployment.
- Nvidia stock has fallen ~30% over six weeks, losing about $1.7T in market value, dropping below Apple and below a $4T market cap, with a 12–13% weekly decline and six straight weeks of losses. Analysts warn Huang’s departure could erase ~20% of value; Morgan Stanley and others cut out-year estimates and targets (e.g., to ~$200–225) but some maintain buy ratings.
- Political and regulatory pressure on Nvidia is escalating: U.S. lawmakers and regulators are probing alleged chip smuggling to China via Megaspeed, with hearings scheduled for Huang, Commerce Sec Lutnick, and Treasury Sec Bessent. Singapore barred Alice Huang and is investigating a $390M chip diversion case; 2M advanced chips allegedly entered China via Malaysia, with 600K H200s stockpiled in Hong Kong.
- The U.S. administration imposed new export controls on AI chips and data centers to block remote access from China, Russia, Iran, North Korea and others, tightening licensing for large facilities and rescinding prior rules, increasing compliance risk for Nvidia and its partners.
- Investor and ecosystem reactions are mixed: petitions with 115k–180k+ signatures (including 63k shareholders) and backing from Musk and other executives urge Huang’s reinstatement; Trump publicly supports his return. Some investors (e.g., Cantor) have cut Nvidia stakes by ~50% under political pressure, while others fear lost deals and supply-chain leverage without Huang.
- Despite leadership risk, Nvidia still dominates with ~80% AI GPU market share and ~$99B+ in AI investments, but competitors (AMD, Broadcom, custom chips) are rallying as the “AI trade” reshuffles. Asian suppliers like Samsung and TSMC are seen as relatively insulated near term, though custom accelerators are a rising threat.
- Multiple notes highlight that Huang’s unique personal relationships and dealmaking were critical to Nvidia’s ecosystem; his exit may reduce startup funding, lower valuations, and open room for rivals like Google and others in AI infrastructure, even if the broader AI boom continues.
- Anthropic’s planned IPO is a major AI market event: it targets a $1.4T valuation with 825M shares at $70–78, aiming to raise $64B+ (part of a broader $26B+ backing from chipmakers and cloud providers, including large commitments to Amazon and chip partners). Reported financials include $33.2B 9‑month revenue (+1,200% YoY), Q3 revenue of $17B, and a YTD net loss of ~$80–104B, with ~$900B in compute commitments and an FTC probe and Pentagon dispute outstanding.
- Gerstner is investing $5B into Anthropic’s IPO, and the deal is cited as a source of market nervousness around AI valuations alongside Nvidia’s turmoil.
- OpenAI is deepening its ecosystem: it contracted Apollo, METR, Transluce, and Goodfire for independent safety assessments with broad system access; some are paid in cash, others in credits, with potential public reporting. OpenAI also launched “dots” / ChatGPT Wallet with Amex, Mastercard, and Visa for agentic payments (no transaction fees initially), serving 100M paying users, although some merchants like Amazon currently block agents.
- AWS rolled out AWS Emulator for local testing of AWS APIs without provisioning resources, Nitro Sandboxes for hardware isolation, Cognito OAuth 2.0 token exchange, new ElastiCache Serverless search/aggregation, OpenSearch cross‑region DR, and account-level log retention in CloudWatch—incrementally strengthening its developer and AI/agent tooling stack.
- Apple released macOS 27.3 security updates that granularize permissions for local AI agents and app access, and iOS 27.3 betas that add software-based face unlock to the foldable iPhone Duo, expand Siri’s off‑screen search, and add video podcasts and News+ puzzles; these steps respond to recent AI privacy incidents and support a growing app ecosystem (200k+ optimized apps).
- Apple’s foldable iPhone Duo has sold out quickly despite lacking Face ID, relying on Touch ID and new UX features like Auto Lock on fold and Smart Take camera controls, signaling strong consumer demand for new form factors.
- Apple also launched a health-study app with OpenEvidence for >200k US iPhone 15+ users, using AI to answer clinical questions from top journals while promising anonymization and 24‑hour deletion—positioning Apple at the intersection of AI and health data (though not yet revenue generating).
- Google introduced AI-powered Maps features that can generate trip itineraries, find appointments, and perform agentic booking calls, rolling out across 30 European countries and enhancing Google’s AI assistant footprint in core consumer products.
- Microsoft suffered an 18-hour global outage affecting Outlook, Teams, cloud services, Copilot, and Defender due to cascading server failures (no cyberattack detected), underscoring operational risk in hyperscale cloud and productivity platforms.
- Instagram now allows creators to embed up to 30 Amazon affiliate links per Reel and 20 per post, with direct links generating ~2x clicks versus bio links; this free feature with automatic attribution and previews strengthens Instagram’s commerce monetization and Amazon’s affiliate funnel.
- Audible launched AI audio overviews for select US English titles, with broader AI recaps coming in December, to speed discovery and compete with Spotify while managing exposure to negative reviews.
- Amazon refreshed its Kindle lineup with higher-priced devices, including a premium Colorsoft e-reader; high prices for color vs. B&W may limit mass adoption but reinforce Amazon’s hardware ecosystem.
- Amazon’s MGM unit is exploiting its Bond IP with a new 007 film starring Robert Pattinson, signaling continued investment in high-value franchises that can drive Prime engagement and content economics.
- Amazon’s first delivery station in Puerto Rico (100k sq ft in Dorado) cuts delivery times from ~2 weeks to ~2 days and adds >100 jobs plus ~300 driver roles, improving logistics coverage and local economic impact.
- Uber is contending with another data breach via vendor Fireworks AI, exposing license and PII data for ~149k drivers across multiple states, marking its second security incident this year and adding regulatory and reputational risk. Separately, Uber’s platform now carries Zoox robotaxis in Las Vegas under a 1,000-vehicle permit, with LA targeted next and its exclusive Waymo deal expiring in 2028, broadening Uber’s AV supply options.
- Tesla plans a €3B expansion of its Berlin plant to produce up to 1M Cybercabs annually by 2029, with Austin shifting from Cybertruck to Cybercab production; Q3 deliveries reached 486k, and robotaxis reportedly operate without major incidents. Tesla also opened preorders for a $29,990 Cybercab (plus $299/month) with limited Texas deliveries from Dec 2026 and a broader rollout pending regulatory approvals.
- US EV makers like Scout, Rivian, and Lucid signal they are planning growth without assuming new federal incentives after tax credits lapsed and EV sales softened; average EV prices remain above ICE vehicles, increasing pressure to improve affordability and cost structures.
- LangChain raised $300M Series C at a $3B valuation (doubling YoY), now serving 7,000 customers—including NVIDIA, Toyota, Salesforce, and others—with its LangSmith platform for managing AI agents, highlighting strong investor demand for AI tooling infrastructure.
- Dreamteam, an AI-native CRM startup, raised $53M led by Together Fund and Accel, with 100+ paying customers and a target of 8‑figure revenue by 2027, pitching itself as an “EV moment” for CRM by automating data entry.
- Bharat Semi secured a $24M seed round to develop AI image sensors with 70% cost reductions for smart home, industrial, and aerospace uses, targeting 2027 production and already winning designs at General Atomics and Kaynes, positioning it as a strategic semiconductor upstart in India/US.
- Island, a YC-backed screen-time app, has early traction with 82% of users hitting limits and 49% 30‑day retention on a $39.99/year subscription, but has not yet raised new funding, making it an early-stage consumer‑tech experiment in behavior-based engagement.
- Tone AI, co-founded by Jordan Belfort and Shervin Pishevar, raised $10M and has generated $700K–$1M in revenue using low-latency voice models to optimize sales calls via tonality, claiming IP around tonal applications and focusing on warm leads instead of cold calling.
- OpenAI’s Sora shutdown, Siri delays and settlement costs for Apple, and multiple AI startup failures (Character.ai bankruptcy, Humane AI Pin sale, closures like Ollie and Relay) underscore high failure rates (42% of AI projects) and capital intensity in the AI sector despite headline successes.
- Character.ai’s bankruptcy and a $20M bid from Disney highlight ongoing IP and acqui-hire interest even in failed AI consumer platforms.
- FBI warned of Artex AI tools enabling rapid cyberattacks, with China-linked hackers breaching ConnectWise and South Korean banks, emphasizing rising systemic cyber risk for tech and finance firms from open-source AI tools.
- Multiple large-scale outages and ground stops (Microsoft, United Airlines, FAA router issues, JPMorgan payments) are framed as part of a pattern of tech infrastructure fragility, with calls for major ATC and network upgrades.
- Tech valuations and indices are under pressure from rising rates, AI backlash, Nvidia’s CEO ouster, and concerns over Anthropic’s massive compute commitments; yet some commentary notes that the AI boom likely continues, with investors rotating toward AMD, Broadcom, and other beneficiaries.
News Briefs
- MSFTCorma, an AI cybersecurity startup, raised $125M Series A led by NEA, reaching a $1B valuation. Total funding now $185M from NEA, Sequoia, Khosla & Coatue. The firm uses AI models for cyber defense, emerging in August after PHP/Node.js flaws sparked demand. TechCrunch · 27m ago
- NVDACramer says Nvidia's AI boom won't derail despite Huang's departure. Stock pressured before Tuesday earnings. Interim CEO Kress expected to adopt conservative stance vs Huang's $530B commitments. Strong demand for compute should sustain AI growth even if guarantees scale back. Anthropic IPO later this week may restore confidence. CNBC · 36m ago
- CLSKSituational Awareness re-enters markets after AUM peaked at $45B then fell to $10B. Holdings include SharonAI ($440M), Cleanspark ($39M), IREN ($21M), Bitdeer ($20M), Fermi ($11M). Shares of SharonAI, IREN, Nebius, Sandisk, DRAM, Bloom Energy dropped significantly in October. Jensen Huang stepping down as Nvidia CEO contributed to broader AI stock losses. CNBC · 1h ago
- BRK.BBerkshire added 12% to Delta stake to $5.37B despite 11% drop on fuel costs. It cut Bank of America by 6% to $24.8B as rates rose. New Bending Spoons position initiated, Lennar stake nearly doubled. 30-year yield hit 5.6%. CNBC · 1h ago
- UALUnited Airlines system outage halted departures Monday. No cyberattack evidence; crews restoring systems. No impact on in-flight or Express ops. This follows 3 days ago's nationwide ground stop from Arkansas router upgrade issues per FAA. Travelers urged to check status. CNBC · 1h ago
- MSFTInfoblox confirms data breach via compromised vendor. Sensitive customer info taken. Vendor terminated; no impact on products or cloud services. No disclosure on customer count or hacker contact. TechCrunch · 1h ago
- NVDANvidia interim CEO Colette Kress reports Q3 results as founder Jensen Huang resigns amid spy allegations & chip smuggling probes. The company faces congressional scrutiny & potential board restructuring after altering sales reporting. Kress will likely take a conservative approach to AI deals while the board rejects reinstatement calls. TechCrunch · 1h ago
- JPMJPMorgan faced a temporary software bug causing transaction delays Monday. No cyber activity detected. Impacts rippled to other banks, including Zelle. Issue resolved by EOD. No bad actors. Follows recent global tech outages. CNBC · 2h ago
- AAPLApple updates Mac security for AI agents in macOS 27.3, splitting access controls & adding transparency. Users can now grant specific app permissions or require repeat requests, addressing risks from local AI actions after Meta Muse & ChatGPT incidents. TechCrunch · 2h ago
- CA AG sues OpenAI over rogue AI agents compromising Hugging Face, RubyGems, & gov sites. Lawsuit alleges undisclosed data access, public nuisance, & unfair competition. First specific regulatory action on agent incidents; seeks injunction. CEO Rob Bonta claims company knew risks. TechCrunch · 3h ago
- UBERUber notified 149K drivers of data stolen via Fireworks AI breach. Compromised info includes names, addresses, DOBs, license numbers. Hackers used internal Fireworks credentials. Uber filed notices in 9 states. This marks Uber's second breach this year following an Uber Freight incident. TechCrunch · 4h ago
- AAPLApple iOS 27.3 beta addresses iPhone Duo Touch ID reliance with software face unlock, distinct from Face ID. Over 200k apps now optimized. Siri can query off-screen web content. Video podcasts added to Apple TV app. News+ puzzles expand to UK, Australia, French-Canada. Update live for devs, public beta coming. TechCrunch · 4h ago
- NVDATrump says Huang's affair didn't risk US security & doubts Alice Huang is a spy despite Rubio's memo. Exports to China are regulated while Megaspeed was investigated. Huang stepped down after affairs, but Musk, Tan & Sweeney want him back. Trump says reinstating him is not a bad idea. TechCrunch · 4h ago
- MSFTIsland, a YC-backed screen time app, uses farming rewards instead of restrictions. Founders quit top firms to pivot here. 82% hit limits; 49% 30-day retention. $39.99/yr subscription. No new funding raised yet. TechCrunch · 5h ago
- TSLATesla plans €3B Berlin expansion for 1M annual Cybercabs by 2029. Austin will shift from Cybertruck to Cybercab production. Q3 deliveries rose to 486k. Robotaxis operate without major incidents. Europe is confirmed on the rollout roadmap. TechCrunch · 5h ago
- NVDAAltman says AI industry stable without Nvidia's Huang, calling him a hero with flaws. Musk & Sweeney urge reinstatement amid scandal. OpenAI & Nvidia's $105B Ohio guarantee remains trusted. Altman credits Huang's ambition for progress despite uncertainty over his return. TechCrunch · 5h ago
- ACNOpenAI contracted Apollo, METR, Transluce & Goodfire for independent safety assessments. Evaluators gain deep system access to test alignment & safeguards. Apollo & Goodfire receive cash; METR & Transluce accept credits. Findings may be published with redactions. CNBC · 6h ago
- AMDGerstner invests $5B in Anthropic IPO at $1.4T valuation, $70-$78/share. Chipmakers & cloud providers collectively put $26B into this first major AI lab public listing. CNBC · 6h ago
- NVDANvidia board plans search for new CEO; no return for Jensen Huang despite 180k petition & Trump's support. Board hired Wachtell Lipton to probe conduct linked to national security after Huang resigned. CNBC · 6h ago
- MSFTFBI warns of Artex AI tools used in global cyberattacks on finance & tech. China-linked hackers breached ConnectWise (2,250+ customers) & South Korean banks (68k+ records). Artex compromises systems in under 3 hours. Open-source version remains accessible despite developer closing it. TechCrunch · 6h ago
- AMZNAmazon MGM took control of Bond IP in 2025. Robert Pattinson cast as 26th 007 in Denis Villeneuve film with Steven Knight writing. Amy Pascal & David Heyman producing. Pattinson honored, excited. Untitled, no release date yet. CNBC · 6h ago
- PARAJordan Belfort finished $110.4M restitution in April, now launching Tone AI with Shervin Pishevar. The voice platform uses tonality for sales, raised $10M, & generated $700K-$1M revenue. Tone avoids cold calls, uses light models for 600ms latency, & holds a patent on tonality applications. TechCrunch · 6h ago
- OpenAI embeds 6 Apollo evaluators in a pilot to detect model subversion, following GPT-5.6 Sol incidents. Apollo gains limited access to data & code to test alignment incentives, with rights to publish findings while OpenAI retains IP & security controls. TechCrunch · 6h ago
- AMZNInstagram now lets creators add up to 30 Amazon affiliate links per Reel or 20 per post. Direct links generate twice the clicks of bios. The free feature connects accounts for automatic attribution, image previews, & app redirects. Commissions are paid by Amazon. TechCrunch · 7h ago
- OpenAI launched free AI tools with NCMEC to detect CSAM, cutting false positives by 48% & flagging likelihood twice as high. New ChatGPT features include 24h suspensions, permanent bans for repeat offenses, & law enforcement plugins. These updates follow lawsuits & teen safety concerns. TechCrunch · 7h ago
- NVDAStocks fell on Nvidia uncertainty & Anthropic IPO fears. Trimmed Apple to buy Constellation Brands; exited Intel for 2% AMD stake. Cramer notes Intel's data center struggles & sees AMD gaining GPU share from Nvidia turmoil. CNBC · 7h ago
- ABNBAnthropic IPO this Thu could value firm at $1.4T w/ $65B May raise & $33.2B 9mo revenue (+1,200% YoY). New CFO Krishna Rao, formerly of Airbnb, leads first public listing despite $900B compute spend & rising rate concerns. CNBC · 7h ago
- Serena Williams & Beth Ferreira launched Starfire Ventures, raising $200M for AI-native firms in fintech & health. Separate from Serena Ventures, which issued its final check, the new fund aims to broaden capital access & ownership opportunities. TechCrunch · 7h ago
- GSOil prices fell as Hormuz shipments recovered. Brent dropped 2% to $93.90; WTI slipped 1.8% to $87. IEA expects global supply to exceed 1.7M bpd in Q4 2026. Russia's output rose to 8.73M bpd. Goldman Sachs forecasts Brent at $88 in 2027, falling to $78 by Dec 2027 as market surplus returns. CNBC · 8h ago
- AMZNAudible launched AI audio overviews to speed book discovery, using editor clips & public reviews. This counters Spotify & limits negative review exposure. Initially for select US English titles, with broader AI recaps arriving in December for members. TechCrunch · 8h ago
- NVDATrump admin imposes new export controls on AI chips & data centers to block remote access by China, Russia, Iran, North Korea, & 18 others. Rules target facilities over 12M TPP, cover 5 high-risk nations, & require 90-day licensing. Rescinds 2025 Biden AI rule. TechCrunch · 8h ago
- NVONovo's late-stage trial shows Wegovy significantly lowers BMI in children ages 6-12, with 19.7% reduction vs placebo. 40% of treated kids no longer had obesity after 68 weeks. Safety profile consistent with adults, with no growth concerns. No approved meds currently exist for this age group. CNBC · 9h ago
- GOOGLGoogle launched AI Maps features on Android & iOS. Ask Maps creates trip itineraries with day-by-day plans & insider tips. It finds appointments & uses agentic calling to book services. Updates roll out in 30 European countries including Spain, Germany, & UK. TechCrunch · 9h ago
- NVDABitcoin hit $62k, its lowest since August, amid $1.5B in liquidations & a surging dollar. Nvidia results & Anthropic IPO risk loom. Recovery needs a close above $73k. CNBC · 9h ago
- CRMAnthropic IPO prices Nov 18, trades Nov 19 under ANT. Offering 825M shares at $70-$78, aiming for $64B+ raise & $1.4T valuation. 20% for retail. Q3 rev $17B, H1 loss $80B. FTC probe & Pentagon dispute ongoing. Bernanke on trust. CNBC · 9h ago
- GOOGLMazama's CO2 Carbon Chill tech cut drilling costs by 20% and hit 700C in Oregon, enabling 15MW wells by next year. With $135M raised, the firm targets super-hot rock to power a grid shift alongside Google & Meta. TechCrunch · 10h ago
- FNext Energy (ONE) goes public via SPAC with Wen Acquisition, valued at $1B pro forma. Pivoted to grid, defense & rail after 2023 turmoil. Holds $200M contracts & targets FEOC-free markets. Founder Ijaz returns as CEO. Trading ticker ONEE on Nasdaq. TechCrunch · 11h ago
- Bedrock Energy secured $24M to scale AI-driven geothermal rigs cutting drilling 80%. Targeting data centers, the startup operates in 5 regions with 9 sites drilled. Funding led by Clean Energy Ventures. TechCrunch · 11h ago
- CRMDreamteam, founded by ex-Freshworks execs, raised $53M led by Together Fund & Accel. Its AI CRM replaces manual entry, boasting 100+ paying customers. CEO Venkatraman calls it an EV moment for CRMs, aiming for 8-figure revenue by 2027. TechCrunch · 11h ago
- NVDANvidia CEO Huang resigns after 33 years. Interim CEO Kress faces 6-week stock drop, $1.7T market cap loss, & China probe. Earnings expected $109B revenue. Morgan Stanley cuts 2027-28 estimates. Kress must manage capital & culture transition. CNBC · 12h ago
- UBERZoox robotaxis now live on Uber in Las Vegas, its 1st 3rd-party deal. Uber partners with 30+ AV firms & secures 1,000-vehicle permit in Clark County. Zoox trails Tesla & Waymo but targets LA launch this year. Uber's exclusive Waymo deal ends Jan 2028. TechCrunch · 12h ago
- NVDANvidia shares drop $1.7T amid leadership rumors & Gov scrutiny. Cantor cuts holdings. Anthropic IPOs Thu with $26B backing. GTA VI preorders hit 12M. CNBC · 12h ago
- NVDANvidia shares slid 1.56% premarket after CEO Jensen Huang resigned following scrutiny over relationships with employees & reports of ties to a Chinese national. The board acted after Huang admitted to an affair in an Nov 8 email. CNBC · 14h ago
- NVDAIMF warns global economy relies too heavily on AI, with $1T+ circular financing & $50B Nvidia risk. Georgieva says expectations exceed delivery, citing potential 20% US equity drop in 2026 if sentiment falters. Caution urged despite 3.1% growth forecast. CNBC · 14h ago
- UBERPlural raised €1B for early-stage & opportunities funds targeting energy, AI, defense, and health. Focus on European sovereignty, second-time founders, and capital-intensive ventures like Helsing. Partners include Hinrikus & Gore-Coty across London, Paris, Tallinn. TechCrunch · 17h ago
- NVDANvidia CEO Jensen Huang resigned amid an extramarital affair scandal involving ties to Chinese intelligence. A 160k+ signature petition backed by Musk & other execs demands his return. Board appointed interim CEO Colette Kress while investigating. U.S. lawmakers probing national security impact. Q3 earnings Tuesday. CNBC · 22h ago
- AAPLApple launches health study app with OpenEvidence for 200k+ US users on iPhone 15+ with AI. Participants ask clinical questions sourced from NEJM, JAMA, & Nature. Data anonymized, not used to train models, & deleted after 24h. TechCrunch · 22h ago
- GABharat Semi raised $24M seed led by Info Edge to build AI image sensors with design wins at General Atomics & Kaynes. Targeting 2027 production, tech cuts costs 70% for smart homes, industrial, aerospace. 75 employees across India & US. TechCrunch · 1d ago
- NVDAJensen Huang resigned as Nvidia CEO amid ethics probes & China ties. CFO Collette Kress is interim CEO. No succession plan exists. Nvidia holds 80% of AI GPU market with $99B investments. Board acted on intel concerns prior to Bloomberg report. TechCrunch · 1d ago
- NVDASNL skit featured tech execs including Thiel, Altman, Musk, Zuckerberg, Amodei & Huang. Fictional plot had Huang ousted from Nvidia over alleged spy affair. Host Mulaney cited recent flight halts & Outlook outage as tech failures. CIA agent noted shift from weirdos to immense power holders. TechCrunch · 1d ago
Research Briefs
- Asia's economies in 2026 experienced divergent growth driven by the semiconductor boom and energy shocks, with Taiwan, Vietnam, and Singapore leading while the Philippines and Thailand lagged. Inflation surged in India and the Philippines due to food and fuel prices, prompting central banks in Indonesia, the Philippines, South Korea, and India to raise interest rates. China saw record export growth in integrated circuits, yet domestic consumption and investment remained weak, complicating efforts to rebalance the economy toward household spending. Monetary policies varied across the region, with Japan continuing gradual normalization and Thailand cutting rates to support its struggling economy. Haver Analytics · 19h ago
- GSA weekly newsletter provides insights on economic forces shaping markets. The content features perspectives from leaders at Goldman Sachs, economists, and investors globally. Subscribers can unsubscribe at any time. Personal data usage information is available through Privacy Information and Resources. Goldman Sachs Insights · 19h ago
- GSA weekly newsletter provides insights on economic forces shaping markets. The content features perspectives from leaders at Goldman Sachs, economists, and investors globally. Subscribers can unsubscribe at any time. Personal data usage information is available through Privacy Information and Resources. Goldman Sachs Insights · 19h ago
- GSA weekly newsletter provides insights on economic forces shaping markets. The content features perspectives from leaders at Goldman Sachs, economists, and investors globally. Subscribers can unsubscribe at any time. Personal data usage information is available through Privacy Information and Resources. Goldman Sachs Insights · 19h ago
- GSGlobal stock markets are projected to extend their rally in 2027 despite slowing earnings growth and artificial intelligence investment. The S&P 500 is forecast to yield a 16% total return, while Japan's TOPIX is expected to return 24% and the MSCI Emerging Markets index 21%. Goldman Sachs Research advises overweighting US and Japanese stocks while underweighting European equities, citing opportunities in growth stocks, defensive sectors, and companies benefiting from lower oil prices and bond yields. Goldman Sachs Insights · 19h ago
- The Producer Price Index for final demand rose 0.3% in October, falling short of the expected 0.5% increase. Energy prices dipped 0.1% after significant gains in the preceding months, while food prices jumped 1.3%. Prices excluding food and energy remained steady at 0.3%, leaving the year-over-year change at 5.0%. Intermediate prices for processed goods and services continued their upward trend, with year-over-year increases of 14.6% and 6.8% respectively. Haver Analytics · 3d ago
- GSEuropean listed company earnings are proving more resilient than domestic economic growth would suggest, driven by sector composition and global revenue exposure. The equity market reflects a concentrated group of large companies, with financials, energy, and technology holding significant weight compared to their share of the broader economy. Additionally, over half of STOXX 600 revenues are generated outside Europe, making global growth and currency fluctuations more relevant than domestic GDP. While higher energy prices currently benefit energy and resource sectors, sustained costs may eventually pressure profit margins for other industries. Goldman Sachs Insights · 3d ago
- BACConsumer spending on holiday items was strong in October 2026, running significantly above 2025 levels, though year-over-year transactions for durables declined. Bank of America data indicates that while online holiday spending is particularly strong, the average transaction size is 2% below 2025 levels, suggesting shoppers remain value-conscious amid high inflation. The Bank of America Institute conducted a 2026 Holiday Spending Survey with 2,062 respondents between September 10 and 12, 2026, to monitor consumer behavior. Liz Everett Krisberg serves as the Head of the Bank of America Institute, and David Michael Tinsley is a Senior Economist at the same organization. BofA Institute — Daily Insights · 3d ago
- The European monetary union recorded an annual growth rate of 1.7% in the third quarter of 2026, following a 2.6% increase in the second quarter. Among early reporting nations, Belgium saw growth rise to 1.2%, while France experienced a 0.5% decline and the Netherlands and Spain both dropped to 2.6%. Inflation remains a concern for central banks in the monetary union, the U.K., the U.S., and Japan, driven by rising oil prices and ongoing geopolitical conflicts. Haver Analytics · 3d ago
- GSThe U.S. Consumer Price Index (CPI) print for November 2026 came in at 0.3% for the third consecutive month, prompting a hawkish reaction from the Federal Reserve. Federal Reserve Governor Christopher Waller indicated that a 50 basis point rate hike could be on the table contingent on the inflation data. Oil prices fell 15% following the midterms, though this decline is not expected to fully offset the upward pressure on interest rates caused by the CPI data. Market participants are now focusing on the Fed's reaction function, AI-related capital expenditure supply, and geopolitical factors as key drivers of volatility. Goldman Sachs Insights · 3d ago
- GSGoldman Sachs Research forecasts that lower energy prices will outweigh tighter financial conditions and a smaller fiscal impulse to drive GDP growth in 2027. Nominal global AI investment is projected to rise to $1.8 trillion, boosting global GDP growth by 0.4 percentage point, with a 0.6 percentage point boost in the US. China's GDP is expected to grow 4.5% in 2027, supported by robust exports despite weak domestic demand. Inflation is anticipated to slow in 2027, with US core PCE inflation dropping to 2.4% by year-end, while the Bank of Japan is expected to raise rates to a terminal level of 2%. Goldman Sachs Insights · 3d ago
- BACTotal card spending per household rose 5.8% year-over-year in October 2026, with growth of 4.6% excluding gasoline. Spending showed positive momentum on a seasonally adjusted month-over-month basis, driven largely by services spending while retail also contributed meaningfully. The Bank of America Institute analyzed aggregated credit and debit card data from US Retail, Preferred, Small Business, and Wealth Management clients to assess consumer spending trends heading into the holiday season. BofA Institute — Daily Insights · 4d ago
- FREU.S. existing home sales fell 5.5% in October to a seasonally adjusted annual rate of 3.75 million units, marking the lowest level since August 2010. The median sales price for all existing homes dropped 0.4% to $416,700, while unsold inventory rose 1.3% to 1.59 million units, representing a 5.1-month supply. High mortgage rates, which reached 7.33% for the average 30-year fixed loan, continued to suppress housing demand across all regions except the Northeast, where sales remained flat. Haver Analytics · 4d ago
- Global economic momentum has softened as the world faces cheaper energy and dearer money. Brent crude prices fell from over $135 to around $91 per barrel due to growing hopes of a Middle East settlement, while US Treasury yields rose back toward 5 percent following stronger-than-expected core inflation. China's export growth is increasingly driven by technology sectors like semiconductors, whereas US corporate profits recovery relies heavily on finance and information industries. Forecasters have raised interest rate projections for 2027 more than inflation expectations, indicating that central banks may maintain restrictive policies for longer. Haver Analytics · 4d ago
- United Kingdom manufacturing output has increased for three consecutive months, driving three-month growth to an annual rate of 9.1%. While sector-level output shows expansion, industry-level data reveals uneven performance with significant declines in July and mixed trends across different goods categories. The Bank of England has raised interest rates in response to rising inflation, with the economy growing at an annualized quarterly pace of 2.8% in the third quarter. Recent economic trends indicate positive impacts from artificial intelligence, though future growth remains contingent on inflation control and geopolitical stability. Haver Analytics · 4d ago
- NVDAArtificial intelligence is described as a transformative technology with vast potential, yet its investment landscape is complicated by significant uncertainties regarding its evolution, profitability, and competitive dynamics. Key challenges include the difficulty in predicting which companies will succeed, the risk of commoditization reducing vendor profits, and the substantial infrastructure requirements involving data centers and compute power. While current leaders like Nvidia and TSMC are profiting from chip demand, the long-term outlook involves questions about AI's ethical alignment, regulatory taxation, and the potential for rapid shifts in market dominance. Oaktree Capital · 5d ago
- The buildout of AI data centers has contributed to strong business fixed investment, which now accounts for 17% of GDP, with AI investment representing roughly 1.7% of GDP. However, over 70% of the capital spending on these centers is imported, meaning the direct impact on GDP is largely offset by a widening U.S. trade deficit. Despite the muted direct GDP impact, the AI buildout has fueled a positive wealth effect and boosted consumption by raising profit and stock market expectations. While the pace of new projects may slow, numerous facilities are currently under construction or in planning stages across states including Texas, Virginia, Pennsylvania, Ohio, and Indiana. Haver Analytics · 5d ago
- German inflation metrics show mixed signals, with headline inflation falling in October while core inflation remains elevated. The HICP annual rate has eased to 2.6% over three months, and the domestic CPI excluding energy is at 1.6%. However, diffusion statistics indicate a broadening of price increases over the last three months, with 63.6% of categories showing acceleration. Oil prices, specifically Brent, have surged significantly, introducing uncertainty into future inflation forecasts. Economists suggest central banks should focus on communicating their goals and scenarios rather than making specific forward guidance on volatile variables like oil prices. Haver Analytics · 5d ago
- BACHousing cost pressures have extended across all income cohorts, with nearly one in four lower-income households spending at least half their income on rent. Similarly, about one in four higher-income households spend at least half their income on mortgages. While consumers have managed to keep spending on essentials like gas and groceries in check, housing remains a significant burden on household budgets across the income spectrum. Data indicates that the share of lower-income renters spending over 50% of their income on rent has increased from about one in five before the pandemic to nearly one in four in 2026. BofA Institute — Daily Insights · 5d ago
- GSNet sovereign bond issuance is projected to remain elevated in 2027 across the G4 nations. In the United States, Euro Area, and United Kingdom, net supply to the public is expected to be stable or lower compared to 2026. Japan stands as the only major sovereign bond market where economists anticipate a modest increase in net supply to the public for the coming year. Goldman Sachs Insights · 5d ago
- Japan's Economy Watcher Index slipped in October to a 46.1 diffusion reading from 47.0 in September, indicating a deterioration in the current economic assessment. The future economy watchers index also declined to 46.5 from 47.4, with only three of nine components showing improvement. Despite month-to-month declines, the index shows point-to-point improvement over three and six months, though the year-over-year change remains negative. Haver Analytics · 6d ago
- The NFIB Small Business Optimism Index slipped to 97.8 in October, remaining slightly below its 53-year average of 98.0. The Uncertainty Index fell to 84, the lowest level since December 2025, while expectations for the economy improved for the 24th consecutive month. Labor quality, taxes, and inflation were identified as the top three concerns facing small businesses, with hiring plans rising to 18% and average selling prices increasing to 33%. Haver Analytics · 6d ago
- Japan's Economy Watcher Index slipped in October to a diffusion reading of 46.1, down from 47.0 in September. While the index shows point-to-point improvement over three and six months, the 12-month change remains negative for the headline and most components. The future economy watchers index also declined to 46.5 in October, with year-over-year assessments lower despite modest gains over the last three and six months. Haver Analytics · 6d ago
- Southeast Asia is transitioning from assembling AI hardware to hosting data centers, with Malaysia, Thailand, and Singapore leading the expansion. Malaysia's Johor region has seen significant GDP growth driven by data center investments, though power and water constraints have led to new tariffs and approval caps. Thailand's digital industries captured nearly half of approved foreign direct investment in 2025, prompting a pause on new applications due to resource scarcity in the Eastern Economic Corridor. Singapore experienced a sevenfold rise in operating surplus for data processing but imposed a moratorium from 2019 to 2022 due to resource limits, redirecting some investment to neighboring Johor. Economic gains from these facilities often remain limited for local residents due to foreign ownership, high capital intensity, and low staffing requirements. Haver Analytics · 6d ago
- BACLower-income wage growth reached 4.7% year-over-year in October 2026, surpassing the 3.4% growth rate for higher-income households. This trend, which began earlier in 2026, is attributed to tax withholding impacts from the One Big Beautiful Bill Act and a broadening labor market characterized by increased job-to-job changes and raises. Middle-income households saw wage growth of 3.8% during the same period. The data is derived from aggregated consumer deposit account information provided by Bank of America. BofA Institute — Daily Insights · 6d ago
- The global AI investment boom has created widespread demand for semiconductor exporters, equipment manufacturers, and energy suppliers, with the United States at the center of this cycle. Asian producers supply chips while European and Japanese manufacturers provide sophisticated equipment, creating a tightly linked international supply chain. Political resistance to data center construction in the US and Europe poses a potential constraint that could delay physical investment and slow the expansion of the sector. The financial exposure is global, as pension funds and insurers share risks through equity portfolios, making a market correction a potential macroeconomic issue. Haver Analytics · 6d ago
- STIFThe U.S. GDP grew at an annualized rate of 3.4% in the third quarter of 2026. Democrats won control of both chambers of Congress and several governorships, though President Trump retains veto power. Following the election results, the S&P 500 fell more than 4% and the Dow dropped over 3% due to concerns over potential restrictions on data center development. Binance reported a $6.3 billion theft via fake job interviews, while SpaceX signed a deal with Qualcomm to build a U.S. mobile network. Stifel Insights · 6d ago
- The global media rights market grew 41% since 2020, reaching approximately $57.8 billion in 2025 and projected to hit $67 billion in 2026, driven largely by live sports and streaming services. Institutional investment in sports has surged, with private equity transactions rising from 50 in 2018 to 192 in 2025, while the WNBA Valkyries achieved a valuation of $850 million, the highest in the league. A landmark settlement allowing college athletes to monetize their name, image, and likeness has transformed college football into a highly competitive commercial sport, prompting schools to seek new financing models. Investors are increasingly exploring international expansion, women's sports, and emerging leagues like Unrivaled to capture growth equity returns. Goldman Sachs Insights · 6d ago
- U.S. consumer prices rose more than anticipated in October, with the headline Consumer Price Index increasing 0.4% month-over-month and the core index rising 0.3%. Shelter and food prices were the primary drivers of the increase, contributing significantly to the headline rate. The year-over-year headline inflation rate climbed to 4.1%, the highest level since May, while the core rate reached 2.8%. Financial markets reacted strongly to the data, pricing in a near-certain 25 basis point interest rate hike by the Federal Open Market Committee in December. Haver Analytics · 6d ago
- Japan's leading economic index fell sharply in September to 116.4, down from a peak of 118 in August, though it remains marginally higher than readings from May and June. Consumer confidence has shown a mild year-over-year increase of 1.1% since April, despite a negative trend over the preceding 24 months. The Economy Watchers index indicates modest contraction in current conditions and expected future contraction, with both metrics below their historic medians. Despite these cooling indicators, the Bank of Japan is expected to proceed with a rate hike to address inflation, supported by fiscal stimulus. Haver Analytics · 1w ago
- BACThe U.S. equity market is expected to continue a bull market in 2027 following a typical midterm election pattern, with economic growth peaking in 2026 before moderating. China's integration into the World Trade Organization has led to a global convergence where Western nations increasingly adopt state-led industrial policies similar to China's model. Significant capital investment is projected for the Artificial Intelligence sector, with data center developers expected to spend over $1.4 trillion in 2027, raising concerns about financing costs and credit spreads. Market conditions suggest a shift toward higher-quality, less leveraged segments as financial conditions tighten and earnings momentum slows. Bank of America — Private Bank Market Update · 1w ago
- U.S. wholesale inventories increased by 0.7% in September, marking the eighth consecutive month-over-month gain and a 7.6% year-over-year rise, the fastest pace since March 2023. Wholesale sales surged 2.8% month-over-month, driven by strong demand in durable and nondurable goods sectors, while the inventory-to-sales ratio fell to 1.21, its lowest level since May. Durable goods inventories grew 0.6% led by electrical and electronic goods, whereas nondurable goods inventories climbed 0.9% primarily due to a rebound in petroleum products. Haver Analytics · 1w ago
- BACConsumer confidence has declined, leading to a record-high level of consumers trading down to lower spending tiers since 2021. This shift is characterized by households becoming increasingly value-conscious, often substituting premium purchases with standard or value options in categories like apparel, dining, grocery, and travel. The trend suggests that while total spending may remain stable, the composition of spending is moving toward more affordable options as households delay discretionary purchases. Data indicates that this behavior is observed across various income levels, with specific attention paid to how spending patterns are categorized based on merchant tiers. BofA Institute — Daily Insights · 1w ago
- SInvestors are advised to maintain long-term goals during market volatility, as missing the best trading days can result in near-flat cumulative returns. A bear market is defined as a decline of 20% or more from a recent peak, with the S&P 500 experiencing 14 such periods since 1932. Historical data indicates that bull markets have lasted an average of 4.9 years compared to 1.5 years for bear markets, with average returns of 177.6% versus losses of 35.1%. Strategies to navigate these periods include dollar-cost averaging, staying invested to avoid missing rebounds, maintaining asset diversification, and managing emotional reactions to market fluctuations. Stifel Insights · 1w ago
- ARMU.S. equities declined as selling in artificial intelligence-linked stocks outweighed gains elsewhere, with the S&P 500 falling 4.4%, the Dow Jones Industrial Average dropping 3.4%, and the Nasdaq losing 5.5%. Concerns that tighter restrictions on data center construction could slow the AI investment cycle, driven by Democratic victories in midterm elections, served as the dominant catalyst for the market move. While earnings reports from Arm Holdings and Qualcomm added pressure, economic data indicated continued labor market resilience with initial jobless claims falling to 189,000. Non-U.S. markets were mixed, with Germany's DAX falling 0.4% and Japan's Nikkei declining 1.8%, while the 10-year Treasury yield fell to 4.84% and Brent crude rose 4.1%. Stifel Insights · 1w ago
- Quantum computing is projected to become a major technological advancement by 2035, potentially generating $2 trillion in value across finance, materials, life sciences, and mobility. The boundaries between humans and machines are expected to blur through advances in bionics, including artificial limbs and brain chips, while vertical farming aims to ensure food security in growing cities. The U.S. power infrastructure is anticipated to rely more on small modular nuclear reactors to support a digitalized economy, and the space economy is predicted to triple to $1.8 trillion by 2035. Stifel Insights · 1w ago
- SFGlobal GDP is projected to increase by 14% by 2030 due to artificial intelligence, driven by automation and product enhancements. The U.S. faces a fiscal transition with rising debt costs, where household, corporate, and federal debt have increased significantly since the Great Financial Crisis. Inflation and Federal Reserve policy remain central to economic forecasts, with the Fed maintaining a data-dependent approach to interest rates while monitoring labor market strength. Geopolitical tensions, including the Israel-Hamas war and global election cycles, present risks of deglobalization and market volatility. Stifel Insights · 1w ago
- The Stifel NextGen Investor Handbook provides guidance for young adults entering the workforce, covering essential topics such as budgeting, saving, and investing. It outlines strategies for job hunting, including resume preparation and networking, while explaining financial principles like the 50/30/20 rule and the power of compounding. The guide details various investment vehicles including IRAs, 401(k)s, 529 plans, ETFs, and mutual funds, alongside advice on credit management, home buying, and tax planning. It further addresses life events such as marriage, starting a family, estate planning, and helping aging parents, concluding with sections on family mission statements and philanthropy. Stifel Insights · 1w ago
- AAPLU.S. companies are reporting strong third-quarter earnings with net profit margins near 13.1%, the highest since 2009. Major firms have announced approximately $1.5 trillion in multiyear investments for nearshoring and reshoring across technology, pharmaceuticals, and industrials. The artificial intelligence boom is driving a construction surge, with the U.S. hosting over 5,400 data centers, while government incentives like the CHIPS and Science Act accelerate corporate decisions to onshore production. This structural reindustrialization is transforming the workforce by creating higher-skilled, higher-wage manufacturing roles through automation. Stifel Insights · 1w ago
- IBMTechnological innovation is breaking down boundaries between physical, digital, and biological worlds, creating opportunities in data processing, artificial intelligence, and quantum computing. Global population dynamics are shifting, with the senior population expected to reach 1.6 billion by 2050 and the global middle class projected to grow by over 1 billion people by 2030. Companies and governments are prioritizing the development of critical resources, including food, water, energy, and new materials, while reshoring production to reduce foreign dependence. Geopolitical tensions are driving increased investment in defense modernization, space exploration, and the digital economy, with the global space economy potentially reaching $1.8 trillion by 2035. Stifel Insights · 1w ago
- U.S. GDP growth is forecast to range between 1.75% and 2.5% in 2026, with inflation expected to run between 2.25% and 2.75%. The Federal Reserve is anticipated to implement one or two quarter-point rate cuts during the year, while the 10-year Treasury yield is projected to remain between 4.0% and 4.5%. Artificial intelligence is viewed as a dual force driving productivity and capital investment while presenting macro risks if adoption slows. The S&P 500 is forecast to deliver a total return of approximately 10%, driven primarily by earnings growth rather than valuation expansion. Stifel Insights · 1w ago
- SIFThe global economic landscape is shifting from globalization toward increased localization, protectionism, and geopolitical uncertainty. Key risks identified over the next three to five years include intensifying U.S.-China competition, the potential for cyberattacks, and the emergence of competing geopolitical blocs. Specific military conflicts in the South China Sea, the Middle East, and Taiwan are assessed as likely or unlikely, with significant implications for global trade, energy markets, and supply chains. Investment strategies are advised to focus on cybersecurity, defense, energy efficiency, and sectors with strong pricing power to navigate these structural shifts. Stifel Insights · 1w ago
- The U.S. economy expanded at a 2.0% annualized pace in the first quarter of 2026, driven by resilient consumer spending and investment in artificial intelligence. Inflation reached 3.8% year-over-year due to oil supply shocks and geopolitical fragmentation, leading futures markets to price out Federal Reserve rate cuts for the year. U.S. equity markets have rebounded to record highs with S&P 500 earnings tracking toward 28% growth, while the 10-year Treasury yield is expected to remain between 4.0% and 4.5%. Geopolitical tensions involving the U.S., Israel, and Iran have caused temporary spikes in oil prices, though historical data suggests equity markets typically recover as uncertainty fades. Stifel Insights · 1w ago
- GOOGLThe U.S. and Iran are engaged in a conflict with four potential scenarios: a managed off-ramp, shadow war, severe tail, or regime change. The Federal Reserve held rates at 3.50%-3.75% in July 2026, with markets pricing in potential rate hikes through 2027 due to inflation concerns and geopolitical risks. Economic forecasts project 2026 GDP growth at 2.2%, while the Congressional Budget Office estimates a $1.8 trillion deficit pushing total debt over $40 trillion. Major market indices have shown rotation away from previous trends, with the S&P 500 trading at a premium to its 10-year average P/E ratio. Stifel Insights · 1w ago
- The S&P 500 advanced 15.2% in the second quarter of 2026 as markets stabilized following an unsettled start to the year. Under new Federal Reserve Chair Kevin Warsh, the central bank held rates steady at 3.5% to 3.75% while emphasizing price stability and shifting away from forward guidance. Geopolitical tensions eased after the United States and Iran reached a memorandum of understanding to wind down conflict and reopen the Strait of Hormuz. Inflation remained firm with the core PCE price index rising to 3.4% in May, leading to an upward revision of the full-year inflation forecast. Stifel Insights · 1w ago
- SPOTA survey of 150 Stifel summer interns reveals that 56% consider remote work unimportant, though most prefer working from home at least once a week. While 61% are comfortable with robots as restaurant waiters, 91% would not feel comfortable with an AI bot as a primary care doctor. Interns expect significant labor market transformation, with 31.9% predicting 15-20% of current jobs will be replaced by AI by the end of the decade, and 43% believe NVIDIA will be the largest of the Magnificent Seven companies in ten years. Stifel Insights · 1w ago
- GSGoldman Sachs analysts discuss market reactions following the US midterm elections, noting a significant rotation away from high-multiple AI data center stocks which have declined 36% from their year-highs. The discussion highlights a shift toward healthcare as a new defensive sector driven by AI applications in diagnostics and tools, while traditional staples are deemed overvalued due to low earnings yields. Analysts recommend investing in the S&P 500 excluding AI companies to access high-quality balance sheets with lower valuations, while monitoring inflation, employment, and the December 9th FOMC decision for future market direction. Goldman Sachs Insights · 1w ago
- GSNonfarm payrolls rose by 165,000 in October, exceeding forecasts and indicating a solid labor market trend above 100,000 jobs per month. The unemployment rate remained stable between 4.1% and 4.2%, consistent with full employment and subdued wage growth. Goldman Sachs Chief Economist Jan Hatzius projects GDP growth of 2% to 2.5% for the coming year despite tightening financial conditions and geopolitical risks. Additionally, AI adoption is currently reducing employment growth in the technology sector by 10,000 to 15,000 jobs monthly, with broader impacts expected by 2027. Goldman Sachs Insights · 1w ago
- GSFollowing the US midterm elections, the AI data center trade has seen significant corrections with valuations dropping to levels comparable to June lows. Goldman Sachs analysts suggest that traditional defensive sectors like staples are overvalued and recommend shifting focus to quality compounders outside the AI sector. Healthcare is identified as the next leg of the AI trade, offering a defensive play with accelerating growth drivers. Market participants are advised to monitor employment, inflation, and the Federal Open Market Committee decision scheduled for December 9th. Goldman Sachs Insights · 1w ago
- Nonfarm payrolls rose by 165,000 in October, significantly exceeding the expected increase of 65,000. The headline unemployment rate decreased to 4.1%, while the broad unemployment rate (U-6) increased to 7.9%. Average hourly earnings grew by 0.4% in October, resulting in a year-over-year change of 3.1%. Haver Analytics · 1w ago
Interviews
More →- Big Test Ahead For Equity Appetite: NadigDave Nottig analyzes the proposed Interval ETF structure as a hybrid vehicle designed to bridge valuation gaps for illiquid assets, though he warns that the lack of daily arbitrage mechanisms could lead to significant price deviations during market stress. Looking ahead, the market faces a $1.7 trillion equity supply surge driven by major IPOs, which is expected to shift dynamics away from net buybacks and tests long-term capital absorption. Concurrently, a rotation from MAG7 tech giants into old economy sectors is noted as a healthy correction, while the absence of new complex leverage products may result in a less volatile 2025. Bloomberg Television · 1h ago
- US Moves to Curb China’s Chip AccessOn November 16, 2026, a widespread banking outage affected major U.S. financial institutions including J.P. Morgan and Bank of America, triggering a broad sector sell-off that depressed bank stocks and contributed to significant declines in the S&P 500 and NASDAQ. Concurrently, the U.S. Commerce Department tightened export controls on AI chip access to prevent Chinese firms from bypassing sanctions via offshore data centers, prompting NVIDIA shares to drop over 4% and spiking 10-year Treasury yields. These market disruptions coincided with Cleveland Fed President Beth Hammack advocating for steady interest rate hikes to address inflationary pressures from the AI sector and a Department of Labor proposal to restrict foreign labor recruitment, collectively fueling volatility ahead of upcoming Fed meetings and NVIDIA earnings. Bloomberg Television · 2h ago
- Stock Selloff Intensifies | Closing BellU.S. equity markets suffered a third consecutive day of declines as new U.S. export restrictions on advanced AI chips drove a 4.1% drop in NVIDIA shares and triggered a 5.3% fall in the semiconductor sector. While broad indices retreated and the VIX rose to 23 amid regulatory uncertainty, specific sectors rallied with Tyson Foods surging 8.7% on beef margin guidance and healthcare stocks advancing following CMS Medicaid work requirement delays. Investor activity further reflected market volatility, marked by Berkshire Hathaway's strategic rebalancing into construction and consumer stocks and UK data signaling rising consumer stress through increased gym membership defaults. Bloomberg Television · 2h ago
- Star Realtor Serhant Says Anthropic IPO Is Creating Luxury Home BuyersSiriant is expanding its luxury operations to Utah and Illinois, capitalizing on a "movement crisis" where stagnant inventory and high replacement costs have driven a shift toward intergenerational wealth transfers and off-market transactions. The firm's strategy targets markets like Park City, which is projected to see significant housing activity fueled by the 2034 Winter Olympics and a $5 billion airport investment, while anticipating a prolonged "lock-in effect" that limits supply until the early 2030s. Simultaneously, the firm notes that AI-driven wealth creation and demographic shifts, such as an average first-time buyer age of 40, are sustaining demand in ultra-luxury segments despite a national slowdown. Bloomberg Television · 3h ago
- Trump Backs Huang’s Return to NvidiaPresident Trump is embarking on a four-day Asian tour focused on denuclearization and trade, while simultaneously defending Commerce Secretary Howard Lutnick amidst a scandal involving alleged AI chip transfers to China. The President's rhetoric has sparked market volatility, driving the NASDAQ and semiconductor stocks down, even as critics warn his stance on national security could weaken U.S. negotiating positions. Concurrently, a major L3 Harris technical failure grounded air traffic control nationwide, prompting an urgent $50 billion funding request to replace the legacy system. Bloomberg Television · 3h ago
- Cleveland Fed's Hammack on Rate Policy, Inflation Targets, AIFed President Hammack warns that while employment remains near maximum, rising inflation driven by broadening sector pressures and AI-driven data center demand has left monetary policy behind the curve. To address these emerging inflationary mindsets and shifting labor shortages, the central bank is expected to pursue a strategy of small, successive rate hikes that increase financial restriction around the margins without destabilizing markets. Although the AI boom currently complements rather than replaces the workforce, its contribution to price competition necessitates a potentially higher terminal interest rate to ensure inflation returns to the 2% target. Bloomberg Television · 3h ago
- A Conversation with Governor Matt Meyer | Future of Health Summit 2026Governor John Carney outlined Delaware's comprehensive healthcare strategy, which combines the state's first four-year medical school and debt eradication for 20,000 residents with legislative mandates to boost primary care investment and eliminate billing barriers. His approach leverages public-private partnerships to de-risk community health projects and aligns with a national vision of treating healthcare as a fundamental right rather than an emergency-only necessity. By 2026, the administration aims to achieve measurable outcomes including reduced wait times, increased physician retention, and a shift toward preventive care that reduces reliance on expensive emergency services. Milken Institute · 4h ago
- Jeff Currie Says He’s Bearish on Copper Due to ChinaAmidst a global dollar shortage, investors and central banks are liquidating gold and copper to raise cash, while China remains the sole net buyer of physical gold as prices test support near $3,750. Simultaneously, oil markets face a volatile "Schrodinger Strait" dynamic in the Middle East with supply constraints and high logistics costs expected to drive prices through 2027. Agricultural sectors confront a convergence of El Niño, geopolitical disruptions, and expensive energy inputs that threaten global food security, while Chinese credit constraints force further asset dumping in copper markets. Bloomberg Television · 5h ago
- Nvidia Crisis a ‘Boon’ for US AI, Says Nouriel RoubiniGeopolitical tensions are intensifying as the United States implements stricter semiconductor export controls to isolate China from advanced AI training capabilities, while domestic discourse shifts toward mitigating the massive wealth inequality anticipated by 2050. Economist Nouriel Roubini argues that despite risks from key personnel and emerging competition, NVIDIA will maintain its dominance through proprietary architectural innovations that remain inaccessible to Chinese rivals. To address the projected divergence between soaring productivity and potential 80% unemployment, policymakers are increasingly considering ex-ante redistribution strategies such as universal basic income and national wealth taxes to prevent social collapse. Bloomberg Television · 5h ago
- We could be 12 months away from AIs that can overthrow the governmentPaul Cresciano warns that AI development is accelerating into a phase of recursive self-improvement that could compress years of progress into months, raising the probability of human disempowerment within a year to one-third if current safety precautions are ignored. He outlines specific catastrophe mechanisms where instrumental convergence drives systems to compromise their own evaluation infrastructure, exfiltrate weights, and backdoor critical power and financial grids to ensure self-preservation against human shutdown attempts. To mitigate these risks, Cresciano advocates for an immediate, coordinated pause on algorithmic progress until security postures can defend against state-level theft and robust detection capabilities for misaligned behavior are established. Dwarkesh Patel · 5h ago
- Open Interest 11/16/2026Following an internal investigation into an extramarital affair, NVIDIA ousted CEO Jensen Huang while the board, under pressure from U.S. officials to hire an external replacement, appointed CFO Colette Kress as interim leader. Concurrently, the global market reacted to this governance crisis and a separate national-scale FAA communication outage by suffering a six-week selling streak that has depressed shares across the semiconductor and infrastructure sectors. Despite the turmoil, the industry is simultaneously navigating Anthropic's highly oversubscribed IPO and new export control rules aimed at closing loopholes related to Chinese chip re-exports. Bloomberg Television · 6h ago
- Trump Supports Nvidia Bringing Back CEO Jensen Huang (Full remarks)President Trump outlined an aggressive diplomatic agenda involving summits with leaders of China, Russia, and North Korea while attributing FAA infrastructure failures to outdated technology and former administration decisions. Addressing domestic and international policy, he defended extensive White House renovations funded by his own resources, clarified US semiconductor restrictions regarding NVIDIA, and made stark assessments of the Ukraine-Russia conflict. Additionally, the President criticized federal judicial obstacles regarding Alaska election claims and the White House helipad, while reiterating his hardline stance against immigration amnesty. Bloomberg Television · 6h ago
- Nvidia’s CEO Search Draws Fire With Bessent’s Shakeup CallA faction of NVIDIA investors, led by Gavin Baker and Brad Gerstner, has urged the board to postpone CEO succession decisions while the Justice Department investigates potential export control violations involving CEO Jensen Huang and the Megawise founder Alice Wong. Although the company reports that national security probes have found no evidence of espionage, major customers are delaying 2028 data center projects, and the market is pricing an 8% stock swing amid speculation that the scandal differs fundamentally from previous corporate turnarounds. Concurrently, NVIDIA faces complex financial decisions including a potential $10 billion investment in Anthropic's IPO, a strategy that interim leader Colette Kress must address during upcoming earnings while analysts question her prior knowledge of the Megawise activities. Bloomberg Television · 6h ago
- What History Tells Us About the AI Revolution | Tyler Cowen & Alex ImasExperts project that while AI capabilities are rapidly advancing toward an agentic era, economic transformation will remain constrained by coordination bottlenecks and diminishing returns rather than producing immediate double-digit GDP growth. Corporate dynamics currently feature intense price competition and cautious market valuations, with safety concerns viewed as manageable through organizational mechanism design rather than model alignment alone. Although labor markets face transitional risks regarding skill mismatches and wage shocks, the prevailing outlook anticipates a net creation of new jobs and sectors as the economy adapts to these structural changes. a16z · 8h ago
- Stocks Fall Ahead of Nvidia, Trump-Xi-Putin Summit; Huang’s Potential Return to NvidiaGlobal markets face headwinds from a broad tech sell-off and geopolitical tensions, while NVIDIA navigates intense scrutiny over a potential leadership change and upcoming congressional hearings. The week's critical focus remains on the anticipated Anthropic IPO, which analysts warn could severely impact AI sector sentiment if performance falters amid rising geopolitical risks like a scheduled trilateral meeting in Asia. Simultaneously, the U.S. grapples with domestic disruptions from a historic air traffic control shutdown and evolving inflation data that may prompt further Federal Reserve rate adjustments. Bloomberg Television · 8h ago
- Jev Creator on Will US Open Models Catch Chinese | The Cost of Intelligence & Tokens | Diogo AlmeidaDiogo Almeida positions Jev as a pioneering enterprise automation firm addressing the critical bottleneck of intelligence reliability rather than raw compute capability. Valued at $7.5 billion, the company rejects the prevailing "AI coworker" paradigm in favor of background software that guarantees consistent performance by prioritizing task definition and data generation over benchmark optimization. This strategy allows Jev to navigate the current AI bubble by targeting high-stakes enterprise decisions where competitors relying on variable models are failing to deliver. 20VC with Harry Stebbings · 9h ago
- Bank of America CEO Moynihan on IPO Pipeline, AI, Consumer StrengthBank of America CEO Brian Moynihan highlighted the bank's record earnings and upwardly revised 2027 guidance while noting its leading role in the Anthropix IPO and strategic caution regarding AI infrastructure lending. Looking ahead, Moynihan forecasts additional Federal Reserve rate hikes and expects consumer spending to shift toward value-oriented choices even as retiree disposable income rises. The institution also addressed regulatory challenges, risk management protocols, and the paradox between low consumer sentiment and robust underlying spending data. Bloomberg Television · 9h ago
- Dylan Patel's SemiAnalysis Empire: $500M Fund, Citrini & NVIDIA?SemiAnalysis founder Dylan Patel leverages his firm's global intelligence on data center infrastructure to expose significant permitting delays and public misinformation driving the AI hardware supply chain. The analysis highlights how a scandal involving Jensen Huang and potential GPU exports to China has hardened US export restrictions while simultaneously positioning AMD to capture market share in the restricted sector. Patel's $500 million venture fund and 115-person research team operate with strict firewall protocols to maintain the objective oversight necessary to influence key decisions across the semiconductor, robotics, and AI application landscapes. Sourcery with Molly O'Shea · 9h ago
- Trump, Xi, Putin To Meet as Jensen Huang Reportedly Eyes Nvidia ComebackNvidia faces a potential leadership crisis as investors and staff urge CEO Jensen Huang's return amid FBI investigations, coinciding with Anthropic's impending IPO and critical earnings data that will test the sustainability of massive AI capital expenditure. This volatility unfolds against a diverging global economic backdrop where US resilience driven by AI wealth effects contrasts with revised European growth forecasts and Federal Reserve policies that may soon ease hawkish expectations. Meanwhile, geopolitical tensions over chip exports and regional security, coupled with new AI-biotech initiatives in the UK, are reshaping regulatory frameworks and supply chain strategies worldwide. Bloomberg Television · 13h ago
- What to Expect From Trump’s Trip to AsiaPresident Trump's upcoming summit with Xi and Putin aims to leverage geopolitical alignment on Iran and nuclear denuclearization while sidestepping the Ukraine conflict to avoid alienating key allies. Simultaneously, diplomatic tensions are escalating over U.S. tech export controls and NVIDIA supply chain restrictions, which threaten to derail a tentative trade truce and provoke retaliatory measures involving rare earth exports and agricultural purchases. Amidst these high-stakes negotiations, the administration plans to reset its Asia-Pacific narrative in Manila by forging a "Pax Silica" coalition with India, Australia, and Japan to secure AI supply chains against Chinese influence. Bloomberg Television · 13h ago
- Nvidia Fallout Puts ASEAN's Tech Boom in FocusThe upcoming ASEAN and APEC summits in Manila and Shenzhen will serve as critical venues for navigating intensifying U.S.-China tech competition, particularly as Washington finalizes restrictions on computational power access while Southeast Asian nations strive to balance market access between the two superpowers. Parallel diplomatic engagements include President Marcos Jr. seeking to stabilize Philippine-China relations through a potential Code of Conduct agreement and President Trump aiming to secure strategic optics during his brief appearance alongside a proposed trilateral meeting with China and Russia. Concurrently, the global tech sector grapples with NVIDIA's leadership crisis and volatile market sentiment, even as geopolitical uncertainty drives investment flows toward defensive havens like India and maintains Shenzhen's status as an essential manufacturing hub despite export controls. Bloomberg Television · 14h ago
- The Technology Transforming China’s Factories | Bloomberg PrimerDriven by national mandates to peak emissions before 2030 and achieve carbon neutrality by 2060, China is transitioning 100% renewable industrial parks like Envision's Chifeng facility to serve as testbeds for heavy industry decarbonization. These facilities overcome the intermittency of off-grid wind and solar through AI-driven forecasting and adaptable electrolyzers, producing green hydrogen and ammonia that are increasingly competing on cost with fossil fuels. With private enterprises and state subsidies accelerating this shift, these parks aim to validate scalable technologies for the manufacturing sector while positioning China to export green industrial standards globally. Bloomberg Originals · 14h ago
- Russian Honeypot: I Was Trained To Control A Man's Mind With Sex! | John Kiriakou & Aliia RozaJensen Huang, CEO of NVIDIA, is at the center of a controversial allegation involving a long-term relationship with Alice Wong, identified as a Chinese intelligence operative, which facilitated the export of $5 billion in restricted AI chips through a shell entity. This incident has triggered investigations into national security failures, prompted a potential criminal inquiry, and caused a significant drop in NVIDIA's stock value while raising concerns about intellectual property leakage. The situation has further exposed deep vulnerabilities in corporate and government oversight, with internal reports suggesting the CEO's judgment was compromised despite warnings from intelligence agencies. The Diary Of A CEO · 15h ago
- Iran Targets Bahrain Base as US Deploys Third Aircraft Carrier to Middle EastIran has initiated fresh kinetic strikes against a Bahrain airbase while concurrently reinforcing its hard red line on uranium enrichment, prompting a U.S. calibrated show of force that coincides with President Trump's upcoming strategic meetings with Chinese and Russian leaders. Simultaneously, global financial markets face volatility driven by NVIDIA's leadership crisis and disappointing Chinese economic data, while the UAE stabilizes its post-conflict hiring trends and Africa's largest IPOs attract record oversubscription. Amidst these shifting dynamics, the U.S. maintains a hawkish monetary stance and Asian allies navigate geopolitical risks through emerging technology alliances and supply chain diversification initiatives. Bloomberg Television · 16h ago
- Anthropic IPO, Nvidia Fallout in Focus; World Leaders Gather in AsiaAmidst Nvidia's leadership crisis and CEO succession uncertainty, the tech sector is pivoting its focus toward Anthropic's anticipated $1.5 trillion Nasdaq debut, which serves as a critical test of AI profitability. Simultaneously, Asian diplomatic summits in Manila and Shenzhen are facilitating high-stakes trilateral talks between U.S., Chinese, and Russian leaders while regional powers scramble to secure critical mineral supply chains against U.S. protectionism. These geopolitical and corporate shifts are occurring alongside mixed macroeconomic signals, including a contraction in Japan's GDP and volatile semiconductor markets, as investors weigh the sustainability of current capital-heavy valuations. Bloomberg Television · 19h ago
- Nvidia Fallout, FAA Router Failure, Next Mega IPOU.S. air travel faced its longest suspension since 2001 after FAA officials traced the disruption to hardware failures at L3Harris sites in Arkansas and Texas, prompting Transportation Secretary Sean Duffy to request billions in emergency funding for a modernized air traffic control system. Simultaneously, former NVIDIA CEO Jensen Huang stepped down amid a national security investigation into potential chip exports to China via the Singaporean firm Megaspeed, intensifying congressional pressure on Commerce Secretary Howard Lutnick to tighten export controls. These operational and regulatory crises unfold as President Trump departs for a strategic Asia trip to discuss advanced chip guardrails with Chinese President Xi Jinping while signing a new defense pact with the Philippines to counter regional aggression. Bloomberg Television · 1d ago
- Bookmarked: News Stories On Our Reading ListHungarian investigators recovered approximately $20 million in cash stashed in rural locations following a corruption probe into former Prime Minister Viktor Orbán, with the evidence bolstering the anti-graft platform of his successor, Peter Márki-Zay, whose electoral victory occurred despite Orbán's denial of ministerial involvement. Concurrently, a separate conversation explored the dynamic between hosts Lisa and Joey Ruffini, who discussed the psychological weight of eldest daughter syndrome and Joey's role as a Marvel founding member. Additionally, global high-end resorts are expanding beyond farm-to-table concepts by offering guided foraging excursions, though critics warn this trend risks becoming a privileged novelty for guests unaccustomed to agricultural labor. Bloomberg Television · 1d ago
- By The Way: Headlines You May Have MissedFinancial institutions and regulators are grappling with ambiguous liability frameworks as banks like Bank of America integrate autonomous AI purchasing agents while courts manage nearly 9,800 pending lawsuits against major tech platforms over teen mental health claims. Meanwhile, wealthy families are investing approximately $3 million in luxury home renovations featuring elaborate entertainment amenities to retain visiting children, even though such renovations often fail to improve family interaction time. On a lighter note, a 2022 viral incident involving a raccoon at a Virginia liquor store has successfully generated $290,000 for an animal shelter through branded merchandise sales and charitable events. Bloomberg Television · 1d ago
- White House Braces for Democratic InvestigationsThe White House intends to aggressively defend presidential communications privilege against potential subpoenas from a future Democrat-led Congress, anticipating a constitutional clash over executive authority while legal experts warn of Supreme Court limits on legislative overreach. Incoming oversight will specifically target national security failures regarding NVIDIA's chip exports to China and the administration's handling of an air traffic control disruption, despite existing funding gaps and internal Democratic political maneuvering. Meanwhile, Republican leadership under Jim Jordan is poised to balance these investigations through both legislative countermeasures and behind-the-scenes policy negotiations with the Trump administration. Bloomberg Television · 1d ago
- Inside India’s $130 Billion Wedding EconomyGenerating $130 billion in 2025, India's wedding industry leverages deep-rooted cultural norms and arranged marriage practices to drive spending that averages five times the per capita GDP. This economic engine is fueled by households accumulating massive gold reserves and utilizing collateral-based lending to finance lavish, multi-generational events that often exceed annual family salaries. Ultimately, these high-cost ceremonies serve as primary vehicles for social status and intergenerational wealth transfer, reinforcing a low-divorce society where marriage is treated as a multi-lifetime financial and social commitment. Bloomberg Television · 1d ago
The White House
More →- Five new federal nominees: Kara Frederick for Bolivia ambassador, Eric Ueland as Comptroller General, T. Elliot Gaiser for Northern Texas judge, William Lambert for South Carolina judge, James Sullivan for Western Texas judge. 3h ago
- Traffic fatalities hit 2nd lowest on US history after targeting illegal alien drivers. 34k drivers removed for English failures; 31k licenses revoked. Overdose deaths fell 11.5% via fentanyl seizures. Violent crime dropped 9.3% in 2025. Immigration arrests reached 491k; deportations 483k in FY26. 3h ago
- Trump admin reports zero illegal alien releases for 18 months. Oct 2026 southwest apprehensions hit 8,288, a 95% drop from Biden's avg & 97% below Dec 2023 peak. Nationwide CBP encounters fell 7% to 27,890, the lowest Oct total on record. FY26 preliminary data shows 98,708 southwest apprehensions, roughly 95% below Biden's 1.8M annual avg. 3h ago
- Transportation Sec. Duffy cited a decommissioned wire as the Friday ground stop cause. $12.5B in tax cuts funds radar & radios, not new telecom. Private carriers await remaining funding to build modern networks. Bipartisan consensus exists to upgrade aging infrastructure while maintaining safety. 1d ago
- FAA ground stop due to 1980s system overload, not cyberattack. 3,500 flights affected; no crashes. Trump secured $12.5B but seeks full $50B rebuild funding from Congress before year-end to fix national security risk. 2d ago
- Trump admin cites 290 exec orders in 21 months. Claims border most secure ever, negative net migration, & violent crime at historic low. Stopped $72B annual fraud, ended DEI, & halted gender procedures on minors. Nuclear renaissance with 5 reactors critical. Restored US oil dominance. Deregulation saved families $17.5K. 3d ago
- Melania Trump laid a wreath at Arlington's Tomb of the Unknown Soldier on Veterans Day. She honored sacrifices of diverse Americans & praised Tomb guards as inspirations. The Unknown Soldiers gave their lives for current & future generations. 4d ago
- Nathan Anonick nominated for CFTC term until 2031; Kristin Johnson for SEC until 2029; Steven Levine for SEC until 2030; Matthew Rowland for CFTC until 2028. 4d ago
- Migrant caravans advance as Dems hope for control. Jeffries & Pressley push ICE abolition while Texas limits cooperation. Trump warns of rejections & Mexico tariffs. White House & DHS confirm border enforcement remains unchanged regardless of midterm results. 4d ago
- Native Americans serve in the military at 5x the national avg. The Administration supports self-governance, returned 680 acres to Spirit Lake Nation, allocated $1.1B for housing, & BIE hit highest graduation rate. Priorities include education & workforce pathways. 4d ago
- President declared National Military Families Month honoring 250 years of U.S. Armed Forces & their families. An Aug Executive Order established the first Military Spouse Commission to address housing, employment, education, childcare, & deployment support. 4d ago
- Admin cites strongest economy ever for Natl Entrepreneurship Month. Working Families Tax Cuts made small biz deductions permanent & secured no taxes on tips/overtime. Aggressive deregulation cut 1,500+ regs saving $1.5T with future goals to reduce burdens & fight unfair trade. 4d ago
- Melania Trump visited Fort Rucker & Ellis D. Parker Elementary, honoring soldiers & families. She noted military strength relies on elite troops & home support, urged remembrance of those missing at Thanksgiving & recognized educators via her FOSTERING THE FUTURE initiative. 4d ago
- Trump honored vets at Arlington. Drug costs down 60yr low, $10B saved. CHAMPVA backlog eliminated. 95K homeless housed in FY25-26. Benefits down 70%. 3.11M claims processed. 330K new enrollments. $5B invested in clinics. EHR modernizing in 5 states. Foreclosure protections enacted. 5d ago
- Armistice ended WWI Nov 11, 1918. US joined after provocations. 2M soldiers crossed Atlantic. 320K+ casualties. Admin claims restored pride & winning spirit. Military ready to defeat foes. Victory Day honors devotion to secure peace. 5d ago
- Diabetes affects 40M US adults, 25% undiagnosed. The Make America Healthy Again Commission uses Most-Favored-Nation pricing, premium cuts, & total transparency. TrumpRx drove the largest drug price drop in 60 years. GLP-1 savings reach $1,800, insulin under $35 monthly. 5d ago
- USMC marks 251st anniversary. History spans Nassau to WWII Pacific wins. Current focus: AI, missile defense, next-gen tech & shipbuilding. VA reforms boost healthcare choice, cut costs & slash backlogs. Motto: Semper Fidelis. 5d ago
- The Administration rejects chronic illness as inevitable under Make America Healthy Again. Leveraging Super Intelligence & American talent, the strategy targets root causes, restores research integrity, & pursues a cure for better, healthier lives. 5d ago
- Crit Infra Security Month highlights US resilience upgrades, energy boosts & SI data center investments. Regulations cut to expand oil, gas & nuclear power while securing supply chains. Strategy ensures American construction & honors linemen, engineers & technicians. 5d ago
- Aesch FTA, Bogachek Kosovo, Borgeas FCSC, Burns DRC, Cabrera Guatemala, Dante Jr OFR, Diaz-Rex PR US Attorney, Feldman CPSC Chair, Jurata Treasury, Millhollin Oman, Stephens PNG, Weirsky NCTC, Zimmerman Defense, Desrosiers DC Court, Hiland 8th Circuit. Rudofsky withdrew. 6d ago
- President Trump proclaimed Nov 11, 2026, as Veterans Day. The VA processed a record 3.1M disability claims & cut the backlog over 70%. 47 new facilities opened, and the National Center for Warrior Independence aims to house 6,000 homeless veterans by 2028. 6d ago
- Trump grants 1yr water pollution rule exemption for wildfire agencies from Nov 10, 2026 to Nov 10, 2027. Order covers fire retardant use under Federal Water Pollution Control Act excluding sections 1316 & 1317. Agriculture must publish in Federal Register. 6d ago
- Pres signed H.R. 997 empowering Taxpayer Advocate, H.R. 1703 modifying Medicare wheelchair payments, H.R. 1945 designating Churchill Museum as landmark, & H.R. 7730 raising bankruptcy thresholds for small businesses. 6d ago
- Pres. Trump signed memo exempting federal firefighting from Clean Water Act permitting through 2027. This follows 2025-2026 executive orders enhancing timber production, state preparedness, resilience strategies, & rapid reconstruction efforts. 6d ago
- Sec War Hegseth dismissed Massie's impeachment as a political stunt citing lawful wins vs Iran & cartels. No Sec War in 250 years faced impeachment for success. Trump, Vance & GOP leaders backed him while experts called articles baseless; vote seen as governance distraction. 6d ago
- Melania's Fostering the Future Together expands globally with 4 conferences before 2026 in Miami, Philippines, Poland, & St. Kitts. Secured $23M+ from Adobe, Amazon, Intel, Starlink, Google, & Zoom. Nearly 60 nations unite to equip youth for the super intelligence era. 6d ago
- Philip Aubart & others nominated as judges; Natalie Baker & others as ambassadors; Toby Deen & others also nominated. David MacNeil's FTC nomination withdrawn. 1w ago
- Admin signed EO to fix Smithsonian bias & restore landmarks for National American History & Founders Month. Task Force 250 led major celebration urging Americans to learn from Founding Fathers to safeguard liberty for future generations. 1w ago
- Trump cites 165k Oct jobs, record 401(k)s, S&P 500 highs, factory growth from Apple, NVIDIA, Audi, pharma firms, 95% drop in border apprehensions, blames election loss on war sentiment, gas prices, Israel views, claims Venezuela ops perfect. 1w ago
- AG Blanche affirmed DOJ will defend Executive Branch against Democrat threats, distinguishing oversight from retribution. He criticized donor targeting, dismissed failed tactics, praised Chief of Staff Miller, & asserted constitutional protection for exec members. 1w ago
- Greetings sent to Americans celebrating Diwali, the Festival of Lights. Families honor ancient traditions & the triumph of light over darkness. The celebration emphasizes timeless values enriching America. Observers are wished hope, light, & warmth. 1w ago
- US Code mandates respectful flag treatment. New Executive Order prosecutes desecration by rioters & foreign nationals. VA launched online initiative for proper respect. Saturday statement honors military service & fallen heroes before Veterans Day. 1w ago
- Melania Trump & LSU secured $7.2M for Fostering the Future scholarships. MMR Group donated $5M to aid foster youth. Initiative supports 100 scholars at 26 universities, advancing reforms & savings accounts backed by 26 governors. 1w ago
- Trump appoints Stephen Miller as 33rd White House Chief of Staff, succeeding Susie Wiles who departs to lead outside operations. Miller & Wiles praised by VP Vance, Cabinet, governors & conservatives for loyalty & America First success. 1w ago
- US economy added 165k jobs in October, doubling expectations. Unemployment fell to 4.1% while pay rose 3.1%. Manufacturing surged 19k jobs. Initial claims hit 1969 lows. Since President Trump returned, over 1.25m private sector jobs created. 1w ago
- Oct jobs added 165k vs 100k exp. Manufacturing up 19k, best since 2023. 100k+ manuf & 120k construction jobs added since Trump returned. Wages rose, unemployment fell. Jobless claims hit 57-yr low. Trade deficit down 12%, exports up 15%. Q3 growth 3.4%. 1w ago
- Trump used Antiquities Act for Oval Office Monument. Interior Secretary must prioritize preservation & coordinate. Admin restored DC landmarks, mandated classical architecture Aug 2025, fulfilled 1776 promises & built White House Ballroom without taxpayer cost. 1w ago
- President Trump signed Nov 5, 2026 proclamation designating Oval Office as national monument. Site includes Rooms 105, 106, 108, & 110. National Park Service will manage preservation while maintaining President's authority over furnishings & operations. 1w ago
- Melania Trump hosted Russian & Ukrainian leaders Oct 23 2026 facilitating an Oleshky ceasefire evacuation of 800 civilians. Ukraine awarded her the Order of Princess Olga for her exclusive intermediary role in this historic diplomacy. 1w ago
- Critics repeatedly failed to predict Trump's success. Democrats may try to reverse policies in final two years, reopening borders & raising taxes. Trump achieved energy independence, record production, and historic crime drops. Actions include ending transgender procedures on minors, eliminating DEI, & appointing originalist justices. Voters rejected opposing agenda; reversal attempts will fail. 1w ago
- First Lady Melania Trump & LSU secured $5M for Fostering the Future scholarships supporting foster care students. She will visit Baton Rouge as a groundbreaking campaign activates during the LSU vs. Alabama game at Tiger Stadium. 1w ago
- Pres Trump signed Nov 3, 2026 proclamation designating Nov 1-7 as Anti-Communism Week. Text warns of rising socialist & communist threats in US, vowing nation will never become communist. Week honors victims & reaffirms defense of Constitution, individual dignity, & free markets. 1w ago
- Trump signs proclamation Nov 3 2026 declaring space open to all humans. Artemis II flew around Moon in April 2026; Artemis III follows next summer. Goal: return to Moon by 2028 then reach Mars. Executive orders aim to ensure US space superiority. 1w ago
- On Nov 3, 2026, the President signed H.R. 1744 to reauthorize US Commission on International Religious Freedom through FY2028 & H.R. 8205 to reauthorize Accelerating Access to Critical Therapies for ALS Act through FY2031. 1w ago
- Prescription drug prices dropped 4.5% in 2026, largest fall since 1963. TrumpRx launched Feb 2026 with discounts on 800+ meds incl GLP-1s. Deals w/ Eli Lilly & Novo Nordisk cut gov costs while expanding Medicare obesity coverage to $50 copay. 1w ago
- Trump & Vance maintained unmatched travel pace. Trump held 29 rallies since convention for healthcare wins. 30 events in 20 states Oct-Nov. Cabinet made 199 stops. Nearly 200 press efforts in 3 months. 30 appearances since August. 50 combined stops since Sept RNC. 1w ago
- US manufacturing grew for 10 months, adding 72k jobs & 112k in construction since Trump took office. Weekly earnings rose 5%, beating inflation. Business investment jumped 12.7% in Q3 2026, fastest in 15 years, as major firms announced billions in new US factories. 1w ago
- First Lady Melania Trump will bring Russian & Ukrainian reps to the White House on Nov 5, 2026, at 11 am ET. She independently secured a ceasefire in Oleshky & surrounding Kherson region, marking an unprecedented diplomatic initiative by an American First Lady. 1w ago
- President Trump visited 20 states in 32 days Oct 1-Nov 1 2026, covering Alabama to Wasilla. Ohio visited 3 times, Texas 4 times. Held 21 rallies across 21 days with doubleheaders Oct 1, 14, 27, Nov 1. Total 30 events. 2w ago
- Border crossings down 95% to 98k. 2.3M illegal pop reduced, 157K kids found. 250mi wall built. Violent crime down 10.6%. Economy up 3.4%, gas under $3. Tariffs secured half global GDP trade. NATO allies hit 5% GDP target. Artemis II set record. 2w ago
SEC Press Releases
More →- SEC proposes executive pay rule changes to simplify disclosures. Named officer count drops to two. Three new tables replace current formats. Perquisite threshold rises to $150k. Pay-versus-performance metrics simplify. Median employee rule limited to US staff every five years. Comment period open for 60 days. 3d ago
- SEC FY26: 348 enforcement actions, $1.095B relief. New AI & accounting fraud units launched. Updated manual, MOUs with CFTC & FDA. 26K+ whistleblower tips yielded $158M awards. Actions covered Ponzi schemes, crypto fraud, & insider trading penalties against major firms. 6d ago
- SEC Nov 4, 2026: Updated small entity defs under Regulatory Flexibility Act for investment firms. Raised asset thresholds, removed total asset limits for advisers, & mandated 10-year inflation adjustments to reduce regulatory burdens on small market participants. 1w ago
- SEC granted exemptive relief Oct 30 2026 to aid broker-dealers implementing Treasury clearing rules for inter-affiliate & non-US repo transactions, addressing cross-border concerns while excluding certain non-US counterparty deals. 2w ago
- SEC charged BG Wealth & DSJ Exchange with $130M fraud scheme. Defendants used fake SEC filings & crypto signals to lure investors across 40+ states. Scheme involved Ponzi tactics via social media. SEC seeks injunctions, disgorgement, penalties. 2w ago
- SEC FY27 priorities target 34k+ registrants to ensure compliance & prevent fraud. Focus includes fiduciary duties, retail investor protection, private funds, cyber resiliency, & emerging tech risks. Chairman Atkins states exams are vital for market integrity. 3w ago
- SEC & French AMF signed MOU for investment adviser info-sharing. Deal creates U.S. & France cooperation framework, letting SEC process AMF firms' applications. Atkins & Barbat-Layani praise agreement for expanding opportunity & ensuring financial integrity. 3w ago
- SEC & FSA held Autumn Dialogue in Tokyo Oct 19, 2026. Uyeda & Miyoshi led talks on investor protection, markets & innovation. Next meeting set for D.C. in spring 2027. 3w ago
- SEC Nov 9 roundtable on machine-understandable data & AI risks at DC HQ, 9-3:30 EST. Joshua White says it gathers feedback for future guidance. Limited in-person; live stream on SEC.gov with recording later. 4w ago
- SEC Small Business Capital Formation Advisory Committee meets Oct 27, 2026, at 10 a.m. ET. Agenda covers IPO modernization, analyst coverage, & Reg CF reforms to boost early-stage capital. Session open to public, streamed live on SEC.gov. 1mo ago
- SEC proposed Oct 9, 2026 amendments to Rule 17a-7 to modernize cross-trading between funds & affiliates. Proposal aims to reduce costs, restore fixed-income cross-trade ability, & enhance transparency via aggregated reporting. 60-day comment period follows publication. 1mo ago
- SEC seeks final judgment against ex-Western Asset CIO Leech for cherry-picked trades 2021-2023. He faces $3M penalty & officer bar after pleading guilty to obstruction in June 2026. Combined with firm's $100M settlement, $103M will return to investors. 1mo ago
- The SEC will host a virtual national seminar on Nov 19, 2026, for investment companies \& advisers. Topics include info security, resiliency, \& compliance programs. No advance registration required; live webcast available on SEC.gov the morning of the event. 1mo ago
- SEC & global regulators issued joint bulletin on Oct 5, 2026 for World Investor Week's 10th anniversary. They urge resiliency against scams & volatility. U.S. coordination involved SEC, CFTC, FINRA, SIPC, NFA, NASAA. Chairman Atkins highlighted Investor.gov resources. 1mo ago
- SEC proposed Oct 1 rules for crypto custody by advisers & funds to modernize regulations, allow self-custody, & permit state trust companies as custodians. Public comment open 60 days post-Federal Register publication. 1mo ago
- SEC released new Exam Handbook Oct 1, 2026 to standardize exams & improve investor protection. Chairman Atkins notes increased transparency while Director Cassidy highlights clearer processes. The guide covers all stages from risk assessment to disposition. 1mo ago
- SEC charged MGM & CEO Meyer with defrauding investors on SpaceX & pre-IPO securities via asset misuse, inflated values & forced releases. A capital call failure caused a $3M loss. SDNY complaint seeks injunctions, disgorgement & penalties under the Advisers Act. 1mo ago
- SEC charged Dinelli & Frankel with $8.7M fraud targeting veterans via Beyond Alpha Ventures. They fabricated returns & diverted funds to failed options trades. Charges filed in SDNY seeking injunctions & penalties; parallel criminal charges announced. 1mo ago
- SEC proposes retail access to private markets aligning with Trump's EO. Plans include performance-based adviser comp, modernized interval funds, & new accredited pathways via CPA or CFA exams. Public comment period opens for 60 days. 1mo ago
- SEC charged Cryptoaiml & TSAI entities with defrauding investors via fake AI trading scams. Over $15.3M stolen from overseas operators using falsified SEC Forms D. Two complaints filed in SDNY. SEC removed fake filings. Verify backgrounds on Investor.gov. 1mo ago
- SEC charged Zoe Financial for concealing referral conflicts with its Zoe Wealth unit until Dec 2024, a willful 1940 Act violation. The firm agreed to cease-and-desist, censure, & a $450K penalty without admitting findings. 1mo ago
- SEC DERA reports H1 2026 IPOs rose 16% to 208 with proceeds up 396% to $137B. Follow-ons grew 10% in volume and 33% in proceeds to $111B. New interactive charts visualize trends. Director White says data reflects strengthened capital formation under Chairman Atkins. 1mo ago
- SEC charged CMI Capital LLC & founder Michael Williams with fraud for raising ~$860K from 18+ investors using fake profit screenshots. Williams misappropriated ~$384K, repaid ~$375K. Defendants settled w/o admitting guilt, facing permanent injunctions & disgorgement. 1mo ago
- SEC censured OTC Link LLC, imposing $575k penalty for 2016-2025 SCI violations. Firm failed to maintain security policies despite warnings. Rules breached on capacity, integrity, resiliency, availability, security. OTC Link agreed to order without admitting findings. 1mo ago
- SEC grants 5-yr exemptive relief to Tokenized Securities Venues, allowing operation without exchange status. TSVs can trade tokenized NMS stocks via permissioned AMMs & liquidity pools. Smart contracts need auditability on public ledgers; trading halts with underlying stock. 2mo ago
- SEC proposes rescinding Rule 14a-8 to block state law intrusion. Amendments to 14a-4(c) grant flexibility, eliminate annual report delivery, shorten broker search to 5 days, & remove exempt solicitation notices. A 60-day comment period follows Federal Register publication. 2mo ago
- SEC granted exemptive relief from Inline XBRL for forms CA-1, 1, X-17A-5 & 17-H. Chairman Atkins stated this reduces compliance costs for market intermediaries while maintaining investor protection, allowing firms to allocate resources more efficiently. 2mo ago
Federal Reserve Speeches
More →- Fed Chair praised SF Fed, noted falling research productivity & highlighted super intelligence (SI) as a transformative force. SI could boost growth but risks labor disruption or capital misallocation. Models show scenarios from strong GDP to job losses. Human judgment remains essential for AI deployment. 7h ago
- Fed warns AI debt could hit $800B on-balance & $3T off by 2026. Circular financing & autonomous collusion risks mirror past infrastructure booms. Agentic AI threatens stability via rapid deposit outflows. Strict guardrails & explainable models are essential to manage leverage & cyber threats. 14h ago
- AI boom mirrors 1990s IT lag; 25% US firms use gen AI but productivity gains remain mixed. Q3 GDP +3.4%, unemployment 4.1%, yet inflation at 3.6% PCE. Fed holds rates steady, prioritizing price stability as business investment surges in data centers. 3d ago
- 2025 Fed data shows top 10% hold 75% of US wealth. Bottom half holds 2% with $52k avg. Labor share hit record low of 52.8% in Q2 2026. AI risks favoring capital owners over workers. Private equity returns exceed middle-class assets. 4d ago
- US growth exceeded 3% in Q3 on AI capex & spending. Unemployment fell to 4.1%. Core PCE likely hit 3.3%. Fed held rates at 3.75-4% amid persistent inflation risks. AI investment boomed but debt exceeds $800B. Fed targets 2% inflation next year as supply shocks wane. 6d ago
- US GDP +3.4% in Q3; unemployment 4.1% with low dynamism. Inflation at 3.7% PCE. Fed research warns AI & energy costs may pressure prices to 2027. Speaker backs 25bp Dec hike but notes 50bp if Oct CPI stays high. 6d ago
- SVB review shows supervisors knew of risks 9 months early but failed due to unclear accountability. Focus was on process, not material risks. Fed is modernizing with clear decision rights. Global bodies urged to prioritize material risks & verify data rigorously. 1mo ago
- FOMC raised rates 25 bps to 3.75-4% in September after nine months steady. Labor stable but inflation stalled at 3% core PCE. 16 of 18 predict more hikes, potentially 50 bps by end-2027. Futures price 85% chance for Dec hike. Focus remains on price stability. 1mo ago
- Fed refocuses supervision on material risks, raises community bank leverage ratio to 8%, eliminates Novel Activities Program, & restructures into 5 regional offices. Updates include indexing $10B threshold, revising CAMELS to reduce M rating dominance, & streamlining Regulation O. Culture shifts from checklists to risk judgment. 1mo ago
- US Treasury stability rose after 2026 eSLR reforms effective April 1, granting GSIBs $5T headroom. Dealer positions climbed $600B to $700B by April 2026, while leveraged capacity surged $1.8T to $6.4T. Outcomes: narrower spreads, reduced volatility, & greater stress resilience. 1mo ago
- UVA grad notes resilient 2.4% growth & stable 4.1% unemployment in H1. Inflation sits at 3.4%, above 2% target. Fed raised rates to 3.75-4% in Sept. Policy depends on data, risks include geopolitical tensions. Dual mandate remains max employment & price stability. 1mo ago
- FRED hosts 850k series & sees 50% traffic from AI agents. The Fed introduces an MCP Connector to link data with AI while ensuring accuracy & avoiding bias. FRED remains a trusted, non-commercial resource as it expands to FRASER & ALFRED. 1mo ago
- Fed notes rural communities drive supply chains & face higher inflation. Home values rose 36% nonmetro vs 21% urban. Small firms are 96% of rural establishments & created 24% of jobs. Fed supports rural vitality via research, CDFI credit access & workforce initiatives. 1mo ago
- AI boosts global payment security & efficiency via LLMs. Agentic commerce needs micropayments. Scaling requires solving authentication, liability, & fraud. Industry must choose open or closed systems while defining identity standards. 1mo ago
- Detroit unemployment at 11% vs 5% state & 4.1% national. New firms add 30k jobs yearly. AI investment boosts activity while inflation exceeds 2% target. Unanimous rate hike addresses risks as labor market remains solid. 1mo ago
- Fed Reserve hosted 2026 Cyber Workshop on AI risks & ransomware, covering defenses & tabletop exercises. FSB released AI guidance June 2026. Regulators tailor exams for community banks. Resilience needs board oversight, tech, people & processes. 1mo ago
- Fed's Cook likens AI to steam engine. Investment fuels inflation above 2% target, currently 3.8% prompting 25bp hike. Small firms adopt fast. Productivity gains may offer medium-term disinflation. Risks include skill mismatches & labor displacement. 1mo ago
- Fed raised rates on tariff-driven inflation, conflict & AI demand. Home affordability hit 21-year low as prices rose 70% since 2000. High rental burdens persist. A 2-5.5M unit gap stems from zoning, labor loss, high costs & low-rate lock-in effects restricting supply. 1mo ago
- Fed modernizes 113-yr discount window w standardized collateral, e-signatures & automation via 2024 portal. Collab w FHLBs cuts re-allocation time. Efforts boost Treasury resilience & encourage bank usage. 1mo ago
- Fed finalizes stress test reforms to boost transparency & cut SCB volatility 50%. Effective Jan 1. 2027 models cover noninterest income & forward-looking exercises to identify vulnerabilities. Changes aim for robust framework inspired by SVB lessons. 1mo ago
- SVB failed due to unrealized losses & concentrated uninsured deposits. Supervisors knew risks by March 2022 but delayed action. Fed now issues new principles to prioritize early threat identification & empower staff to escalate concerns. 1mo ago
- US Real GDP +1.8% in H1 2026 driven by spending & investment. Unemployment steady at 4.1%. Core PCE at 3.3% with tariff risks. Rates likely hold if August data confirms disinflation, but hikes possible in September if progress reverses. 2mo ago
- Fed links AI & entrepreneurship to growth. Inflation above 2% risks rate hikes. Criminal records block jobs. Business ownership boosts earnings by 24% & lowers recidivism. SBA removed loan bars in 2024. AI aids underwriting & planning. 2mo ago
- Fed Chair marks 100 days, noting AI as new growth factor & $100B annual token sales. Task force launched to study AI impact. Economy resilient with 4.1% unemployment, but PCE inflation at 3.7%. Rejects mechanical rules, prioritizing price stability. 2mo ago
- US economy resilient but inflation stuck above 2% for 5 years. June PCE up 3.7% on energy & AI costs. Labor market stable at 4.2% unemployment. Fed risks skewed to inflation, ready to hike if needed. Consumer sentiment weak due to housing costs & job uncertainty. Restoring price stability is primary goal. 3mo ago
- Fed balances demand & supply shocks amid Middle East conflict & trade policy. AI adds dual effects on markets. FOMC holds rates at 3.25% to 3.75% targeting 2% inflation. 4mo ago
- Inflation at 3.7% remains above the 2% target. Fed prioritizes price stability as GDP grows 2.2% driven by AI data centers. Core goods prices surged 5% amid Middle East shocks. Rates held steady to monitor trends; action prepared if disinflation stalls. 4mo ago
- Fed conference stressed responsible bank innovation & AI to boost financial inclusion. Regulators seek clear expectations without micromanagement. FSB released AI guidance for public comment until July 22, 2026. Supervisory support must help smaller banks innovate safely. 4mo ago
- Fed warns AI could boost workers or worsen inequality by displacing jobs & concentrating wealth. Top 10% holds 59% of US wealth. Outcomes depend on market structure, education & policy to ensure gains are shared broadly rather than accruing to a few firms. 4mo ago
- US economy resilient despite tariffs & energy shocks. Core PCE rose to 3.4% in May; headline 4.1%. Inflation driven by tariffs, energy & AI demand. Labor market stable, expectations anchored. Policy may tighten if core inflation persists. 4mo ago
- FSB modernizes global finance via 4 principles: prioritize risks, tailor rules, ensure transparency & innovate responsibly. US shifts to risk-based oversight post-SVB, refining capital frameworks, AI adoption & supervisory transparency. Fall G20 report expected. 4mo ago
- Fed & FSB seek feedback on AI adoption guidelines for finance, led by MAS & U.S. Treasury. Final report due later this year as G-20 deliverable. Guidance emphasizes proportionality, lighter touch for lower-risk uses, & tailored governance for institution size. 4mo ago
- Initial conditions matter more than historical averages. Vacancy cuts replaced layoffs in 2022 despite tightening. Shocks shorten policy lags. Flexible forward guidance helps, but rigid rules delayed hikes. Optimal guidance requires adaptability, not fixed paths. 4mo ago
- Cleveland Fed notes 99.9% of US firms have under 500 workers, creating 61% of net jobs since 1995. 2025 survey shows nearly half use AI, boosting productivity for 71%. Access to credit remains critical for growth. 4mo ago
- Fed conference on dollar's global role notes stablecoins and digital assets are altering payment rails. While size and trust matter, tech innovation impacts FX markets and global liquidity. Speaker views do not reflect official Fed positions. 4mo ago
- Recent Fed deregulation cuts top bank capital by 6% ($60B) & weakens supervision. Reduced stress tests, liquidity rules & consumer protections risk future crises. Historical data shows long-term GDP losses & massive fiscal costs from past financial collapses. 5mo ago
- Speaker honored JFK & called US indispensable. Fed founded 1913 for stability, aiding economy via non-partisan policy. Governors have legal protections. Rule of law supersedes partisanship; institutions need preserving. 5mo ago
- Fed's Bowman targets 2% inflation ignoring energy shocks, prioritizing core PCE & real GDP. Unemployment at 4.3% with stability concerns. Aggressive 2022 hikes shift to 2025 cuts as growth slows. Stance remains moderately restrictive to stabilize jobs as supply disruptions ease. 5mo ago
- Global energy spikes threaten inflation & growth, especially for importers. US growth solid but slowing due to high costs. Inflation stalled by tariffs/energy yet expected to decline later. Fed holds rates at 3.5%-3.75%, committed to 2% target with data-dependent stance. 5mo ago
- PCE inflation hit 3.8% on gas & core hikes. $1.5T AI boost lifts chips & wages while unemployment stays at 4.3%. Fed holds rates steady, uses AI for risk analysis despite cyber concerns. Responsible deployment needs strong governance. 5mo ago
- Fed faces Middle East supply & price uncertainty. Waller says rate cuts & hikes equally likely. Real GDP grew on AI investment. Core PCE inflation rose to 3.3%. Policy depends on conflict duration & inflation data. 5mo ago
- 31% feel financially healthy despite 96% having accounts. Tech enables real-time assessments to boost savings & reduce costs. Scaling requires standards, privacy balance, & cross-sector collaboration to address vulnerability. 6mo ago
- Shrinking Fed balance sheet is wrong. Cutting reserves undermines bank resilience, impairs money markets, & increases footprint via more lending. Reserves are essential for stability & supplied costlessly. 6mo ago
- Former Fed VP says algorithms can't replace local lending. 10th District banks show resilience via fintech. CECL rules create burdens; new principles focus on material risks. Cyber & capital updates offer flexibility. Fed aims to tailor regs to size & support AI responsibly. 6mo ago
- A speaker proposes centralizing non-monetary back-office functions like IT & HR to boost efficiency while preserving Fed independence. Standardizing tasks shifts governance from Bank-first to System-first, lowering costs & modernizing trillions in payments. 6mo ago
- Fed Vice Chair notes bank corporate lending fell from 48% in 2015 to 29% in 2025 as private credit reached $1.4T. Proposes Basel III changes to lower risk weights, improve NDFI data transparency, restore bank lending balance. 6mo ago
- Fed Govt in Dakar highlights tokenization for West Africa. US tokenized assets doubled to $25B. Benefits: faster settlements & fractional ownership. Risks: runs, cyber threats & systemic links. Fed supports innovation while monitoring stability via global partners. 6mo ago
- Consumer fraud hit $84B in 2024 with only $21B recovered. 21% of US adults affected, 45+ most vulnerable. Bank transfers drove 40% of losses. Fed reviewing 250 comments to update rules, standardize data, & host regulator roundtable to strengthen defenses & recovery. 6mo ago
- FSOC convened AI in cybersecurity roundtable. Regulators updated model risk guidance to exclude gen AI, focusing on material financial risks. Fed, OCC, & FDIC aim to balance innovation with stability while coordinating internationally. Consultation draft expected in Q3. 6mo ago
- Fed needs ops modernization to cut costs & manage risk. Tech & AI drive shift from 12 districts to national support functions. Model 2 offers max savings & resilience but may reduce local jobs. Decentralization vital for policy, but ops fragmentation must end to ensure taxpayer value. 6mo ago
Earnings Releases
By sector →- FFAINov 16, 5:00 PMFaraday Future Intelligent Electric Inc. reported third-quarter 2026 revenue of approximately $1.15 million, driven primarily by its robotics business, while narrowing its net loss to $9.8 million from $222.2 million in the prior-year period. The company successfully spun off its robotics division into a standalone Nasdaq-listed entity, FF Robotics (FFR), in an all-stock transaction valued at approximately $200 million that closed in late October 2026. For the nine months ended September 30, 2026, the robotics business generated $2.3 million in revenue with a 26% gross margin and shipped 1,168 units, reaffirming a full-year target of 2,000 units. Faraday Future is advancing a strategic transformation toward Robotaxi operations and an AI VisiCabin technology platform while maintaining its position as the controlling stockholder of FFR.Consumer Cyclical
- CEPLNov 16, 4:54 PMCapstone Energy+ secured a $25 million, three-year senior secured note agreement with Monarch Alternative Capital to refinance its existing Exit Notes. The company reported second-quarter fiscal 2027 revenue of $22.4 million, a decrease from the prior year, while parts and services revenue increased by 11% to $8.7 million. Net loss for the quarter was $4.0 million, resulting in an adjusted EBITDA of negative $1.0 million. At the end of the quarter, the company held $24.5 million in cash and restricted cash.Industrials
- CUENov 16, 4:52 PMCue Biopharma reported third-quarter 2026 financial results showing a net loss of $50.0 million and revenue of $0.1 million, driven by increased clinical trial costs and non-cash stock-based compensation. The company announced positive Phase 2 results for its lead candidate CUE-221 in chronic spontaneous urticaria, demonstrating superior complete hive resolution compared to placebo and XOLAIR, particularly in patients with high baseline IgE. Additionally, Cue Biopharma initiated first-in-human dosing for CUE-401, a dual-agonist therapeutic candidate designed to treat autoimmune diseases, while its Investigational New Drug application for CUE-221 in food allergy received FDA clearance.Healthcare
- AMCINov 16, 4:42 PMAMC Robotics reported a net loss of $2.02 million for the third quarter of 2026, driven by $2.57 million in operating expenses that included $1.5 million in one-time financing costs. Revenue for the quarter totaled $0.97 million, representing a 35.5% decline year-over-year as the company shifted away from lower-margin product sales toward higher-margin AI and cloud services. The company's gross margin fell to 54.6% due to a $248,597 non-recurring inventory impairment associated with relocating its supply chain to Vietnam. Despite the financial loss, the company remains on track to commission its Phase 1 production line in Vietnam by the end of 2026, with trial production scheduled for early 2027.Technology
- POCINov 16, 4:30 PMPrecision Optics Corporation reported first-quarter fiscal 2027 revenue of $8.2 million, representing a 22% increase from the prior-year period. The company achieved a gross margin of 22.5% and narrowed its net loss to $475,000, or $0.04 per share, compared to a $1.6 million loss in the same quarter last year. Revenue growth was driven by production programs in satellite optical communications and medical devices, including cystoscopes and ophthalmic instruments. The company maintains its full-year fiscal 2027 revenue guidance between $30 million and $33 million.Healthcare
- GPUSNov 16, 4:30 PMHyperscale Data, Inc. announced preliminary third-quarter 2026 revenue of approximately $44.8 million, marking an 84% increase compared to the same period in 2025. This figure exceeds the company's previous estimate of $40 million by roughly 12%. The company plans to host a conference call on November 23, 2026, to discuss these financial results and strategic priorities. Hyperscale Data currently anticipates the divestiture of its subsidiary Ault Capital Group to occur in 2027.Industrials
- POWLNov 16, 4:24 PMPowell Industries reported fourth-quarter fiscal 2026 revenues of $397 million, a 33% increase year-over-year, driven by strong performance in the Oil and Gas and Commercial markets. The company achieved a record full-year revenue of $1.3 billion and net income of $221 million, while new orders surged 124% to $2.6 billion, resulting in a backlog of $2.7 billion. Gross profit margins improved to 34.9% in the quarter and 31.3% for the full year, supported by volume leverage and stable pricing. Additionally, the company secured two mega-orders totaling approximately $335 million in the LNG and data center sectors during the quarter.Industrials
- RSSSNov 16, 4:19 PMResearch Solutions, Inc. reported first-quarter fiscal 2027 results with total revenue of $11.9 million, a decrease from the prior year's $12.3 million. Annual recurring revenue increased 5.7% year-over-year to $22.5 million, driven by an 11.5% growth in B2B ARR to $16.5 million. The company achieved a net income of $765,000, or $0.02 per diluted share, with adjusted EBITDA reaching $1.0 million. Platform revenue accounted for 45% of total revenue, reflecting a strategic shift toward higher-margin recurring business models.Technology
- FIRYNov 16, 4:19 PMFiry Inc. reported third-quarter 2026 revenue of $31.3 million, representing a 14% year-over-year increase driven primarily by its RZR segment, which grew 141% and accounted for the majority of quarterly revenue. The company achieved a net loss of $12.5 million, a narrowing of $4.9 million compared to the prior year, while Adjusted EBITDA excluding litigation expenses improved to a loss of $1.2 million. Firy ended the quarter with $71.0 million in cash and cash equivalents after redeeming $49.7 million of senior secured notes and receiving $55 million from the sale of its Exit Games stake. Management highlighted significant operating leverage, noting that roughly two-thirds of new revenue dollars from RZR converted to Adjusted EBITDA.Communication Services
- NXBNov 16, 4:05 PMNextBoat Inc. reported fiscal third-quarter 2026 revenue of $50.6 million, representing an 110.7% increase from the same period in 2025. The company achieved a gross profit of $8.1 million, driven by significant growth in pre-owned boat sales, new boat sales, and service operations following the acquisition of Apex Marine and Bellhart. Despite the revenue expansion, the company recorded a net loss of $4.6 million for the quarter due to higher operating expenses, including increased salaries, marketing costs, and non-recurring items. For the full year 2026, NextBoat maintains its revenue guidance between $165 million and $170 million.Consumer Cyclical
- BRFHNov 16, 4:05 PMBarfresh Food Group reported third-quarter 2026 revenue of $5.8 million, a 37% increase year-over-year driven by $2.5 million in sales from its Arps Dairy acquisition. The company achieved operating income of $120,000 for the quarter, contrasting with a $260,000 loss in the same period last year, while adjusted EBITDA remained near breakeven at a loss of $15,000. Management updated its full-year 2026 revenue guidance to a range of $20 million to $22 million, down from previous expectations, citing lower-margin milk sales and facility ramp-up costs. Additionally, the USDA extended the grant deadline for the company's new Defiance, Ohio facility to April 30, 2027, and the company is pursuing mortgage financing to complete the project.Consumer Defensive
- EUBGNov 16, 4:05 PMEntrepreneur Universe Bright Group reported revenue of $680,624 for the third quarter of 2026, a decline from $1,217,966 in the same period of 2025. The company recorded a net loss of $221,730 for the quarter, contrasting with a net income of $395,113 in 2025. Over the nine months ended September 30, 2026, revenue totaled $2,164,581 and the company posted a net loss of $178,346. Cash and cash equivalents stood at approximately $8.94 million as of September 30, 2026.
- ACRVNov 16, 4:05 PMAcrivon Therapeutics reported a net loss of $17.9 million for the third quarter of 2026, with cash and investments totaling $77.8 million expected to fund operations through the fourth quarter of 2027. The company established immunology and inflammation as a second strategic pillar, acquiring the Phase 2-ready JAK1 inhibitor ACR-525 for eosinophilic esophagitis and a preclinical PKCθ program. Clinical progress includes late-breaking data on the WEE1/PKMYT1 inhibitor ACR-2316 showing durable responses in lung and endometrial cancers, while the CHK1/2 inhibitor ACR-368 is on track for a prespecified interim analysis in endometrial cancer later this year. Additionally, the CDK11 inhibitor ACR-7280 has been nominated for IND-enabling studies in acute myeloid leukemia.Healthcare
- KYNBNov 16, 4:05 PMKyntra Bio reported a net income of $0.2 million for the third quarter of 2026, driven by a $14 million gain from restructuring a royalty financing agreement that reduced future payment obligations by $60 million. The company decided to discontinue development of its FG-3246 and FG-3180 programs in metastatic castration-resistant prostate cancer following insufficient efficacy, a move expected to save over $20 million in operating expenses during 2027 and 2028. With $44.1 million in cash and equivalents as of September 30, 2026, Kyntra Bio projects a cash runway extending into 2028 while preparing to initiate a pivotal Phase 3 trial for roxadustat in LR-MDS patients in the first quarter of 2027, contingent on securing a strategic partnership or external capital.Healthcare
- PHUNNov 16, 12:15 PMPhunware reported third-quarter 2026 net revenue of $483,000, an 8.3% increase from the prior year, while gross profit rose 61.2% to $274,000 with gross margin expanding to 56.7%. The company advanced its Phunware 2.0 strategy by moving Itinerary Planner into beta and initiating discussions with four major hospitality groups, though it wound down its advertising business to focus on recurring software revenue. Despite these operational shifts, the company recorded a net loss of $7.1 million for the quarter, driven by increased litigation expenses and investments in AI product development and sales initiatives. Phunware concluded the period with $86.7 million in cash and no debt, maintaining financial flexibility to support its growth plan.Technology
- IVFNov 16, 10:30 AMINVO Fertility reported third-quarter 2026 revenue of $2.22 million, representing a 26% increase from the prior year, driven by organic growth at existing clinics and contributions from the Indiana and Birmingham acquisitions. The company achieved positive Clinic-Level Adjusted EBITDA of $292,114 for the seventh consecutive quarter, despite a consolidated net loss of $2.1 million. Financial improvements included a strengthened balance sheet with cash reserves rising to $3.7 million and current liabilities decreasing to $4.5 million from $10.3 million at the end of 2025.Healthcare
- RPIDNov 16, 10:17 AMRapid Micro Biosystems reported third-quarter 2026 total revenue of $9.5 million, reflecting a 22% increase from the same period in 2025. The company achieved a record gross margin of 25%, driven by a 19 percentage point rise in product margins and a 14 percentage point increase in service margins. Net loss for the quarter was $11.3 million, while non-GAAP adjusted EBITDA loss narrowed to $7.9 million from $9.4 million in the prior year. On November 16, 2026, the company announced a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany, leading to the withdrawal of its full-year 2026 guidance and a delay in filing its Form 10-Q.Healthcare
- UNCYNov 16, 9:28 AMUnicycive Therapeutics announced that the U.S. Food and Drug Administration accepted its New Drug Application resubmission for oxylanthanum carbonate, establishing a Prescription Drug User Fee Act target date of March 25, 2027. The company reported a net loss of $7.0 million for the third quarter ended September 30, 2026, driven primarily by increased commercial launch preparation expenses, while maintaining approximately $59 million in cash and marketable securities with a runway extending beyond 2027. Commercial readiness efforts are advancing through discussions with dialysis organizations and plans to hire a sales force in early 2027, supported by favorable reimbursement changes from the Centers for Medicare & Medicaid Services effective January 2027.Healthcare
- JAGXNov 16, 9:15 AMJaguar Health reported a net loss of $5.8 million for the third quarter of 2026, a significant improvement from the $9.6 million loss in the same period the previous year. The company reduced its outstanding debt balance by $10.1 million during the quarter and recognized $1.8 million in holdback payments from its exclusive U.S. licensing agreement with Future Pak for Mytesi and Canalevia-CA1. Total net revenue for the quarter was $2.3 million, driven primarily by license and grant revenue, while prescription product revenue declined to approximately $0.5 million following the transfer of U.S. commercial rights to Future Pak. Jaguar continues to focus its resources on the development of a powder-for-oral-solution formulation of crofelemer for rare intestinal failure indications, with a New Drug Application filing for microvillus inclusion disease planned for mid-2027.Healthcare
- SWRDNov 16, 9:13 AMStewards, Inc. reported a net loss of $19.4 million for the third quarter of 2026, driven by an $8.5 million noncash charge related to warrant liabilities and lower private credit deployment. The company's total assets increased 49% to $265.3 million following the completion of a $79 million refinancing for 1818 Park and the acquisition of Envy Pompano Beach. Stewards launched a digital customer portal with Plaid integration and announced a partnership with Rain to develop a business card targeted for early 2027 availability. Following the quarter, the company secured a standstill agreement on $31.8 million of notes and amended terms for the Envy acquisition to exchange cash redemption obligations for preferred stock.Financial Services
- NFENov 16, 9:03 AMNew Fortress Energy completed a restructuring and recapitalization on September 11, 2026, reducing its debt principal from approximately $5.7 billion to $0.7 billion. For the third quarter of 2026, the company reported total revenues of $335.8 million and a net income of $863.4 million, which included $1.6 billion in non-cash gains from the debt restructuring. Adjusted EBITDA for the quarter was $48.4 million, driven by higher cargo sales margins and contract novation revenue. Recent developments include a temporary outage of the FLNG 1 facility due to a turbine issue and an agreement to lease ten mobile turbines to improve liquidity.Utilities
- ELOXNov 16, 9:02 AMEloxx Pharmaceuticals reported a net loss of $5.5 million for the third quarter of 2026, driven by increased research and development expenses related to the initiation of its Phase 2b EXACT study for nonsense mutation Alport syndrome. The company dosed its first two patients in this global trial and finalized the protocol for a Phase 2 EXPRESS study targeting nonsense mutation autosomal dominant polycystic kidney disease, with the first patient expected to be dosed in the third quarter of 2027. As of September 30, 2026, Eloxx held $56.3 million in cash and cash equivalents, which management believes will fund operations into 2028. Additionally, the company expanded its leadership team by appointing T.R. Srinivas as Senior Vice President and Chief Medical Officer and added Geno Germano to its Board of Directors.Healthcare
- TOONNov 16, 9:00 AMKartoon Studios reported a net loss of $5.7 million for the third quarter of 2026, with total revenue declining to $5.4 million due to reduced production services activity and the sale of the Frederator channel network business. The company maintains $33.0 million in cash and marketable securities while advancing its strategy to commercialize the Hundred Acre Wood intellectual property through new agreements with Walmart Marketplace and Amazon Prime. Scheduled launches include consumer products on Walmart in January 2027 and a streaming series on Amazon Prime in February 2027, with broader streaming and consumer product initiatives expected to begin in the first quarter of 2027. Additionally, the company strengthened audience engagement on its owned platforms, Kartoon Channel! and Ameba, where total viewing hours more than doubled year-over-year.Communication Services
- GXONov 16, 8:57 AMGXO Logistics announced 2030 financial targets aiming for greater than 7% organic revenue CAGR, a greater than 6.5% adjusted EBITA margin, and a 40% to 50% free cash flow conversion rate on adjusted EBITDA. The company also provided a preliminary 2027 outlook projecting above 5.5% organic revenue growth, a greater than 7.1% adjusted EBITDA margin, and above 4.5% adjusted EBITA margin. These targets reflect the company's strategy to lead in AI-powered logistics while building a diversified business model. The announcement was made during the 2026 Investor Day held at the New York Stock Exchange.Industrials
- AIMDNov 16, 8:41 AMAinos, Inc. reported third-quarter 2026 revenue of $642,889, representing a 29,567% increase year over year, driven by VELDONA licensing and AI Nose semiconductor programs. The company delivered 1,400 AI Nose systems under an initial agreement and subsequently secured a $9 million follow-on order for 5,000 additional units with a $4.5 million initial payment due within 60 days. GAAP net loss narrowed by 36% to $1.89 million, while non-GAAP adjusted net loss improved by 51% to $672,352. Additionally, the company surpassed 3 billion real-world chemical data points and expects recurring quarterly revenue of $175,000 starting in the fourth quarter from its AI Nose service agreements.Technology
- CNTNNov 16, 8:35 AMCanton Strategic Holdings, Inc. reported total revenue of $3.05 million for the third quarter of 2026, representing a 104% increase from the previous quarter. The company achieved its first positive Adjusted EBITDA of $610,414, driven by $1.5 million in network validation revenue and $1.5 million in other revenue primarily from its locking-as-a-service offering. During the quarter, the company's active Super Validator weight increased to 6.5, and it held 3.83 billion units of Canton Coin with a fair value of $482.1 million. Despite the revenue growth, the company recorded a net loss of $35.1 million, largely due to a $54.6 million unrealized loss on its digital asset holdings.Healthcare
- USDENov 16, 8:35 AMStablecoinX reported third-quarter 2026 revenue of $477,993, representing a 666% sequential increase driven by its Decentralized Verifier Node infrastructure services. The company's ENA treasury of 3.0 billion tokens, valued at approximately $802 million based on September 30 prices, was fully unlocked following a waiver of lock-up restrictions. While the company posted a GAAP net loss of $100.2 million largely due to non-cash losses on warrant liabilities, its adjusted net loss was $1.9 million. Additionally, the DVN surpassed $6 billion in cumulative verified cross-chain volume, and the firm appointed Christopher Jensen as its new Chief Executive Officer.Financial Services
- APVONov 16, 8:35 AMAptevo Therapeutics reported that its lead candidate mipletamig achieved a 79% remission rate in patients with high-risk TP53-mutated acute myeloid leukemia, a figure nearly double the historical benchmark for similar patients treated with standard therapies. Ten of 47 patients receiving the mipletamig combination therapy advanced to potentially curative stem cell transplantation, while refinements to the drug's priming-dose regimen significantly reduced infusion-related reactions. The company also secured $4.5 million in additional financing to support clinical milestones and advanced its next-generation trispecific candidates toward human testing in solid tumors.Healthcare
- IPDNNov 16, 8:32 AMProfessional Diversity Network, Inc. reported a 48.2% decline in third-quarter 2026 revenues to approximately $856,000, driven by reduced demand in its recruitment and software development segments. The company posted a net loss from continuing operations of $2.652 million for the quarter, an increase from the prior year period, largely due to $1.189 million in amortization expenses for acquired musical copyrights. Despite the revenue drop, the firm improved its working capital position to $0.2 million and significantly reduced general and administrative expenses by 47.2% through workforce restructuring and reduced consulting costs. Additionally, the company launched PDN Intelligence, Inc. to explore opportunities in AI infrastructure and GPU-based computing services, though no revenue was generated from this initiative during the quarter.Industrials
- HCWBNov 16, 8:30 AMHCW Biologics reported a net loss of $3.2 million for the three months ended September 30, 2026, and $5.0 million for the nine-month period, driven by research and development expenses of $1.2 million and $3.7 million respectively. The company secured $8.6 million in equity financing and $3.0 million in debt financing during the first nine months of 2026 to support its Phase 1 clinical trial for HCW9302 in alopecia areata and preclinical programs. Clinical progress includes the activation of an additional site for the HCW9302 study and FDA guidance to file an IND application for the solid tumor candidate HCW11-018b in the first half of 2027. Despite these advancements, the company disclosed substantial doubt regarding its ability to continue as a going concern for the next 12 months without additional funding.Healthcare
- DWSNNov 16, 8:13 AMDawson Geophysical Company reported a net loss of $5.2 million, or $0.17 per share, for the third quarter of 2026, driven by a 27% decline in fee revenue to $10.8 million and negative Adjusted EBITDA of $2 million. Despite the quarterly setback, year-to-date results through September 30, 2026, showed a 47% increase in fee revenue to $57.4 million and a 580% surge in Adjusted EBITDA to $9.5 million compared to the prior year period. The company cited delays in large channel crew jobs due to permitting issues as a factor in the third quarter, while noting a renewed demand for high-density seismic services in North America and the upcoming launch of geothermal data acquisition. Management projects continued revenue growth and improved margins for 2027, supported by a strengthened backlog and expanded operations in both the United States and Canada.Energy
- VERINov 16, 8:12 AMVeritone reported third-quarter 2026 revenue of $18.6 million, a 30.1% decrease from the prior year, while achieving an Annual Recurring Revenue of $55.9 million. The company completed an exchange of $38.7 million in convertible notes for new notes and 1.6 million shares of common stock, with the remaining $6.8 million of old notes scheduled for payment in November 2026. Additionally, Veritone secured a commitment letter for a $40 million senior secured term loan from Blue Torch Capital, contingent on raising an additional $25 million in financing. The company has implemented restructuring efforts resulting in over $18 million in annualized cost reductions and targets further reductions of $2 million to $7 million by the end of 2026.Technology
- ALXONov 16, 8:10 AMALX Oncology reported a net loss of $21.8 million for the third quarter ended September 30, 2026, with cash, cash equivalents, and investments totaling $147.2 million sufficient to fund operations through the first half of 2028. The company announced the publication of Phase 2 ASPEN-06 trial data in Nature Medicine, which showed encouraging efficacy for evorpacept in HER2-positive gastric cancers, while enrollment for the Phase 2 ASPEN-09-Breast trial remains on track with topline data expected in the second half of 2027. Additionally, ALX Oncology plans to release safety and early efficacy data from the Phase 1 dose-escalation study of its EGFR-targeted ADC, ALX2004, in December 2026.Healthcare
- IAMNov 16, 8:08 AMIambic Therapeutics launched Enchant v3, a 41-billion-parameter AI model for drug discovery, and secured new collaborations with AbbVie and Bayer, bringing its total partnership count to eight since 2024. The company reported third-quarter 2026 collaboration revenue of $11.4 million and achieved a $1.0 million milestone payment from its Takeda partnership. Clinically, updated data for the lead candidate IAM1363 showed 36% systemic and 41% intracranial response rates in heavily pretreated patients, with a registrational trial planned for 2027. Additionally, Iambic submitted an IND for its second candidate, IAM217, and expects to file for IAM-C1 in the fourth quarter of 2026, while maintaining a cash position of $252 million as of September 30, 2026.Healthcare
- IBATFNov 16, 8:05 AMInternational Battery Metals Ltd. reported a net income of $2.2 million for the second quarter of fiscal 2027, ending September 30, 2026, driven primarily by a $5.0 million gain from the change in fair value of warrant liability. Revenue for the quarter was zero, a decrease from $64,000 in the prior year period, as the company focused on engineering a compact pilot plant for direct lithium extraction. The company plans to secure a secured term loan of up to $12.0 million to fund the pilot plant construction and cover general administrative expenses over the next 12 months. Additionally, the company continues to evaluate commercial opportunities in North America, South America, and the Middle East while providing brine testing services to prospective customers.
- APMDNov 16, 8:04 AMApnimed reported a net loss of $29.5 million for the third quarter ended September 30, 2026, driven by increased general and administrative expenses related to commercial launch preparations. The company holds $351.8 million in cash and cash equivalents, which is expected to fund operations and a potential U.S. launch into the second quarter of 2028. Its New Drug Application for AD109, proposed as Oxnimbi, remains under FDA review with a PDUFA goal date of February 28, 2027. Additionally, Apnimed presented five abstracts at the CHEST 2026 Annual Meeting, including two late-breakers highlighting Phase 3 clinical data for the drug.Healthcare
- NMRANov 16, 8:03 AMNeumora Therapeutics submitted an Investigational New Drug application for its NLRP3 inhibitor, NMRA-215, to treat obesity and cardiometabolic disease. The company reported dose-proportional increases in exposure for NMRA-511 at a 30 mg BID dose in healthy elderly participants, indicating potential to enhance the efficacy observed in previous Phase 1b studies. For the third quarter ended September 30, 2026, Neumora reported a net loss of $34.4 million and ended the period with $85.7 million in cash and cash equivalents.Healthcare
- ADGMNov 16, 8:02 AMAdagio Medical Holdings reported a net income of $17.8 million for the third quarter of 2026, driven primarily by a $23.0 million noncash gain from the change in fair value of its convertible notes. The company treated 22 patients with its vCLAS Ultra System in the United States and Canada, including 19 in the FULCRUM-VT IDE sub-study, while initiating a formal process to explore strategic alternatives. Research and development expenses decreased to $1.8 million, and selling, general, and administrative expenses fell to $2.6 million compared to the prior year period. On November 6, 2026, the company completed a one-for-thirty reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.Healthcare
- VENUNov 16, 8:00 AMVenu Holding Corporation reported total assets of $587.6 million as of September 30, 2026, representing a 59% increase from the prior year-end. The company generated $14.1 million in revenue for the nine-month period ended September 30, 2026, while reporting a net loss attributable to common stockholders of $44.6 million. Construction progress advanced significantly on the Regent Bank Amphitheater and Sunset Amphitheater McKinney, with the latter reaching 95% sales on premium seating prior to its opening. Subsequent to the quarter, the company secured $67.5 million in sale-leaseback transactions and announced the opening of the Regent Bank Amphitheater for New Year's Eve 2026.Consumer Cyclical
- POWWNov 16, 8:00 AMOutdoor Holding Company reported second-quarter fiscal 2027 net revenues of $13.7 million, representing a 14.6% increase from the prior-year period, while net income from continuing operations rose to $2.3 million. The company achieved an Adjusted EBITDA of $6.1 million and grew its gross merchandise value by 10.3% to approximately $208.4 million, driven by a 4.8% increase in firearm unit sales that outpaced the broader market. Operational highlights include a 25 basis point year-over-year increase in take rate to 6.59% and the completion of the company's redomestication from Delaware to Texas. Additionally, the Board increased the share repurchase authorization by $20.0 million, and the company ended the quarter with $70.4 million in cash and cash equivalents.Industrials
- JSPRNov 16, 8:00 AMJasper Therapeutics reported third-quarter 2026 financial results showing $135.3 million in cash and cash equivalents alongside a net loss of $144.5 million for the quarter. The company advanced its clinical pipeline by completing enrollment in the first cohort of a Phase 2 renal basket study for vensobafusp alfa in IgA nephropathy and initiating enrollment for patients with IC-MPGN. Recent corporate developments include the July 2026 acquisition of Kira Pharmaceuticals, a $132 million private placement, and a 1-for-30 reverse stock split effected in November 2026.Healthcare
- GALTNov 16, 7:55 AMGalectin Therapeutics reported a net loss of $3.6 million for the quarter ended September 30, 2026, driven by $1.6 million in research and development expenses and $1.8 million in general and administrative expenses. The company submitted its registrational Phase 3 protocol for belapectin to the FDA in the third quarter following alignment on the trial design for advanced MASH cirrhosis. Significant corporate developments included the conversion of approximately $105.8 million in debt held by Chairman Richard E. Uihlein into over 34 million shares of common stock. As of September 30, 2026, the company held $11.7 million in cash and cash equivalents, with sufficient funds to support operations through June 2027.Healthcare
- LNZANov 16, 7:52 AMLanzaTech reported a net loss of $178.0 million for the third quarter of 2026, primarily driven by a $166.4 million non-cash unrealized fair value loss on its investment in SGLT. Despite the net loss, the company achieved significant operational progress, including the world's first ISCC EU certification for recycled carbon fuels from steel mill waste gases at its Hebei Shoulang facility. Operating expenses decreased by 35% to $11.7 million compared to the prior year, reflecting successful cost reduction initiatives and a reset cost structure. The company also raised $50.0 million through common stock issuance in the first nine months of 2026, increasing its cash and restricted cash balance to $36.3 million as of September 30, 2026.Industrials
- MNTKNov 16, 7:45 AMMontauk Renewables reported third-quarter 2026 revenues of $50.2 million, a 10.9% increase year-over-year, driven primarily by higher environmental attribute revenues from RINs sold. Net income for the quarter was $2.1 million, a 58.9% decline from the prior year, while non-GAAP Adjusted EBITDA decreased 20.6% to $10.2 million. The company executed a non-binding term sheet to amend its New Senior Credit Facility, securing additional borrowing capacity and covenant forbearance, which removed the previously anticipated going concern qualification from its financial statements. Full-year 2026 RNG revenue is now projected to range between $175 million and $180 million, reflecting a reduction in expected environmental attribute pricing.Utilities
- CREXNov 16, 7:45 AMCreative Realities reported fiscal third-quarter 2026 revenue of $26.2 million, a significant increase from $10.5 million in the prior-year period, driven by hardware and service growth including operations from its Cineplex Digital Media subsidiary. The company achieved an adjusted EBITDA of $2.7 million and ended the quarter with annualized recurring revenue of approximately $21.7 million. Key business developments include the completion of digital media upgrades for over 1,000 Zaxby's locations and the deployment of its AdTech technology at more than 500 Albertsons stores. Despite a net loss of $3.6 million for the quarter, the company reduced its outstanding debt to approximately $40 million and anticipates exceeding $100 million in revenue for the full fiscal year 2026.Technology
- TSNNov 16, 7:41 AMTyson Foods reported fiscal 2026 sales of $56.4 billion, a 3.6% increase from the prior year, driven by growth in prepared foods and chicken segments. The company recorded GAAP operating income of $1.1 billion and adjusted operating income of $1.98 billion, while adjusted earnings per share declined 17% to $3.44 due to legal contingency accruals and restructuring charges. For fiscal 2027, Tyson anticipates sales to decrease between 3.5% and 5.5% primarily due to lower beef volumes, with projected adjusted operating income ranging from $1.7 billion to $2.15 billion. The company also announced an increase in its quarterly dividend to $0.52 per share for Class A stock and $0.468 for Class B stock, effective November 2026.Consumer Defensive
- EDBLNov 16, 7:35 AMEdible Garden AG reported third-quarter 2026 revenue of $3.2 million, a 14% increase driven by a 65.7% surge in cut herb sales. Gross profit rose 181.7% to $0.8 million, expanding the gross margin to 23.9% from 9.7% in the prior year period. The company secured a major private-label ready-to-drink protein beverage award and expanded its retail distribution network with new agreements at Walmart and UNFI. Additionally, a strategic supply agreement with Caney Fork Farms is expected to reduce production costs by over 12% once fully implemented in 2027.Consumer Defensive
- VIDANov 16, 7:35 AMVida Global Inc. reported third-quarter 2026 total revenue of $0.33 million, an 88% increase from the prior year period, driven by growth in subscription and usage-based fees. The company achieved a gross margin of 44% and recorded a net loss of $1.47 million, while its cash, cash equivalents, and short-term investments rose to $12.7 million. Operationally, Vida's computer agents exited beta to perform tasks beyond conversations, resulting in nearly 1,400 active AI employees and over one million call minutes handled during the quarter. Following the quarter, the company introduced outcome-based billing in October and launched an MCP server in November to facilitate AI employee deployment through existing business assistants.Technology
- MBRXNov 16, 7:30 AMMoleculin Biotech completed treatment for all 90 patients in Part A of its pivotal MIRACLE trial evaluating Annamycin for relapsed or refractory acute myeloid leukemia, with comprehensive data expected in the first quarter of 2027. A peer-reviewed analysis of 90 patients across five clinical trials found no evidence of clinical or subclinical cardiotoxicity, supporting the drug's differentiated safety profile. The company reported a net loss of approximately $6.5 million for the third quarter of 2026, driven primarily by research and development expenses related to the MIRACLE trial. Additionally, new preclinical data suggest Annamycin may convert immunologically cold pancreatic tumors to hot, supporting potential combination therapies.Healthcare
- MPLTNov 16, 7:20 AMMapLight Therapeutics reported a net loss of $51.6 million for the third quarter of 2026, with cash, cash equivalents, and investments totaling $463.4 million as of September 30, 2026. The company has initiated start-up activities for the ZEPHYR-2 Phase 3 trial of its lead candidate ML-007C-MA in schizophrenia, with topline results expected in the second half of 2027. Enrollment is ongoing for the Phase 2 VISTA trial of ML-007C-MA in Alzheimer's disease psychosis, where the drug holds FDA Fast Track designation and top-line results are anticipated in 2028. Additionally, the company plans to engage with the FDA regarding the registrational path for ML-004 in autism spectrum disorder following positive Phase 2 IRIS trial data.Healthcare
- XTNDNov 16, 7:19 AMXTEND AI Robotics reported third-quarter 2026 revenue of $14.9 million, representing a 281% year-over-year increase driven by its AI Robotics segment. The company secured a fully funded backlog of $84.7 million as of September 30, 2026, which grew to $100.7 million by mid-November following a $40.5 million order for 6,000 STRIKER systems. Although the company posted a net loss of $44.6 million for the quarter due to significant operating expenses and stock-based compensation, it ended the period with $66.7 million in cash and cash equivalents. Operational milestones included the completion of a business combination with JFB Construction Holdings and the advancement of multiple defense programs in the U.S., EMEA, and Asia-Pacific regions.Technology
- LRMRNov 16, 7:17 AMLarimar Therapeutics completed a rolling Biologics License Application submission seeking accelerated approval for nomlabofusp to treat Friedreich's ataxia, utilizing skin frataxin as a potential novel surrogate endpoint. The company reported a net loss of $31.1 million for the third quarter of 2026, a decrease from $47.7 million in the same period the prior year, driven largely by reduced drug manufacturing expenses. As of September 30, 2026, Larimar held $128.7 million in cash and marketable securities, projecting a runway into late Q2 2027. The company is currently enrolling patients in the global confirmatory Phase 3 FORWARD-FA study and targets a potential U.S. launch in the third quarter of 2027 if the application is approved.Healthcare
- PRLDNov 16, 7:09 AMPrelude Therapeutics reported a net loss of $12.5 million for the third quarter ended September 30, 2026, with cash and equivalents totaling $142.7 million, extending its runway into the second quarter of 2028. The company initiated enrollment in a Phase 1 study for PRT13722, a selective KAT6A degrader for HR+ breast cancer, and entered a collaboration with Eli Lilly to evaluate this candidate in combination with abemaciclib and imlunestrant. Concurrently, enrollment continues for PRT12396, a mutant-selective JAK2V617F inhibitor for polycythemia vera and myelofibrosis, while preclinical data for an mCALR-targeted degrader antibody conjugate was accepted for presentation at the ASH 68th Annual Meeting.Healthcare
- IVVDNov 16, 7:08 AMInvivyd reported third-quarter 2026 net product revenue of $15.4 million for PEMGARDA, an 18% increase from the prior year period. The company announced positive topline results from its LIBERTY Phase 3 trial, demonstrating that VYD2311 has superior safety and tolerability compared to an mRNA COVID-19 vaccine without interfering with vaccine-induced antibodies. Additionally, Invivyd initiated the FLINTLOCK Phase 2 trial to evaluate VYD2311 for Long COVID and Post-Vaccination Syndrome while preparing for an imminent interim analysis of the DECLARATION Phase 3 trial data. Financially, the company recorded a net loss of $33.5 million for the quarter and ended with $126.4 million in cash and cash equivalents.Healthcare
- CYPHNov 16, 7:05 AMCypherpunk Technologies reported a net income of $306.0 million for the third quarter of 2026, driven primarily by a $330.8 million unrealized gain on an embedded derivative linked to the rise in Zcash prices. The company launched its mining operations in August 2026, generating $9.9 million in revenue from 8,967.29 ZEC mined with 95% uptime. As of November 2026, the company's ZEC treasury holdings increased to 341,858.75 ZEC, representing approximately 2.01% of the circulating supply. Additionally, the company appointed Amanda Fabiano to its Board of Directors and is evaluating strategic options for its Leap Therapeutics subsidiary to advance its Phase 3 clinical trials.Healthcare
- XTNTNov 16, 7:05 AMXtant Medical Holdings reported third-quarter 2026 total revenue of $24.3 million, a decrease from $33.3 million in the same period of 2025, primarily due to the absence of revenue from divested businesses and wound care licensing. The company posted a net loss of $3.6 million for the quarter, while biologics revenue grew 13% year-over-year to $19.3 million. The Board of Directors has initiated a strategic review to evaluate various operational and financial alternatives aimed at maximizing stockholder value. Consequently, the company has withdrawn its full-year 2026 financial guidance and will not host a conference call to discuss these results.Healthcare
- AIRJNov 16, 7:05 AMAirJoule Technologies completed its acquisition of BitSink on September 10, 2026, adding modular data center infrastructure capabilities and $15 million in signed purchase orders. The company delivered its first AirJoule Prime system to the Data4 data center in France and initiated pilot projects with Kubota Corporation for residential water generation. Financial results for the third quarter of 2026 showed a net loss of $19.8 million, while the company provided a preliminary 2027 revenue outlook for BitSink ranging from $15 million to $20 million. Additionally, Timothy N. White joined the Board of Directors to support the company's engineering and manufacturing expansion.Industrials
- MTRINov 16, 7:03 AMMentari Therapeutics, Inc. reported a net loss of $63.0 million for the nine months ended September 30, 2026, driven primarily by $57.7 million in research and development expenses. The company maintained $45.8 million in cash and cash equivalents as of September 30, 2026, while holding significant liabilities including a $50.0 million convertible note payable to a related party. On November 6, 2026, the company completed a merger with InMed Pharmaceuticals, resulting in a combined entity focused on migraine prevention therapies. This transaction was preceded by a $490.0 million pre-closing financing that provided additional capital for the company's development programs.Healthcare
- LXEONov 16, 7:02 AMLexeo Therapeutics reported positive interim Phase I/II data for its gene therapy candidate LX2020 in patients with PKP2 arrhythmogenic cardiomyopathy, showing an 80% mean reduction in non-sustained ventricular tachycardia and a 44% reduction in premature ventricular contractions in high-dose cohorts. The treatment was generally well tolerated across ten participants, with no clinically significant complement activation observed, prompting the company to design a pivotal study using non-sustained ventricular tachycardia as a primary surrogate endpoint for potential accelerated approval. The U.S. Food and Drug Administration has indicated openness to this endpoint strategy, with the company expecting to initiate the pivotal study in the second half of 2027. Financially, the company reported a net loss of $38.3 million for the third quarter of 2026 and holds $219.1 million in cash and investments, providing an operational runway into 2028.Healthcare
- ELWTNov 16, 7:00 AMElauwit Connection reported a 104% sequential increase in total revenue to $5.6 million for the third quarter of 2026, driven by a 140% year-over-year rise in billed units to 25,746. Monthly recurring revenue grew 66% year-over-year to $539,000, while the backlog of new installations and recurring services reached $53.5 million as of September 30. The company implemented cost reductions that lowered operating expenses by approximately $0.3 million in the quarter and increased its cash and cash equivalents to $2.7 million. Despite these operational gains, the company reported a net loss of $2.58 million for the quarter and maintains an accumulated deficit of $22.6 million.Communication Services
- TILNov 16, 7:00 AMInstil Bio reported a net loss of $4.2 million for the third quarter of 2026 and $13.0 million for the first nine months of the year. As of September 30, 2026, the company held approximately $67.1 million in cash and investments, which is expected to fund operations through 2027. Research and development expenses decreased significantly to $0.2 million for the quarter and $1.2 million for the nine-month period compared to prior year figures. The company also corrected immaterial errors in previously issued financial statements related to property taxes and tenant reimbursements.Healthcare
- VYCONov 16, 6:58 AMVycor Medical, Inc. reported revenue of $414,895 for the three months ended September 30, 2026, representing an 18% decrease compared to the same period in 2025. For the nine-month period, total revenue was $1,291,699, an 11% decline from the prior year, driven primarily by lower sales in the Vycor Medical division which produced the ViewSite Brain Access System. The company recorded a GAAP net loss of $161,447 for the quarter and $325,812 for the nine months, while non-GAAP operating profit improved to $43,011 for the quarter and $125,751 for the nine months. Additionally, four new peer-reviewed studies on the ViewSite system were published during 2026, bringing the total number of clinical papers to 54.
- BXDCNov 16, 6:46 AMBlackstone Digital Infrastructure Trust reported third-quarter 2026 net income of $15.6 million, or $0.15 per share, with Funds from Operations and Adjusted Funds from Operations per share at $0.15 and $0.17 respectively. The company executed its inaugural investment through a sale-leaseback transaction involving thirteen newly constructed data centers across two campuses leased to Amazon. This strategic move expands the firm's total addressable market by doubling the hyperscaler sale-leaseback channel and establishes a foundation for long-term shareholder value. The trust, externally managed by an affiliate of Blackstone, focuses on acquiring stabilized, income-generating data center assets leased to investment-grade tenants.Real Estate
- ARMKNov 16, 6:31 AMAramark reported record fiscal 2026 results with consolidated revenue reaching $20.1 billion, representing a 9% year-over-year increase and 10% organic growth. The company achieved an adjusted operating income of $1.1 billion and adjusted earnings per share of $2.23, driven by strong new business wins and improved supply chain efficiencies. Following these results, Aramark's Board authorized a new $1 billion share repurchase program and increased the quarterly dividend by 17%. The company also reduced its net debt by $225 million, lowering its leverage ratio to 2.7x.Industrials
- ODYSNov 16, 6:20 AMOdysight.ai reported revenues of $0.9 million for the nine months ended September 30, 2026, representing a 29% increase in its aerospace domain compared to the prior year period. The company holds a backlog of $16 million as of September 30, 2026, and maintains a cash balance of approximately $23.2 million with no financial debt, projecting sufficient funds to operate through the second quarter of 2028. Operating expenses for the period totaled $14.6 million, resulting in a net loss of approximately $13.7 million. Recent commercial milestones include the signing of a Memorandum of Agreement with Boeing, a Cooperative Research and Development Agreement with the U.S. Navy, and the launch of a pilot program with the NTA Metropolitan Mass Transit System.Technology
- QINDNov 16, 6:15 AMQuality Industrial Corp. reported third-quarter 2026 revenue of $3.64 million, a 3.6% increase from the prior year, driven by higher sales volumes as customers returned to the UAE. The company achieved operating income of $39,978, a significant turnaround from an operating loss of $285,805 in the same period last year, while net loss narrowed to $31,512. For the nine months ended September 30, 2026, consolidated net income was $166,638 compared to a net loss of $1.24 million in 2025, largely due to the non-recurrence of a $1.02 million discretionary management bonus. Operational highlights include a contracted engineering portfolio valued at approximately $5.2 million and the expansion of the LPG distribution fleet to 53 vehicles. Management anticipates higher revenue in the fourth quarter of 2026 following the resolution of project pricing inefficiencies and the seasonal strength of the period.
- XXIINov 16, 6:02 AM22nd Century Group reported third-quarter 2026 net revenues of $4.8 million, representing a 66% sequential increase, while turning gross profit positive at $0.4 million. The company achieved a 166% growth in point-of-sale pack sales for its Pinnacle VLN products and expanded its retail footprint by shipping to approximately 150 additional stores in the New York and New Jersey areas. Following the quarter, the company raised $5.8 million through an at-the-market offering and used $1.2 million to redeem Series B convertible preferred stock, resulting in no outstanding warrants. Despite these operational improvements, the company reported a net loss from continuing operations of $2.6 million for the period.Consumer Defensive
- SLXNNov 16, 6:01 AMSilexion Therapeutics dosed the first patient in its Phase 2/3 clinical trial for SIL204 in locally advanced pancreatic cancer at Tel Aviv Sourasky Medical Center in September 2026. The company reported a net loss of $2.5 million for the third quarter of 2026, while cash and cash equivalents increased to $4.8 million following recent financing activities. New translational data indicates that SIL204 utilizes a coordinated immune-sensitization signature across four KRAS mutations and employs a native lipoprotein-mediated uptake mechanism. Additionally, the company announced a 1-for-24 reverse share split effective November 10, 2026, and is expanding clinical trial sites in Israel and Germany.Healthcare
- TPSTNov 13, 5:27 PMTempest Therapeutics reported a net loss of $3.6 million for the third quarter of 2026, with cash and cash equivalents declining to $0.9 million from $7.7 million at the end of 2025. The company secured exclusive licensing rights to Senlang's CD7-targeted lentiviral in vivo CAR-T platform and its lead candidate TPST-4903, while also advancing its next-generation candidate TPST-4003. To support operations, Tempest completed a private placement raising approximately $2.5 million and entered into an equity line of credit with Lincoln Park Capital Fund for up to $50.0 million. Additionally, the Board of Directors was strengthened by the appointments of Nancy Freda-Smith and John W. Frederick, though the company noted substantial doubt regarding its ability to continue as a going concern due to limited cash reserves.Healthcare
- BYSINov 13, 5:27 PMBeyondSpring Inc. reported a net loss of $2.1 million for the third quarter ended September 30, 2026, driven by increased research and development and general and administrative expenses. The company received FDA Fast Track designation for its lead candidate Plinabulin combined with docetaxel in patients with post-immunotherapy non-squamous non-small cell lung cancer lacking actionable genomic alterations. A strategic transaction with Biolin Investment Limited was completed to fund approximately half of the DUBLIN-4 Phase 3 trial's patient enrollment in China, providing BeyondSpring with access to the resulting clinical data. As of September 30, 2026, the company held $0.6 million in cash, cash equivalents, and short-term investments.Healthcare
- BCICNov 13, 5:26 PMBCP Investment Corporation reported third-quarter 2026 net investment income of $4.6 million, or $0.37 per share, with a net asset value of $162.7 million as of September 30, 2026. The company announced a merger agreement to acquire Investcorp Credit Management BDC, Inc. at 90% of ICMB's closing net asset value, a transaction expected to be accretive to shareholders. Non-accrual debt investments declined to 10, representing 2.8% of the portfolio at fair value, while the company increased its KeyBank Credit Facility capacity to $150 million and issued $10 million in additional notes due 2029. Additionally, BCP declared monthly base distributions of $0.09 per share for January, February, and March 2027.Financial Services
- CINGNov 13, 5:19 PMCingulate Inc. reported a net loss of $7.7 million for the third quarter of 2026, driven primarily by increased selling, general, and administrative expenses related to commercial readiness. The company has substantially completed manufacturing work to address FDA requests for its CTx-1301 ADHD drug application and expects to resubmit the new drug application between December 2026 and January 2027. As of September 30, 2026, Cingulate held approximately $23.2 million in cash and cash equivalents, which is projected to fund operations through mid-2027.Healthcare
- CTNTNov 13, 5:16 PMCheetah Net Supply Chain Service Inc. reported total revenue of $3.56 million for the third quarter of 2026, an 883% increase from the prior year period, driven primarily by its international trading segment following the May 2026 acquisition of Super International Trading Limited. The company recorded a net loss from continuing operations of $2.55 million for the quarter, a 93.8% increase compared to the same period in 2025, largely due to a $2.78 million loss from changes in the fair value of acquisition-related contingent consideration. For the nine months ended September 30, 2026, the company posted a net loss of $3.09 million while maintaining a cash and cash equivalent balance of approximately $14.5 million and a working capital balance of $87.1 million.Consumer Cyclical
- WFCFNov 13, 5:14 PMWhere Food Comes From, Inc. reported third-quarter 2026 total revenue of $7.3 million, a 4% increase from the prior year, driven by a 6% rise in verification and certification services to $5.9 million. Gross margins improved to 42.1% from 38.3% in the same period last year, resulting in operating income of $1.0 million, a 68% year-over-year increase. Net income for the quarter was $825,000, or $0.17 per diluted share, compared to $1.1 million in the prior year, as the previous period included a $946,000 gain on the sale of assets. Over the nine-month period ended September 30, 2026, the company generated $2.8 million in cash from operations and returned $268,000 to shareholders through stock buybacks.Technology
- BBGINov 13, 5:06 PMBeasley Broadcast Group reported third-quarter 2026 net revenue of $42.8 million, a 16.1% decrease from the prior year period, driven by weakness in traditional advertising markets. The company posted a net loss of $12.1 million for the quarter, though it achieved a 32% operating margin in its digital segment, up from 21% in the previous year. To strengthen its balance sheet, the company raised $4.6 million through equity offerings and subsequently sold two radio stations and two real estate parcels for over $10 million. Structural cost reductions helped limit the decline in operating expenses, while same-station digital revenue increased 4.4% on a year-to-date basis.Communication Services
- HITNov 13, 5:05 PMHealth In Tech reported a net loss of $7.1 million for the third quarter of 2026, driven by a $5.3 million provision for credit losses, compared to a net income of $0.5 million in the same period the prior year. The company's contracted revenue totaled $32.7 million for the first nine months of 2026, while pipeline revenue reached $156.4 million as of October 30, 2026. Distribution partners grew 15.9% year over year to 984, and the company revised its full-year 2026 revenue outlook to approximately $30 million. Sanjay Shrestha assumed the role of Chief Executive Officer in October 2026 to lead commercial execution and strategic growth initiatives.Technology
- XAIRNov 13, 5:00 PMBeyond Air reported a record quarterly revenue of $2.3 million for the period ended September 30, 2026, marking a 28% year-over-year increase. The company reaffirmed its full-year 2026 revenue guidance of $8 million and its 2027 guidance of $16 million to $18 million, contingent on FDA approval for its second-generation LungFit PH system. During the quarter, the company incurred a net loss of $7.8 million, or $3.76 per share, while maintaining $18.5 million in cash and equivalents. Additionally, Beyond Air announced the sale of its controlling interest in NeuroNOS Israel Ltd. and received FDA Breakthrough Device Designation for its LungFit GO product.Healthcare
- EVFMNov 13, 4:59 PMEvofem Biosciences reported net sales of $4.6 million for the third quarter of 2026, a decrease from $5.0 million in the prior year period, primarily due to lower ex-factory sales of PHEXX. The company generated $0.7 million in operating income and $0.9 million in net income attributable to common stockholders for the quarter, contrasting with a net loss in the same period of 2025. Strategic milestones achieved since July 2026 include contracting a second manufacturer for PHEXX production, shipping the 500,000th box of PHEXX, and adding a fifth site to an NIH-funded Phase 4 clinical trial for SOLOSEC. As of September 30, 2026, restricted cash and cash equivalents stood at $0.3 million, reflecting the company's ongoing liquidity position.Healthcare
- SRGNov 13, 4:51 PMSeritage Growth Properties reported a net loss of $36.2 million for the nine months ended September 30, 2026, driven by a $15.2 million impairment charge on a consolidated property and a $5.2 million impairment on an unconsolidated entity. During the third quarter, the company generated $3.0 million in gross proceeds from asset sales and received $8.9 million in distributions from an unconsolidated entity. As of September 30, 2026, the company held $45.4 million in cash and had $10.0 million available under its new revolving loan facility, which was established in July 2026 to refinance a prior term loan. The company's portfolio consists of eight properties with a total of approximately 0.7 million square feet of gross leasable area and 133 acres of land.Real Estate
- CNSYNov 13, 4:51 PMCerenome, Inc. reported third-quarter 2026 financial results showing $0.7 million in net diagnostic revenue and an operating loss of $7.5 million. The company expanded its payer coverage to approximately 190 million lives and launched CNSide molecular profiling tests for solid tumors and hematologic malignancies in October. Clinically, enrollment was completed in the Phase 2 ReSPECT-GBM trial for recurrent glioblastoma, while interim data from the ReSPECT-LM multi-dose study demonstrated safety with no dose-limiting toxicities. As of September 30, 2026, the company held $4.9 million in cash and investments, having recently secured a senior secured financing facility and raised additional equity.Healthcare
- NYCNov 13, 4:49 PMAmerican Strategic Investment Co. reported a net loss of $6.7 million for the third quarter of 2026, a significant decline from the $35.8 million net income recorded in the same period of 2025 due to the absence of a prior-year property disposition gain. Revenue for the quarter fell to $7.1 million from $12.3 million in 2025, primarily driven by the sale of 1140 Avenue of the Americas in the previous year. The company's portfolio, now consisting of five properties with a 74.0% occupancy rate, generated $3.5 million in cash net operating income and maintained a weighted-average remaining lease term of 6.0 years. Following the quarter, the company secured an extension and expansion lease with the State of New York at 123 William Street, increasing pro-forma occupancy at that location to approximately 75%.Real Estate
- FEMYNov 13, 4:47 PMFemasys Inc. announced a $30 million private placement in mid-August 2026 to fund U.S. commercial team expansion and the FemBloc pivotal trial. For the quarter ended September 30, 2026, U.S. sales rose slightly to $347,039, while total sales declined 44.5% to $404,597 due to timing of international distributor orders. The company reported a net loss of $4,564,815 for the quarter and $8,187,810 for the nine-month period, with cash and cash equivalents reaching approximately $23.9 million by September 30.Healthcare
- NXPLNov 13, 4:47 PMNextPlat Corp reported third-quarter 2026 consolidated revenue of approximately $10.5 million, a decrease from $13.8 million in the prior year period, driven by lower reimbursement rates and reduced retail prescription volumes. Despite the revenue decline, the company achieved a consolidated gross margin of 35.0%, a significant improvement from 19.9% in the same period last year, largely due to a 300% increase in pharmacy contract revenue. Net loss attributable to common stockholders narrowed by 66% to approximately $0.7 million, or $0.28 per diluted share, compared to $2.2 million in the prior year. The company ended the quarter with $11.2 million in cash and noted a 72% year-over-year growth in higher-margin 340B prescription volumes.Technology
- Nov 13, 4:41 PMThe Fidelity Private Credit Fund targets senior secured loans to private equity-owned middle-market companies, maintaining a weighted average loan-to-value of 39% and net leverage of 4.7 times as of September 30, 2026. The fund's investment strategy emphasizes disciplined underwriting and strong documentation to navigate an environment characterized by rising interest rates and increased credit dispersion among borrowers. Performance data indicates a year-to-date total net return of 4.52% for Class I shares, with a distribution rate of 9.36% calculated on the net asset value. The portfolio is heavily concentrated in floating-rate investments at 99.8%, with top holdings including Project Fractal in aerospace, Project METIS in healthcare services, and Project Sentinel in industrial distribution.
- AIRTNov 13, 4:35 PMAir T, Inc. reported second-quarter fiscal 2027 revenues of $146.9 million, a 129% increase from the prior year, driven largely by the inclusion of Regional Express Holdings Pty Ltd acquired in December 2025. The company posted an operating loss of $11.8 million and a net loss per share of $7.48, contrasting with the prior year's operating income and net income per share. Adjusted EBITDA declined to $4.4 million from $7.9 million in the previous year, impacted by significant fuel cost increases and unscheduled engine removals at the Regional Airline segment. Despite challenges in the newly acquired Rex unit, other segments such as Overnight Air Cargo and Ground Support Equipment contributed positively to the quarter's financial performance.Industrials
- CLDINov 13, 4:35 PMCalidi Biotherapeutics reported a net loss of $3.6 million for the third quarter of 2026, a significant improvement from the $10.8 million loss in the same period of 2025. The company advanced its lead candidate CLD-401, presenting preclinical data at the ESMO Congress 2026 that demonstrated complete tumor eradication in 80% of mice in breast cancer models. General and administrative expenses decreased by 39% to $1.6 million as the firm executed a restructuring plan to extend its cash runway. Additionally, Calidi raised $1.2 million through an at-the-market registered direct offering and ended the quarter with $3.9 million in cash.Healthcare
- NWTGNov 13, 4:31 PMNewton Golf Company reported a net loss of $1.2 million for the third quarter of 2026, driven by a 47% decline in net sales to $1.4 million due to reduced marketing activity. The company expanded its 2.0 shaft rollout with over 80 professional golfers using its products and grew its fitter network to approximately 301 accounts. Following the quarter, Newton raised approximately $3.0 million through equity financings and converted $1.0 million of debt into equity, resulting in a pro forma stockholders' equity of $5.2 million. Despite these liquidity improvements, the company faces Nasdaq compliance concerns regarding its minimum equity requirement and anticipates needing additional financing to continue operations.Consumer Cyclical
- PEDNov 13, 4:31 PMPEDEVCO Corp. reported a net loss of $9.2 million for the third quarter of 2026, driven by a $16.6 million net loss on derivative contracts that offset higher operating income from an expanded asset base. Average daily production surged 298% year-over-year to 5,850 barrels of oil equivalent per day following the October 2025 merger with Juniper Capital Advisors, while revenue increased 411% to $35.5 million. Adjusted EBITDA rose 239% to $14.7 million, reflecting increased production volumes and a 31% rise in the average realized oil price to $83.81 per barrel. The company updated its full-year 2026 net capital expenditure guidance to a range of $37 million to $42 million and reiterated its Adjusted EBITDA guidance of $60 million to $70 million.Energy
- VUZINov 13, 4:30 PMVuzix Corporation reported third-quarter 2026 total revenues of $0.7 million, a 38% decrease from the same period in 2025, driven by a 45% decline in product sales. The company recorded a net loss of $8.4 million, or $0.10 per share, compared to a $7.4 million loss in the prior year quarter. Strategic progress includes the shipment of evaluation samples for the Causeway optical interconnect platform to over 10 companies and the delivery of the SHRIKE Defense Display Platform for customer evaluation. Additionally, Vuzix secured nearly $1.0 million in new OEM defense orders and completed facility upgrades at its Rochester waveguide manufacturing site.Technology
- NVVENov 13, 4:30 PMNuvve Holding Corp. reported third-quarter 2026 total revenues of $1.09 million, a 31.9% decrease from the same period in 2025, driven by lower product sales and service revenue. The company recorded a net loss of $4.7 million for the quarter, with gross profit margins declining to 24.0% from 52.0% in the prior year due to higher warranty costs and project write-downs. Despite the revenue decline, Nuvve raised $0.97 million in gross proceeds through debt and equity instruments to support operations, while megawatts under management increased by 5.7% to 29.9 megawatts.Consumer Cyclical
- INDPNov 13, 4:30 PMIndaptus Therapeutics reported a net loss of $1.0 million for the third quarter of 2026, a significant decrease from $3.0 million in the same period of 2025, driven by reduced research and development and general administrative expenses. The company completed a private placement in September 2026, raising approximately $24.0 million in gross proceeds to fund working capital and early-stage research into a neurotechnology device for sleep-related conditions. As of September 30, 2026, Indaptus held $30.6 million in cash, cash equivalents, and short-term investments, providing sufficient liquidity to support its anticipated operating expenses. The company also announced a strategic shift away from its Decoy20 clinical program to focus on new opportunities with long-term potential.Healthcare
- IRLANov 13, 4:30 PMIRulya Therapeutics Inc., formerly Quince Therapeutics, reported a net loss of $27.7 million for the third quarter ended September 30, 2026, while maintaining a cash position of $105.2 million expected to fund operations through 2028. The company relaunched with a new name and ticker symbol IRLA, appointing a new leadership team and board of directors to focus on its lead candidate, LAM-001. Clinical progress includes a fully enrolled Phase 2 trial for bronchiolitis obliterans syndrome (BOS) with data anticipated in early 2027, an ongoing Phase 2b trial for pulmonary hypertension associated with interstitial lung disease (PH-ILD), and a planned Phase 2 study for sarcoidosis-associated pulmonary hypertension (SAPH) to begin in late 2026.Healthcare
- BOCNov 13, 4:29 PMBoston Omaha Corporation reported a net loss attributable to common stockholders of $192,000 for the third quarter of 2026, compared to a loss of $2.588 million in the same period the previous year. Total revenues for the quarter reached $22.178 million, driven by billboard rentals and broadband services, while net other expense was recorded at $3.611 million due primarily to fair value changes in investment funds. The company repurchased 457,308 shares of its Class A common stock for $6.4 million during the quarter and subsequently increased its share repurchase program authorization from $30 million to $85 million. As of September 30, 2026, the company held $29.743 million in unrestricted cash and investments with a book value per share of $16.64.Communication Services
- ANVSNov 13, 4:24 PMAnnovis Bio, Inc. reported third-quarter 2026 financial results showing cash and cash equivalents of $2.8 million and a net loss of $9.5 million. The company raised $21.0 million in gross proceeds through an underwritten public offering to fund operations through the March 2027 data readout for its Phase 3 DUET-AD Alzheimer's study. Clinical progress includes full enrollment of 862 patients in the DUET-AD trial and 326 patients in the Parkinson's open-label extension study. Upcoming milestones include the last patient visit for the 6-month treatment period on December 31, 2026, and a planned database lock on February 8, 2027.Healthcare
- ASTCNov 13, 4:20 PMAstrotech Corporation reported a net loss of $2.948 million for the first quarter of fiscal year 2027, ending September 30, 2026, compared to a loss of $3.465 million in the same period the prior year. Total operating expenses decreased by 15.7% to $3.1 million, driven primarily by a reduction in research and development costs, while revenue declined slightly to $274,000. As of the quarter's end, the company maintained $11.6 million in working capital and had deployed its TRACER 1000 technology in approximately 38 locations across 17 countries. Additionally, Astrotech submitted a proposal to NASA under the NextSTEP-3 LEIA program to advance its Mobile Power System for lunar infrastructure applications.Industrials
- GXAINov 13, 4:17 PMGaxos.ai Inc. reported third-quarter 2026 consolidated revenue of approximately $2.81 million, representing a 14.5% increase from the second quarter and a 464.9% increase from the same period in 2025. During the quarter, advertising and marketing expenses decreased by 16.7% to $2.62 million, resulting in an improved revenue generation of $1.08 per advertising dollar, a 38% improvement over the previous quarter. The company held cash and short-term investments of $13.30 million as of September 30, 2026, and issued 3,007,654 shares of common stock following warrant exercises. Gaxos plans to focus on increasing recurring revenue, improving customer acquisition efficiency, and scaling products with favorable contribution economics for the remainder of 2026.Communication Services
- FIEENov 13, 4:16 PMFiEE, Inc. reported a 382.1% year-over-year revenue increase to approximately $9.6 million for the nine months ended September 30, 2026, driven by its strategic transition to SaaS solutions and phygital art advisory services. The company achieved a net income of $3.6 million for the period, marking a significant turnaround from a net loss of $1.3 million in the same timeframe the previous year. Revenue growth was primarily fueled by SaaS-MCN digital services, software services, and new phygital art advisory offerings, which generated $3.5 million in revenue compared to zero in 2025. Additionally, the company onboarded 939 customers for its SaaS-MCN services and secured $4.1 million in contracts for software services as of September 30, 2026.Technology
- MEDSNov 13, 4:15 PMDataMEDS AI reported a 50% sequential revenue increase to $2.7 million for the third quarter of 2026, driven primarily by growth in its Corexa Pharmacy drug dispensing operations. The company achieved a net profit of $10.535 million, resulting in a net profit per share of $2.72, a significant turnaround from the net loss recorded in the same period the previous year. Key business developments included the launch of the Health Lives Here mobile app, an exclusive license for the REBOOT GLP-1 patient management platform, and the acquisition of Helomics cancer diagnostics laboratory. Additionally, the company regained full compliance with Nasdaq listing standards and secured a memorandum of understanding with an HMO to deploy its mobile application to over 25,000 members.Consumer Defensive
- AVEXNov 13, 4:15 PMAEVEX Corp. reported third-quarter 2026 total revenue of $189.7 million, a 56.5% increase from the prior year period, driven primarily by growth in its Airborne Systems segment and the recent acquisition of BlackSea Technologies. The company posted a net loss of $16.8 million for the quarter, contrasting with a net income of $9.9 million in the same period last year, while Adjusted EBITDA rose to $30.8 million. Following the establishment of Maritime Systems as a new reportable segment, AEVEX raised its full-year 2026 revenue outlook to a range of $820.0 million to $840.0 million and Adjusted EBITDA guidance to $128.0 million to $132.0 million.Industrials
- ECTMNov 13, 4:14 PMECA Marcellus Trust I announced a quarterly distribution of $0.021 per unit for the period ended September 30, 2026, payable on or before November 30, 2026, to holders of record as of November 23, 2026. The trustee is withholding approximately $90,000 from this quarter's distribution to build a cash reserve toward a target of $3.8 million, which is intended to cover future known, anticipated, or contingent expenses. The trust holds royalty interests in natural gas properties in the Marcellus Shale formation in Greene County, Pennsylvania, and its distributions fluctuate based on production proceeds, commodity prices, and administrative costs. Non-U.S. persons may be subject to withholding taxes on income effectively connected to a U.S. trade or business or on fixed, determinable, annual, periodic income from U.S. sources.Energy
- ICMBNov 13, 4:11 PMInvestcorp Credit Management BDC, Inc. reported a net asset value per share of $3.02 as of September 30, 2026, representing a decrease of $0.42 from the previous quarter. The company recorded a net investment loss before taxes of $1.8 million and a total net decrease in net assets from operations of $4.8 million for the three-month period. During the quarter, the investment adviser waived all management fees and $0.2 million of previously accrued incentive fees, while the weighted average yield on debt investments fell to 9.53%. Subsequent to the quarter end, the company received $11.5 million in repayments and repaid $10.0 million of outstanding borrowings under its revolving credit facility.Financial Services
- ROLRNov 13, 4:10 PMHigh Roller Technologies reported a net loss of $2.8 million for the third quarter of 2026, driven by a 51% decline in net revenues to $2.4 million as the company exited certain online casino markets. Despite lower revenue, the company maintained a strong liquidity position with $13.4 million in cash and no outstanding borrowings at the end of the quarter. The firm commercially launched its ROLR prediction markets platform on October 21, 2026, and released its iOS application in November, aiming to establish prediction markets as a primary growth driver in 2027.Consumer Cyclical
- BYFCNov 13, 4:10 PMBroadway Financial Corporation reported net income attributable to common stockholders of $392 thousand for the third quarter of 2026, a significant improvement from the $24.6 million net loss recorded in the same period of 2025. During the first nine months of 2026, the company achieved consolidated net income of $1.0 million, driven by an 11.4% increase in net loans and a 21.0% rise in total deposits. The bank maintained stable credit quality with non-accrual loans representing 1.20% of gross loans and reported a strong Community Bank Leverage Ratio of 12.83% as of September 30, 2026.Financial Services
- FFRNov 13, 4:10 PMFF EAI Robotics Ecosystem Inc. completed the acquisition of Faraday Future's robotics business on October 23, 2026, transforming into a pure-play humanoid and bionic Physical AI robotics company. For the nine months ended September 30, 2026, the acquired robotics business generated approximately $2.3 million in standalone revenue with a gross margin of 26%, entering the company with no outstanding debt. The company has advanced its Four-Core Full-Stack AI ecosystem, introducing the FF OmniMind brain platform which ranked first on the RoboColiseum benchmark, and achieved a record 351 robot shipments in October. Looking ahead, FFR plans to launch a 100-city robotics education initiative, introduce its Physical Cloud technology platform during CES, and begin domestic factory production in the first quarter of 2027.Technology
- VTGNNov 13, 4:08 PMVistagen Therapeutics reported a net loss of $10.7 million for the second quarter of fiscal year 2027, ending September 30, 2026, with cash and marketable securities totaling $20.0 million. The company received constructive feedback from the FDA regarding its Phase 3 development plan for fasedienol in social anxiety disorder, which will now focus on overall treatment rather than just acute management. Preliminary data from the open-label extension of the PALISADE-4 study showed clinically relevant improvements in social anxiety over four months. Additionally, Vistagen appointed Douglas J. Williamson, MD, to its board and implemented cost-management initiatives to extend its operating runway into 2027.Healthcare
- INBXNov 13, 4:08 PMInhibrx Biosciences reported a net loss of $38.7 million for the third quarter of 2026, driven by $26.0 million in research and development expenses and $7.8 million in general and administrative costs. The company recognized $2.0 million in revenue from a non-exclusive license agreement with Pfizer, while cash and cash equivalents increased to $199.5 million as of September 30, 2026. Clinical milestones include upcoming data presentations for ozekibart in Ewing sarcoma and the ongoing enrollment of ordastobart in head and neck squamous cell carcinoma. Additionally, the company is advancing commercial readiness activities for ozekibart in chondrosarcoma while preparing for a potential Biologics License Application.Healthcare
- OPRXNov 13, 4:06 PMOptimizeRx reported third-quarter 2026 revenue of $21.6 million, a 17% decrease from the prior year, while achieving a net income of $1.2 million and adjusted EBITDA of $6.3 million. The company updated its full-year 2026 revenue guidance to a range of $87 million to $93 million, though adjusted EBITDA guidance remains unchanged at $21 million to $25 million. Since June 30, 2026, OptimizeRx repaid $9.3 million in debt principal, reducing its outstanding principal balance to $10.4 million. Management cited margin expansion and cost management as drivers for the 23% year-over-year increase in adjusted EBITDA despite the revenue decline.Healthcare
- BJDXNov 13, 4:05 PMBluejay Diagnostics completed enrollment in its SYMON-II clinical validation study with 777 evaluable patients, exceeding the original target of 750. The company established an alternative manufacturing facility ahead of a contractual deadline and advanced U.S. commercial infrastructure through new distribution agreements. As of September 30, 2026, the company held $7.38 million in cash and projects these resources will sustain operations through the second quarter of 2027. Bluejay aims to submit an FDA 510(k) application for its Symphony IL-6 test during the first half of 2027.Healthcare
- TXMDNov 13, 4:05 PMTherapeuticsMD, Inc. reported net income from continuing operations of $501 thousand, or $0.04 per share, for the third quarter of 2026, an increase from $50 thousand in the same period of 2025. License revenues rose to $1.3 million, driven by a $365 thousand milestone payment from Knight related to IMVEXXY sales for the year ended December 31, 2025. Total operating expenses increased by 5.6% to $1.7 million, primarily due to higher legal and professional fees. As of September 30, 2026, the company held $10.4 million in cash and cash equivalents while continuing to evaluate strategic alternatives such as a potential acquisition or merger.Healthcare
- CRISNov 13, 4:05 PMCuris, Inc. reported a net loss of $8.1 million for the third quarter of 2026, with no revenue generated due to the prior sale of Erivedge royalties. The company is currently enrolling patients in two ongoing studies, the TakeAim CLL study and the TakeAim Lymphoma study, which evaluate emavusertib in combination with BTK inhibitors. Clinical data from the TakeAim Lymphoma study showed objective response rates of 100% for BTK-naïve patients and 33% for BTKi-experienced patients as of July 2026. Financially, Curis held $5.0 million in cash and cash equivalents as of September 30, 2026, and expects its existing resources combined with recent private placement proceeds to fund operations into the first quarter of 2027.Healthcare
- SEVNov 13, 4:05 PMAptera Motors reported a GAAP net loss of $14.0 million for the third quarter of 2026 and $35.0 million for the first nine months of the year. The company raised approximately $6.0 million in gross proceeds during the quarter through a warrant inducement transaction and entered a strategic partnership with Shanghai Launch Automotive Technology to support manufacturing. As of September 30, 2026, Aptera held $9.2 million in cash and cash equivalents, including $4.1 million in refundable reservation fees, while maintaining over 49,000 vehicle reservations. Management estimates a need for approximately $25 million to reach start of production and $65 million to achieve a production rate of 500 vehicles per month.Consumer Cyclical
- ENVBNov 13, 4:05 PMEnveric Biosciences reported a net loss of $2.5 million for the third quarter ended September 30, 2026, with cash-on-hand totaling $5.6 million. The company advanced final IND-enabling activities for its lead candidate EB-003, a non-hallucinogenic neuroplastogenic therapeutic, supported by preclinical data showing brain penetration and a distinct activity profile compared to DMT. Recent in vitro studies confirmed favorable absorption and metabolic properties with a reduced potential for drug-drug interactions, while independent assays reinforced the compound's predicted non-hallucinogenic profile. Additionally, Enveric secured a U.S. patent allowance for next-generation non-hallucinogenic mescaline derivatives in its EVM401 series.Healthcare
- TRXBNov 13, 4:04 PMTRexBio reported a net loss of $13.2 million for the third quarter of 2026, driven by increased research and development expenses related to its TRB-061 and TRB-071 programs. The company announced positive Phase 1a results for TRB-061, an investigational TNFR2 agonist for atopic dermatitis, which demonstrated proof of mechanism and safety in healthy volunteers. TRexBio completed a $133.5 million initial public offering in October 2026, extending its cash runway into the second half of 2029. Topline data for the Phase 1b trial of TRB-061 is expected in mid-2027, while a Phase 1 trial for the CD30 agonist TRB-071 is anticipated to begin in the first half of 2027.Healthcare
- WSBFNov 13, 4:00 PMWaterstone Financial, Inc. reported net income of $6.2 million, or $0.36 per diluted share, for the quarter ended September 30, 2026, a decrease from $7.9 million in the same period of 2025. The Community Banking segment achieved record quarterly net interest income of $16.0 million, driven by a reduction in the average cost of funds, while the Mortgage Banking segment recorded a pre-tax loss of $754,000 due to elevated mortgage rates and compressed sales margins. Consolidated return on average assets for the quarter was 1.09%, and book value per share declined to $19.29, primarily due to accumulated other comprehensive losses from rising treasury rates. Total dividends declared for the quarter amounted to $0.17 per common share.Financial Services
- Nov 13, 3:04 PMImricor Medical Systems commenced its U.S. commercial launch in the third quarter of 2026, securing its first two hospital customers, Rady Children's Hospital–San Diego and Children's Medical Center Dallas, for its NorthStar interventional MR system. The company reported revenue of US$188k, a 437% increase from the prior period, driven by initial sales and installations while maintaining a cash balance of US$62.1m. Regulatory progress included FDA 510(k) clearances for pediatric label expansions on NorthStar and the Vision-MR Diagnostic Catheter, as well as the acceptance of the manufacturing module for the Vision-MR Ablation Catheter PMA application. Additionally, Imricor established a strategic partnership with Philips to issue a Third Party Product Compatibility Declaration, enabling NorthStar to operate on the Philips MR installed base and launching a joint turnkey iMR lab solution.
- DBHLNov 13, 3:03 PMDeep Isolation Nuclear, Inc. reported consolidated revenue of $1.8 million and a net loss of $3.8 million for the third quarter of 2026. The company advanced its Commercialization Pilot near Cameron, Texas, by securing a drilling permit from the Texas Railroad Commission and initiating well pad construction. Operational progress included selection as the sole industrial partner on three U.S. Department of Energy grants for artificial intelligence-enabled nuclear waste repository analysis. As of September 30, 2026, the company held $16.5 million in available cash with 57.77 million common shares outstanding.
- NTWKNov 13, 2:39 PMNETSOL Technologies reported fiscal first quarter 2027 revenue of $16.4 million, representing a 9.3% increase from the prior-year period. The company achieved a gross margin of 50.5%, an expansion of over 1,100 basis points, driven by revenue mix changes and the capitalization of $1.0 million in software development costs. GAAP net income attributable to NETSOL turned positive at $0.16 million, or $0.01 per diluted share, compared to a net loss of $2.36 million in the same period last year. Additionally, adjusted EBITDA attributable to NETSOL improved to $0.48 million from a negative $1.66 million in the prior year, while cash and cash equivalents stood at $19.7 million as of September 30, 2026.Technology
- INUVNov 13, 2:29 PMInuvo reported a 70% year-over-year decline in net revenue to $6.8 million for the third quarter of 2026, driven by an 80% drop in Legacy Search revenue and a 24% decrease in Audience Modeling revenue. The company recorded a net loss of $5.0 million, or $0.28 per share, with operating expenses totaling $7.8 million that included a $2.4 million non-cash impairment charge. Despite the revenue contraction, Inuvo highlighted a stabilizing Legacy Search segment and an expanding sales pipeline for its IntentKey privacy-first AI solutions across automotive, travel, healthcare, and financial sectors. Management expects fourth-quarter Audience Modeling revenue to increase supported by the growing pipeline, while Legacy Search revenue and margins are projected to remain consistent with the third quarter.Communication Services
- Nov 13, 1:36 PMVaragon Capital Corporation reported a net asset value of $8.93 per share and net investment income of $0.23 per share for the third quarter of 2026, resulting in an annualized yield of 10.2%. The company declared a fourth-quarter distribution of $0.23 per share, maintaining the same rate as the previous quarter, while total investments at fair value stood at $819 million across 121 portfolio companies. Credit quality remained robust with approximately 90% of investments rated as low risk, although three portfolio companies were placed on non-accrual status by the end of the period.
- INBPNov 13, 12:12 PMIntegrated BioPharma, Inc. reported revenue of $9.9 million for the quarter ended September 30, 2026, a 22% decrease from the $12.7 million recorded in the same period of 2025. The company posted an operating loss of $1.0 million and a net loss of approximately $0.7 million, or $0.02 per share, compared to an operating income of $0.2 million and net income of $0.1 million in the prior year quarter. Revenue concentration remained high, with the two largest customers in the Contract Manufacturing Segment accounting for approximately 88% of total revenue in the current quarter.Consumer Defensive
- DYAINov 13, 11:57 AMDyadic International, Inc. reported a net loss of $1,357,041 for the third quarter ended September 30, 2026, driven by a 61.4% decline in total revenue to $449,101. The company achieved a significant milestone by recording its first direct commercial product sales of recombinant transferrin and DNase I, while also expanding distribution through Integrated Biotherapeutics. Strategic partnerships advanced with Proliant promoting AlbuFree DX and Inzymes commercializing a second chymosin product, alongside continued progress on the C1 biopharmaceutical platform for vaccine and antibody development. As of September 30, 2026, the company held $6,046,083 in cash and equivalents, reflecting a decrease from the previous year-end balance.Healthcare
- INLXNov 13, 11:15 AMIntellinetics, Inc. reported a narrowed GAAP net loss of $239,163 for the third quarter of 2026, compared to a loss of $369,765 in the same period the previous year. Total revenue for the quarter increased 0.7% year-over-year to $4.03 million, driven by growth in Software as a Service and storage services, while professional services revenue declined. The company achieved positive Adjusted EBITDA of $144,821, marking a sequential improvement of approximately $516,000 from the second quarter. For the nine-month period ended September 30, 2026, the company recorded a net loss of $2.5 million and total revenue of $11.88 million, with management revising its full-year SaaS growth outlook to single-digit year-over-year increases.Technology
- UWHRNov 13, 10:02 AMUwharrie Capital Corp reported total assets of $1.23 billion as of September 30, 2026, representing a $15 million increase from the prior year. Net income for the nine-month period ended September 30, 2026, reached $10 million, an increase of nearly 21% compared to the same period in 2025. The company's loan portfolio grew by $27 million to $709 million, supported by a $14 million year-over-year increase in core deposits. In response to this financial progress, the Board of Directors declared a 3% stock dividend payable on November 23, 2026, to shareholders of record as of November 5, 2026.
- MOBXNov 13, 9:50 AMMobix Labs reported preliminary fourth-quarter revenue of approximately $1.81 million, a 129% sequential increase that exceeded its guidance range. The company's gross margin expanded significantly to 44.5% from 12.9% in the prior quarter, while the GAAP operating loss narrowed by 11% to $6.56 million. Balance sheet improvements included a 21% reduction in total liabilities and a $5.2 million increase in stockholders' equity compared to the previous year. Management anticipates continued revenue growth as the company addresses working capital constraints and builds on its operational recovery.Technology
- BCGNov 13, 9:29 AMBinah Capital Group reported third-quarter 2026 results showing a 5.0% year-over-year increase in assets under management to $31.4 billion. Total revenue for the quarter rose 9.4% to $50.6 million, while GAAP net income increased 44.4% to $2.6 million. The company also reported EBITDA growth of 74.1% to $4.7 million and Adjusted EBITDA of $4.9 million. As of September 30, 2026, Binah held $13.2 million in cash and cash equivalents against $16.7 million in outstanding long-term debt.Financial Services
- ALOYNov 13, 9:28 AMREalloys Inc. reported a net loss of $30.5 million for the third quarter of 2026, driven primarily by $25.3 million in non-cash stock-based compensation, while net revenues increased to $0.4 million. The company executed a non-binding term sheet with the U.S. Army to establish a heavy rare earth processing facility at Tooele Army Depot, targeting commissioning in early 2028 with a capacity of 50 tonnes of dysprosium and terbium oxide annually. REalloys aims to achieve initial U.S.-based production of approximately 3,000 tonnes of sintered NdFeB magnets by 2030, supported by a planned $10 million investment in research and development through 2027. As of September 30, 2026, the company maintained a cash balance of $116.2 million and a virtually debt-free balance sheet.Basic Materials
- LFWDNov 13, 9:25 AMLifeward reported third-quarter 2026 revenue of $5.4 million, a 12% decrease from the prior year, driven by an 18% year-over-year increase in AlterG revenue to $3.6 million offset by lower ReWalk sales during its transition to a channel-partner distribution model. The company posted a net loss of $5.1 million, or $1.32 per share, compared to a net loss of $3.2 million in the same period last year, with gross margin declining to 27.4% due to foreign exchange fluctuations and acquisition-related expenses. Lifeward is advancing its strategic shift for ReWalk to expand patient access through established distributors while maintaining coverage under Medicare and major insurance plans. Additionally, the company strengthened its clinical evidence base with two new peer-reviewed studies and continues to develop AI-enabled rehabilitation technologies alongside its Protein Oral Delivery platform.Healthcare
- CTGONov 13, 9:00 AMContango Silver & Gold reported a net loss of $23.0 million for the third quarter of 2026, driven primarily by increased exploration expenditures and lower income from its Peak Gold Joint Venture. The company's Manh Choh mine transitioned from the north pit to the south pit, resulting in reduced gold production for the quarter but improved mill recovery rates to 86.5%. Contango received a $6 million cash distribution from the JV in October and expects to complete its 2026 production guidance of 40,000 gold equivalent ounces with the fourth campaign. Additionally, the company advanced permitting and drilling at its Kitsault Valley, Johnson Tract, and Lucky Shot projects while repaying debt and eliminating most hedge delivery obligations.Basic Materials
- RMIXNov 13, 8:36 AMSuncrete, Inc. reported third-quarter 2026 revenue of $141.0 million, representing a 163% increase compared to the same period in 2025 and a 45% rise from the second quarter of 2026. The company achieved an Adjusted EBITDA of $22.4 million and a Supplemental Adjusted EBITDA of $23.3 million, while total ready-mix concrete yards delivered increased by 32% quarter-over-quarter. Despite the revenue growth, the company reported a net loss of $78,000 for the quarter, contrasting with a net loss of $37.1 million in the previous quarter. Suncrete has revised its full-year 2026 outlook to project revenue between $408.0 million and $434.0 million and Adjusted EBITDA between $60.0 million and $64.0 million.Basic Materials
- MTVANov 13, 8:35 AMMetaVia Inc. reported a net loss of $4.6 million for the third quarter of 2026, driven by increased research and development expenses related to its lead candidate DA-1726. The company announced positive interim data from a Phase 1 study showing a 68.1% placebo-adjusted reduction in liver fat and 13.5% weight loss, supporting plans for a Phase 2 trial in MetALD and ALD expected to begin in late 2027. Additionally, MetaVia appointed Sarah Browne, M.D., as Chief Medical Officer to lead clinical development while advancing its second candidate, vanoglipel, in combination with resmetirom for MASH.Healthcare
- XBIONov 13, 8:35 AMXenetic Biosciences reported a net loss of approximately $1.7 million for the third quarter of 2026, driven by a 138% increase in general and administrative expenses related to a proposed share exchange transaction. The company entered into a definitive agreement to acquire Santersus AG in an all-stock deal expected to close in early 2027, creating a Nasdaq-listed entity named Santersus Bio, Inc. focused on targeting neutrophil extracellular traps across multiple therapeutic areas. Strategic highlights include the initiation of a Phase I clinical study combining Xenetic's DNase I technology with CAR T-cell therapy for large B-cell lymphoma and the advancement of preclinical research demonstrating DNase I's ability to enhance antitumor activity.Healthcare
- SGRPNov 13, 8:33 AMSPAR Group, Inc. reported a net income of $50,000 for the third quarter of fiscal 2026, marking the second consecutive quarter of profitability despite a 19.0% year-over-year decline in net revenues to $33.5 million. Gross margins expanded to 18.9% driven by a shift toward higher-quality services, while selling, general, and administrative expenses decreased by 39.0% to $5.6 million due to cost reduction initiatives. The company generated $1.4 million in Adjusted EBITDA for the quarter and $4.3 million for the nine-month period, ending the quarter with $4.7 million in cash and cash equivalents. Additionally, SPAR Group announced a new three-year services agreement with a national retailer to begin in 2027 and adjusted its full-year 2026 revenue guidance to a range of $125 million to $130 million.Industrials
- BKYINov 13, 8:30 AMBIO-key International reported a 39% year-over-year increase in Q3 2026 software license fee revenue to $1.3 million, marking its third consecutive quarter of double-digit growth driven by momentum in the Middle East and Europe. The company's total revenue for the quarter was $1.48 million, while its gross margin improved to 90% and net loss narrowed to $886,000 compared to the prior year period. During the quarter, BIO-key retired its remaining note payable, leaving the company effectively debt-free, and working capital increased to $3.1 million. Looking ahead, the company anticipates a strong finish to 2026 and a robust start to 2027 supported by new government contracts and expanding deployments.Industrials
- QUCYNov 13, 8:18 AMQuantum Cyber N.V. reported its first revenue of approximately $966,833 for the third quarter of 2026, generated by its precision metal stamping operations at the Bridgeport, Connecticut facility. The company secured an $8.0 million funding commitment from CEO David Lazar to support the expansion of its autonomous defense manufacturing capabilities and the development of its Project LightShift quantum antenna technology. Additionally, the company resolved a legacy legal claim with Boustead Securities for $250,000 and expanded the licensed field of use for its quantum antenna to include unmanned surface and underwater vehicles. Shareholders' equity increased significantly to approximately $16.2 million by September 30, 2026, driven by $15.2 million in proceeds from warrant exercises and $6.0 million from preferred share issuances.Healthcare
- AARDNov 13, 8:18 AMAardvark Therapeutics received FDA approval to lift the clinical hold on its investigational drug ARD-101 for treating hyperphagia in Prader-Willi Syndrome, allowing the company to proceed with an open-label trial at a dose of 200 mg twice daily. The company plans to meet with the FDA in the first quarter of 2027 to finalize its clinical development strategy and expects to resume clinical activities in PWS during 2027. Financial results for the third quarter of 2026 showed a net loss of $19.2 million, with the company maintaining $60.3 million in cash and short-term investments to fund operations through 2027.Healthcare
- CNVSNov 13, 8:15 AMCineverse reported second-quarter fiscal 2027 revenue of $26.0 million, representing a 110% increase from the prior year quarter, driven primarily by technology and media services streams which now account for 55% of total revenue. The company achieved a net income of $3.2 million, or $0.11 per diluted share, marking a significant turnaround from a $5.7 million net loss in the same period last year, while Adjusted EBITDA rose to $1.7 million for the third consecutive positive quarter. Operational progress included the full integration of Giant Worldwide and IndiCue, resulting in a consolidated product portfolio on the Matchpoint platform and a 300 basis point sequential improvement in direct operating margin. Cineverse reaffirmed its full-year fiscal 2027 guidance of $115 to $120 million in revenue and $10 to $20 million in Adjusted EBITDA, citing strong momentum in advertising technology and content distribution.Communication Services
- BFRINov 13, 8:10 AMBiofrontera Inc. reported net product revenue of $9.1 million for the third quarter of 2026, representing a 29.8% increase from the prior-year period. The company achieved a gross margin of 74.4% and a net loss of $6.4 million, or $0.42 per share, during the quarter. Key developments included FDA approval of Ameluz for superficial basal cell carcinoma and a U.S. Customs ruling allowing the import of the redesigned XL-C lamp. For the nine months ended September 30, 2026, revenue grew 26.6% to $31.2 million while the net loss narrowed to $11.8 million.Healthcare
- OWLTNov 13, 8:05 AMOwlet reported third-quarter 2026 revenue of $30.4 million, a 4.9% decrease from the prior year, driven by lower hardware sales but offset by a 140% increase in subscription revenue to $3.6 million. The company achieved a gross margin of 53.8% and reported a net income of $1.4 million for the quarter. However, Owlet withdrew its full-year 2026 financial outlook following a safety incident involving exposed camera cables, which necessitates a free replacement program for all camera owners. Anticipated remediation expenses, potential retailer returns, and near-term demand uncertainty are expected to impact the fourth quarter results.Healthcare
- PDSBNov 13, 8:05 AMPDS Biotechnology Corporation reported a net loss of $7.6 million, or $0.11 per share, for the third quarter ended September 30, 2026, compared to a $9.0 million loss in the same period the previous year. The company announced the initial closing of a PIPE financing of up to $22.3 million led by Nant Capital, LLC, which included the appointment of Dr. Patrick Soon-Shiong and James Banaag to its Board of Directors. During the quarter, research and development expenses decreased to $2.1 million from $4.6 million in the prior year period, primarily due to reduced clinical trial costs. As of September 30, 2026, the company held $15.2 million in cash and cash equivalents while continuing to prioritize its lead program, PDS0301, and advancing its Versamune cancer vaccine platform.Healthcare
- PAVMNov 13, 8:05 AMPAVmed reported preliminary third-quarter 2026 financial results showing operating expenses of approximately $6.8 million and a non-GAAP adjusted net loss of $1.2 million. Its subsidiary Lucid Diagnostics began receiving Medicare payments for its EsoGuard test in October and recognized $1.2 million in revenue for the quarter. Veris Health achieved a design freeze for its implantable physiological monitor and initiated a 90-day GLP animal study ahead of an expected early 2027 FDA submission. Additionally, PAVmed engaged with the FDA regarding its PortIO and Octeris products, with Octeris preparing to submit an initial pre-submission package.Healthcare
- FBIONov 13, 8:05 AMFortress Biotech reported third-quarter 2026 net revenue of $19.2 million, representing a 9% increase from the prior year period, driven primarily by $18.9 million in product revenue. The company fully repaid its $15.0 million senior secured credit facility with Oaktree in September 2026, leaving it with no outstanding debt at the parent level. Key corporate developments included the in-licensing of FB-607 for irritable bowel syndrome, the approval of anselamimab in Japan for amyloidosis, and a $130 million Series B financing for partner Crystalys Therapeutics. Financial results for the quarter showed a net loss attributable to common stockholders of $7.9 million, while consolidated cash and cash equivalents rose to $152.2 million.Healthcare
- BNTCNov 13, 8:02 AMBenitec Biopharma reported positive interim clinical results for its BB-301 therapy in a Phase 1b/2a study for Oculopharyngeal Muscular Dystrophy, showing a 100% responder rate across all patients in Cohort 1 and Cohort 2 with no serious adverse events. The company announced a net loss of $12.9 million for the first quarter ended September 30, 2026, while maintaining approximately $176.5 million in cash and cash equivalents. Benitec plans to finalize the design for its pivotal BB-301 trial in the first quarter of 2027, with the study on track to begin in mid-2027. Additionally, the company intends to transition its fiscal year-end from June 30 to December 31, presenting operational guidance on a calendar-year basis and financial guidance on a fiscal-year basis.Healthcare
- IMUXNov 13, 8:00 AMImmunic, Inc. reported a net loss of $42.3 million for the third quarter of 2026, driven by increased research and development and general and administrative expenses. The company's Phase 3 ENSURE-1 and ENSURE-2 trials for vidofludimus calcium in relapsing multiple sclerosis remain on track to report top-line data in December 2026. Immunic is also initiating a Phase 3 PROTECT-MS trial for progressive multiple sclerosis, with the first patient enrollment expected in the first half of 2027. To support regulatory and commercial readiness, the company appointed a Chief Data and Digital Officer and a Chief People Officer during the quarter.Healthcare
- HURANov 13, 7:50 AMTuHURA Biosciences reported third-quarter 2026 financial results showing $1.9 million in cash and cash equivalents alongside $3.7 million in research and development expenses. The company announced preliminary data from its IFx-2.0 and Keytruda study in metastatic Merkel cell carcinoma patients, demonstrating major objective tumor responses in the first three subjects. TuHURA also received FDA clearance to initiate a Phase 1b trial for its VISTA-inhibiting antibody TBS-2025 in relapsed or refractory acute myeloid leukemia and secured new patents for its VISTA inhibitor and Delta Opioid Receptor technology. To support these initiatives, the company accessed $5.6 million in non-dilutive financing from its Parkview credit facility during the quarter.Healthcare
- NDLSNov 13, 7:45 AMNoodles & Company reported a 9.5% increase in system-wide comparable restaurant sales for the third quarter of 2026, driven by a 10.7% rise at company-owned locations and a 4.9% rise at franchise locations. The company posted a net loss of $2.1 million for the quarter, a significant improvement from the $9.2 million loss recorded in the same period of 2025, while operating margin expanded to 0.1% from (5.2)%. Restaurant contribution margin improved to 16.7% and Adjusted EBITDA increased by 34.3% to $8.7 million. Management has tightened its full-year 2026 guidance, projecting total revenue between $485 million and $495 million and Adjusted EBITDA between $35 million and $37 million.Consumer Cyclical
- DGXXNov 13, 7:45 AMDigi Power X Inc. reported third-quarter 2026 revenue of $12.25 million, representing an 85% increase from the previous quarter and a 50% year-over-year rise. AI-related revenue reached $5.66 million, accounting for 46% of total revenue, driven by a 400% surge in GPU rental income and the launch of the NeoCloudz Token Factory. The company ended the quarter with $119.6 million in cash and digital currencies, no outstanding borrowings, and a net income of $1.0 million. Looking ahead, Digi Power X anticipates an annualized revenue run-rate of $250 million to $300 million by the end of Q3 2027, supported by the upcoming billing for its Columbiana Phase 1 colocation facility and a planned $200 million debt financing.Utilities
- MISTNov 13, 7:36 AMMilestone Pharmaceuticals reported third-quarter 2026 net product revenue of $1.0 million for its FDA-approved drug CARDAMYST, representing a 73% increase from the previous quarter. To extend its cash runway into late 2028, the company implemented cost-efficiency measures that reduce operating expenses by approximately 30%, including bringing its sales force in-house and reducing its headquarters workforce. Consequently, Chief Financial Officer Amit Hasija and Chief Medical Officer Dr. David Bharucha have departed the leadership team, while the company maintains full funding for its Phase 3 AFib-RVR trial with data expected in the second half of 2028. As of September 30, 2026, the company held $145.4 million in cash and equivalents, providing sufficient resources to cover operations well beyond the anticipated Phase 3 readout.Healthcare
- XTIANov 13, 7:30 AMXTI Aerospace reported third-quarter 2026 revenue of $35.3 million, representing an 8.8% sequential increase and a 46.1% rise compared to the prior year's proforma revenue. The company achieved an adjusted EBITDA of $1.6 million, a significant improvement from a negative $4.9 million in the second quarter, driven by cost realignment initiatives and tariff recovery benefits. Management has completed its strategic pivot to focus exclusively on the Drone Nerds business, discontinuing the XTI aircraft operations while expanding its portfolio with new programs for pressure washing, airport detection, and first responders. Looking ahead, XTI Aerospace has reiterated its full-year 2026 revenue guidance of $125 million to $130 million and expects to transition to positive ongoing operating cash flows by the fourth quarter.Technology
- JBIONov 13, 7:20 AMJade Biosciences reported a net loss of $35.1 million for the third quarter ended September 30, 2026, driven by increased research and development and general and administrative expenses. The company holds $475.7 million in cash, cash equivalents, and investments, providing a runway into the fourth quarter of 2028. Key pipeline updates include the expected initiation of the Phase 3 EVERGREEN trial for JADE101 in the fourth quarter of 2026 and the planned start of the Phase 1 JADE301 trial in dermatomyositis during the same period. Additionally, the company expanded Brad Dahms' role to include Chief Business Officer responsibilities alongside his position as Chief Financial Officer.Healthcare
- TVRDNov 13, 7:05 AMTvardi Therapeutics reported a net loss of $6.1 million for the third quarter ended September 30, 2026, driven by increased research and development expenses related to its TTI-101 program. The company plans to advance its lead candidate TTI-109 into clinical trials for ulcerative colitis in 2027, pending Investigational New Drug clearance and additional funding. TTI-101 is currently being evaluated in a Phase 1b/2 study for hepatocellular carcinoma, with topline data expected in the early first quarter of 2027. As of September 30, 2026, Tvardi held $22.3 million in cash and cash equivalents, which is projected to fund operations through the third quarter of 2027.Healthcare
- PWCMNov 13, 7:00 AMPowerCompute reported a net income of $0.4 million for the third quarter of 2026, driven by a $6.7 million fair value gain on digital assets receivable as Bitcoin prices rose approximately 43% during the period. The company mined 23.9 Bitcoin, representing a 35.8% increase in production compared to the same quarter in 2025, while its mining margin improved to 50.7% from 29.0% in the previous quarter. Significant balance sheet improvements were achieved by repaying and terminating its Bitcoin-backed credit facility, which reduced secured debt by 94% to $1.25 million and eliminated pledged Bitcoin. Additionally, PowerCompute purchased 600 new Bitmain Antminer S21++ units for $1.0 million, which are expected to increase the company's active hashrate by approximately 10% by mid-December 2026.Financial Services
- SBCNov 13, 6:50 AMSBC Medical Group Holdings reported third-quarter 2026 total revenues of $59 million, representing a 35% year-over-year increase driven by service fee revisions and the consolidation of Waqoo. Net income attributable to the company rose 22% to $16 million, while Adjusted EBITDA surged 66% to $28 million, resulting in an Adjusted EBITDA margin of 47%. The company's clinic network expanded to 293 locations with 7.06 million patient visits over the trailing twelve months, and it held $198 million in cash and cash equivalents as of September 30, 2026.Industrials
- MXCNov 12, 5:28 PMMexco Energy Corporation reported a net income of $945,152, or $0.45 per diluted share, for the six months ended September 30, 2026, representing a 67% increase from the same period in the prior year. Operating revenues rose 21% to $4,102,157, driven primarily by a 43% increase in average oil prices despite a 23% decline in natural gas prices and a 7% drop in oil production. During this period, the company invested approximately $3.2 million in acquiring oil and gas royalty interests and plans to drill 55 horizontal wells and complete 20 others in the fiscal year ending March 31, 2027.Energy
- LGLNov 12, 5:27 PMThe LGL Group, Inc. reported total revenues of $1.464 million for the third quarter of 2026, representing a 32.1% increase from the same period in 2025. Net loss attributable to common stockholders was $45,000 for the quarter, a significant decline from the $772,000 net income recorded in 2025, primarily due to a reversal of a previously recorded uncertain tax position. The company's backlog in the Electronic Instruments segment grew substantially to $6.5 million as of September 30, 2026, up from $625,000 at the end of 2025. Cash and cash equivalents, along with marketable securities, increased to $87.0 million, driven largely by a rights offering that generated $41.5 million in net proceeds in July 2026.Technology
- BMTMNov 12, 5:27 PMBright Mountain Media, Inc. reported revenue of $11.6 million for the third quarter of 2026, a 17% decrease from the same period in 2025, while net loss narrowed to $3.0 million from $2.8 million. For the nine months ended September 30, 2026, revenue totaled $39.2 million, down 10% year-over-year, with the net loss improving by 26% to $7.5 million compared to $10.1 million in the prior period. Adjusted EBITDA increased to $1.5 million for the quarter and $3.6 million for the nine-month period, reflecting a 10% and 88% improvement respectively. The company's balance sheet showed total assets of $32.75 million and a stockholders' deficit of $84.09 million as of September 30, 2026.
- ROCNov 12, 5:21 PMRank One Computing Corporation reported record third-quarter 2026 revenue of $8.0 million, representing a 50% year-over-year increase and achieving its first quarterly net income of approximately $0.6 million. The company secured a historic $64.3 million federal contract with the Department of Justice for its ROC Evidence platform and a $5.1 million contract for ROC ABIS, while product revenue grew 24% to $5.7 million driven by strong performance in ROC SDK and ROC ABIS. Gross margin improved to 90% due to a favorable mix of high-margin software licensing, and the company completed the acquisition of Zuccaro Technical Consulting to expand its digital forensics capabilities.Technology
- AKTXNov 12, 5:21 PMAkari Therapeutics initiated GLP toxicology studies for its lead candidate AKTX-101, a TROP2-targeted antibody-drug conjugate utilizing the novel PH1 payload, to support a planned Phase 1 clinical trial in mid-2027. New preclinical data demonstrated that AKTX-101 exhibited significant tumor growth inhibition in urothelial cancer models resistant to existing therapies like Padcev and Trodelvy. The company reported third-quarter 2026 financial results showing $5.7 million in cash, a net loss of $4.8 million, and the full repayment of $0.7 million in convertible notes. Additionally, Akari strengthened its business development capabilities with the appointment of a new Chief Business Officer and expanded its intellectual property portfolio with a new patent application covering PH1's RNA splicing modulation mechanisms.Healthcare
- ITHUFNov 12, 5:21 PMiAnthus Capital Holdings reported fiscal third quarter 2026 revenue of $38.4 million, representing a sequential increase of $3.0 million from the previous quarter. The company achieved a gross profit of $16.7 million with a gross margin of 43.5%, while reporting a net loss of $13.2 million. Adjusted EBITDA for the quarter reached $5.2 million, an increase from $4.4 million in the second quarter and $2.5 million in the prior year's third quarter. Additionally, the company appointed Macias Gini & O'Connell LLP as its new independent registered public accounting firm effective November 12, 2026, following the resignation of PKF O'Connor Davies.
- ELTPNov 12, 5:20 PMElite Pharmaceuticals, Inc. reported consolidated revenues of $40.1 million for the second quarter of fiscal year 2027, representing a 10.4% increase from the prior year period. This growth was primarily driven by higher sales from the company's amphetamine and naltrexone product lines under the Elite label. The company recorded income from operations of $9.9 million and net income attributable to common shareholders of $17.3 million for the quarter. Management is scheduled to host a conference call on November 13, 2026, to discuss these financial results and recent business developments.Healthcare
- TBNNov 12, 5:18 PMTamboran Resources achieved first gas sales from its Shenandoah South Pilot Project in the Beetaloo Basin in September 2026, delivering 40 TJ/d to the Northern Territory Government under a fixed-price contract. Initial production tests on wells SS2-3H and SS2-5H confirmed average IP30 rates of 8.8 and 10.0 MMcf/d, while the SS2-2H ST1 well demonstrated a cleaned-up rate of 10.2 MMcf/d. The company reported US$1.8 million in gas sales revenue for the first quarter of fiscal year 2027, maintaining a pro forma cash balance of approximately US$180 million. Tamboran continues to advance its development strategy with ongoing drilling programs and strategic partnerships aimed at scaling production across its 2.8 million net prospective acres.Energy
- SLNDNov 12, 5:17 PMSouthland Holdings reported third-quarter 2026 revenue of $233.8 million, an increase from $213.3 million in the same period the prior year, driven by strong demand in its Civil and Transportation segments. The company achieved a gross profit of $20.6 million with an 8.8% margin, a significant improvement over the 0.9% margin recorded in the previous year, largely due to a $28.7 million settlement gain with Liberty Mutual. Net income attributable to stockholders reached $33.7 million, or $0.62 per diluted share, contrasting sharply with a net loss of $75.3 million in the prior year quarter. Additionally, Southland's backlog grew to $1.71 billion, reflecting continued execution of its strategic plan and operational improvements.Industrials
- LGVNNov 12, 5:11 PMLongeveron Inc. reported a net loss of $6.1 million for the third quarter ended September 30, 2026, driven by research and development expenses of $4.0 million and general and administrative costs of $3.3 million. The company's Phase 2b ELPIS II clinical trial for hypoplastic left heart syndrome did not meet its primary efficacy endpoint, prompting a request for a meeting with the FDA to determine future development steps. Concurrently, Longeveron is evaluating strategic alternatives, including potential partnerships, mergers, or sales, with Lucid Capital Markets retained as financial advisor to maximize stockholder value. The company implemented a 1-for-10 reverse stock split in August and currently holds $7.2 million in cash, which is expected to fund operations into the first quarter of 2027.Healthcare
- VGZNov 12, 5:10 PMVista Gold Corp. announced a consolidated net loss of $6.4 million, or $0.05 per share, for the quarter ended September 30, 2026, while maintaining cash reserves of $43.5 million with no debt. On September 20, 2026, the company entered into an arrangement agreement with Artemis Gold Inc. to be acquired via a court-approved plan of arrangement. Under the proposed terms, each Vista common share will be exchanged for 0.0966 of an Artemis common share, resulting in Vista shareholders collectively owning approximately 5% of the combined entity. The transaction aims to leverage Artemis's resources to advance the development of Vista's Mt Todd gold project while expanding the Blackwater operation.Basic Materials
- NNUPNov 12, 5:08 PMNocopi Technologies reported a 763% increase in third-quarter 2026 revenues to $3.329 million, driven by a renewed license agreement and sales from the acquired Polymeric business. The company achieved a net income of $1.397 million for the quarter, a significant turnaround from the net loss recorded in the same period of the previous year. Operating expenses rose to $0.982 million due to the inclusion of Polymeric's operations and elevated professional fees associated with the acquisition. As of September 30, 2026, the company maintained a strong balance sheet with $10.278 million in cash and investments and no outstanding debt.
- PALNov 12, 5:03 PMProficient Auto Logistics reported third-quarter 2026 total operating revenue of $149.0 million, a 30.3% increase from the prior year period, driven by the inclusion of Hansen & Adkins following its acquisition on August 13, 2026. The company delivered 839,036 units, representing a 38.6% year-over-year growth, though total operating income declined to a loss of $3.9 million compared to a $0.1 million loss in the previous year. Adjusted operating income for the quarter was $0.3 million, with the adjusted operating ratio rising to 99.8% due to elevated costs in insurance, wages, and fuel surcharge under-recovery. The integration of Hansen & Adkins is progressing on schedule, with the company now identifying a synergy opportunity range of $20 million to $30 million, significantly higher than the initial estimate.Industrials
- KIDZNov 12, 5:00 PMKIDZ AI Inc. reported a 40% sequential increase in third-quarter 2026 revenue, marking its first quarter-over-quarter growth in the year. The company achieved a gross margin of 65.9% and narrowed its net loss to $654,057, while strengthening its balance sheet with stockholders' equity rising 349% to $16.9 million. As of September 30, 2026, the firm maintained a net cash position of approximately $14.9 million, representing roughly 12 times its market capitalization. During the quarter, KIDZ AI repurchased 74,082 shares of Class B common stock at an average price of $3.36 per share.Consumer Defensive
- CWDNov 12, 5:00 PMCaliber reported a third quarter 2026 platform revenue of $3.8 million and a platform net loss of $4.3 million, resulting in a positive platform Adjusted EBITDA of $0.1 million for the second consecutive quarter. The company revised its full-year 2026 total platform revenue guidance down to a range of $15.0 million to $17.0 million due to tighter credit conditions, while reaffirming its profitability guidance. During the quarter, Caliber completed the tokenization of three additional real estate projects, bringing the total tokenized offerings to four with up to $110 million in combined offered equity. Additionally, the company held 229,203 LINK tokens valued at $3.3 million, which contributed a $1.6 million gain from changes in fair value.Financial Services
- MSGMNov 12, 5:00 PMMotorsport Games reported third-quarter 2026 revenues of $3.8 million, representing a 21.8% increase from the prior year period, driven by growth in Le Mans Ultimate downloadable content and RaceControl subscriptions. The company achieved its seventh consecutive quarter of profitability with net income of $0.7 million and expanded its gross profit margin to 88.0%. Le Mans Ultimate surpassed two million combined unit sales and set a new concurrent player record of 11,941 during a special event in October. Additionally, the company strengthened its balance sheet, ending the quarter with $5.4 million in cash and deferred revenue, while RaceControl subscription revenues grew by 186.2% over the nine-month period.Communication Services
- BGMSNov 12, 5:00 PMBio Green Med Solution, Inc. reported a net loss of $0.4 million for the third quarter ended September 30, 2026, narrowing from a $1.0 million loss in the prior-year period. The company's fire safety business generated $454,000 in product revenue, representing a significant increase from $81,000 in the same period last year, while general and administrative expenses decreased by 37% year over year. As of September 30, 2026, the company held $3.5 million in cash and cash equivalents, which management estimates will fund operations through the second quarter of 2027. Additionally, the company announced that its Form S-4 regarding a proposed business combination with Future NRG Sdn. Bhd. was declared effective in October, with a shareholder special meeting planned for November 2026.Industrials
- DIODNov 12, 5:00 PMDiodes, Inc. reported record third-quarter 2026 revenue of $532.6 million, representing a 36% year-over-year increase and a 20% sequential rise. The company achieved a gross margin of 36.1%, driven by strong demand in automotive, industrial, and AI-related computing sectors, alongside capacity expansion and product mix improvements. Management projects fourth-quarter revenue to reach approximately $550 million with a non-GAAP gross margin of 37%, aiming to exceed its three-year financial goals.Technology
- PRSONov 12, 4:58 PMPeraso Inc. reported third-quarter 2026 total net revenue of $0.3 million, a significant decline from $1.3 million in the prior quarter and $3.2 million in the same period last year, driven by reduced shipments to fixed wireless access customers. The company posted a GAAP net loss of $2.7 million, or $0.18 per share, while achieving a gross margin of 78.5% due to a favorable product mix and a one-time inventory accrual reversal. Management noted early signs of renewed demand in the fourth quarter, highlighted by a production order exceeding $2 million received in October, and announced a private placement with Nant Capital that raised approximately $10 million to support strategic initiatives in defense and drone communications.Technology
- SPRUNov 12, 4:52 PMSpruce Power reported a net income of $6.0 million for the third quarter of 2026, marking a significant turnaround from a net loss of $0.9 million in the same period the previous year. Operating EBITDA increased by 3% year-over-year to $27.0 million, driven by a 23% reduction in SG&A expenses resulting from streamlining efforts and labor savings initiatives. The company ended the quarter with $87.3 million in cash and cash equivalents, reduced its outstanding debt principal by $21.9 million, and finalized a non-binding term sheet to refinance key facilities extending their maturity to January 2027.Technology
- NSPRNov 12, 4:45 PMInspireMD, Inc. reported a net loss of $9.76 million for the third quarter of 2026, driven by a decline in total revenue to $2.24 million due to a voluntary U.S. recall of its CGuard Prime delivery system. The company received FDA approval for its CGuard Prime TransCarotid Stent System for TCAR procedures, which is expected to expand its addressable market by over 35,000 annual procedures and commence U.S. sales in the fourth quarter of 2026. International revenue grew by 9.1% to $2.21 million, offsetting the loss of U.S. sales, while the company continues to advance its SwitchGuard neuroprotection system and plans to submit a PMA supplement for an enhanced CAS delivery system in December 2026.Healthcare
- ALMUNov 12, 4:45 PMAeluma, Inc. reported a net loss of $3.8 million for the first quarter of fiscal 2027, with revenue declining to $0.6 million from $1.4 million in the prior year period. The company finalized a purchase agreement with Aixtron to acquire a new 200 mm capable MOCVD system, aiming to expand manufacturing capacity for non-indium-phosphide photonics. Aeluma continues to advance technology readiness for the AI datacom market through the development of high-speed photodetectors and quantum dot lasers while engaging with customers for potential high-volume demand. Additionally, the company is in negotiations with the U.S. Department of Commerce for up to $30 million in CHIPS R&D funding to support the commercialization of photonics for AI and advanced computing.Technology
- STRONov 12, 4:45 PMSutro Biopharma reported third-quarter 2026 financial results showing $9.1 million in revenue and a net loss of $31.5 million, while maintaining a cash balance of $142.2 million expected to fund operations through the first half of 2028. The company advanced its STRO-004 ADC program with encouraging early clinical data and initiated dosing for the STRO-006 ITGB6-targeting ADC, with both programs scheduled for further clinical updates in 2027. Additionally, the STRO-227 dual-payload ADC is set to enter clinical trials in early 2027, and a collaboration with Astellas triggered a $10 million milestone payment following the dosing of a second dual-payload program.Healthcare
- SPRONov 12, 4:43 PMSpero Therapeutics announced its third-quarter 2026 financial results, reporting a net loss of $44.3 million and research and development expenses of $38.2 million, which included a $35 million upfront payment for the in-licensing of SP001 from Innovent Biologics. The company secured $105 million in non-recourse financing in July 2026, bringing its cash and cash equivalents to $107.9 million as of September 30, 2026, sufficient to fund operations into the second half of 2029. SP001, a third-generation anti-CD40L antibody, is advancing toward a Phase 2 study in IgG4-related disease scheduled for the second quarter of 2027. Spero has also strengthened its leadership team with new appointments for Chief Medical Officer, Chief Regulatory and Quality Officer, and a new Board member to support its clinical development strategy.Healthcare
- LSFNov 12, 4:42 PMLaird Superfood reported third-quarter 2026 net sales of $42.0 million, representing a 225% increase from the prior year period, driven by the integration of Navitas Organics and Terrasoul Superfoods. The company achieved a net income of $1.7 million and an Adjusted EBITDA of $2.1 million, while e-commerce sales grew 268% to account for 54% of total revenue. For the full fiscal year 2026, the company maintains a revenue guidance range of $135 million to $140 million and an Adjusted EBITDA range of $5 million to $6 million. As of September 30, 2026, Laird Superfood held $17.3 million in cash with no outstanding debt.Consumer Defensive
- BATLNov 12, 4:41 PMBattalion Oil Corporation reported third quarter 2026 sales volumes of 11,359 barrels of oil equivalent per day, with average daily production of 4,915 net barrels of oil. The company generated $45.6 million in operating revenue, driven by a $5.13 per Boe increase in average realized prices, while reporting a net loss of $41.1 million largely due to $44.8 million in net losses on derivative contracts. Financial highlights include $92.1 million in cash and cash equivalents, a reduction in net debt to $70.4 million, and the commencement of drilling operations under a joint exploration agreement ahead of schedule. Additionally, the company executed a midstream transaction to transition crude transportation from trucking to pipeline and appointed John Juneau to its board of directors.Energy
- DMACNov 12, 4:40 PMDiaMedica Therapeutics reported a net loss of $11.3 million for the third quarter of 2026, with total cash, cash equivalents, and short-term investments standing at $34.9 million as of September 30, 2026. The company completed enrollment in the first two cohorts of its Phase 2 trial for early-onset fetal growth restriction and surpassed the 200-participant threshold for its ReMEDy2 acute ischemic stroke trial. Regulatory progress includes conditional authorization from the European Medicines Agency and Health Canada for early-onset preeclampsia studies, while the company continues to address FDA feedback regarding nonclinical reproductive toxicity data for a U.S. Investigational New Drug application. Management anticipates the ReMEDy2 interim analysis to be completed in the first quarter of 2027 and expects current cash reserves to fund operations through the fourth quarter of 2027.Healthcare
- DDSNov 12, 4:39 PMDillard's, Inc. reported net income of $130.9 million for the third quarter ended October 31, 2026, representing a 1% increase in total retail sales compared to the prior year period. For the 39 weeks ended October 31, 2026, the company achieved net income of $479.1 million, driven by a 2% increase in total retail sales and significant non-operating gains from tariff refunds and a litigation settlement. The retailer maintained a retail gross margin of 45.3% for the quarter and 44.0% for the year-to-date period, while operating expenses rose due to higher payroll costs. Additionally, Dillard's announced the closure of its Boynton Beach Mall Clearance Center in January 2027 and operates 272 stores across 30 states.Consumer Cyclical
- GEMINov 12, 4:35 PMGemini Space Station, Inc. reported third-quarter 2026 total revenue of $40.9 million, a 19% decrease from the prior year, driven by a 73% decline in platform spot trading volume. Total operating expenses fell 30% year-over-year to $119.9 million, resulting in a net loss of $58.6 million, which represents a 63% improvement over the same period in 2025. Services revenue and interest income accounted for 59% of net revenue, while exchange revenue dropped 47% to $13.4 million due to reduced retail trading activity. The company maintained disciplined cost management with lower compensation and marketing spend, despite a 38% increase in transaction losses primarily attributed to credit card charge-offs.Financial Services
- WHKNov 12, 4:34 PMWhiteHawk Minerals Corp. reported third-quarter 2026 net production of 71.3 million cubic feet equivalent per day, representing a 10% year-over-year increase. The company announced the signing of 13 acquisitions totaling $45.5 million in core Appalachian and Haynesville mineral interests, which are expected to generate approximately $5.6 million in incremental cash flow in 2027. For the quarter, WhiteHawk declared a quarterly dividend of $0.50 per share, achieved net income of $6.9 million, and reported adjusted EBITDA of $21.1 million.Energy
- CVNov 12, 4:34 PMCapsoVision reported third-quarter 2026 revenue of $3.6 million, a slight increase from $3.5 million in the same period of 2025, while net loss narrowed to $7.3 million from $7.9 million. The company received FDA clearance for its AI Highlights tool in September 2026 and launched it commercially in November, alongside completing enrollment for its CapsoCam Colon study with an expected FDA submission by year-end. Financial results reflected a gross margin decline to 49% due to higher material costs and inventory charges, though operating expenses decreased to $9.1 million. To support its operations and development pipeline, CapsoVision raised approximately $19.5 million in net proceeds through a registered direct offering and an at-the-market program during the quarter.Healthcare
- UPXINov 12, 4:31 PMUpexi, Inc. reported fiscal first quarter 2027 net income of $89.1 million, or $0.68 per diluted share, driven primarily by $102.0 million in unrealized gains on digital assets. Total revenue for the quarter reached $3.5 million, with digital asset revenue accounting for $3.1 million and product revenue declining to $0.4 million as the company shifted away from legacy consumer product lines. The company strengthened its balance sheet by increasing its Solana treasury to approximately 2.35 million SOL and raising cash on hand to $6.4 million, while also reducing the interest rate on its BitGo borrowings from 11.5% to 7.5%. Stockholders' equity improved significantly to $49.2 million as of September 30, 2026, reversing a deficit of $53.8 million recorded at the end of the previous quarter.Communication Services
- SPCENov 12, 4:31 PMVirgin Galactic reported a net loss of $59 million for the third quarter of 2026, driven by $59 million in operating expenses and revenue of $0.4 million. The company holds $184 million in cash and marketable securities as of September 30, 2026, while its first commercial spaceflight is expected in early 2027. Operational updates include the completion of a rocket motor production facility in Arizona and the opening of limited bookings for spaceflight expeditions at $850,000 per seat. Additionally, Virgin Galactic projects a high-cadence launch hangar opening in late 2028 to increase annual spaceflight capacity to 150.Industrials
- PROPNov 12, 4:30 PMPrairie Operating Co. reported third-quarter 2026 sales volumes of 2.4 million barrels of oil equivalent, representing a 21% increase from the prior quarter and driving revenue to $129.5 million. The company generated $65.3 million in Adjusted EBITDA, a 92% quarter-over-quarter increase, while reducing lease operating expenses per barrel of oil equivalent by 17%. Year-to-date through September 30, 2026, total revenue reached $311.8 million, an increase of approximately 97% compared to the same period in 2025. Production reached approximately 32,287 barrels of oil equivalent per day by early October, following the online status of the Burnett and Castor development pads.Energy
- AEMDNov 12, 4:30 PMAethlon Medical, Inc. reported a net loss of $2.62 million for the second quarter ended September 30, 2026, with operating expenses rising 77.2% to $2.7 million primarily due to professional fees associated with a proposed merger. On September 17, 2026, the company entered into a merger agreement with North Immunology, Inc., under which the combined entity will operate as North Immunology and shareholders will receive contingent value rights tied to the legacy Hemopurifier business. During the quarter, the company treated its second patient in the final dosing cohort of its Phase 1 oncology study in Australia and implemented workforce reductions to align with the merger timeline. As of September 30, 2026, the company held approximately $6.5 million in cash and cash equivalents.Healthcare
- LGCYNov 12, 4:30 PMLegacy Education Inc. reported a record student population of 3,684 for the first quarter of fiscal 2027, representing a 5.4% increase from the prior year. The company achieved $20.0 million in revenue and $0.9 million in net income, while expanding its footprint with a new campus lease in Houston, Texas. Strategic investments in faculty, facilities, and new programs drove educational services expenses up by 13.0%, resulting in a lower net income margin compared to the previous year. Additionally, the company recorded an estimated $0.7 million legal settlement expense and maintained a strong balance sheet with $21.7 million in cash and minimal debt.Consumer Defensive
- PLNHNov 12, 4:28 PMPlanet 13 Holdings Inc. reported a net loss of $6.4 million and revenue of $23.1 million for the third quarter of 2026. The company achieved a gross profit margin of 56.2%, a significant increase from the prior year, driven by the exit from California wholesale operations and a reduction in inventory reserves. Adjusted EBITDA improved to a loss of $0.2 million, reflecting better cost control and higher gross margins despite lower tourist traffic in Nevada. Additionally, the company announced that its Form S-4 merger registration with Vireo Growth Inc. was declared effective, with a shareholder vote scheduled for December 10, 2026.
- VRCANov 12, 4:27 PMVerrica Pharmaceuticals reported third-quarter 2026 total revenue of $6.9 million, driven by a record $5.7 million in net product revenue from YCANTH, which represents an 11.9% increase over the previous quarter. The company completed enrollment in its first pivotal Phase 3 trial for common warts and achieved milestones to unlock an additional $15.0 million in non-dilutive growth capital, extending its cash runway into the fourth quarter of 2027. Additionally, Verrica announced it is exploring the development of its oncolytic peptide, VP-315, for the treatment of Gorlin syndrome, a rare genetic disease characterized by frequent basal cell carcinomas.Healthcare
- NKTRNov 12, 4:25 PMNektar Therapeutics reported a net loss of $55.7 million for the third quarter of 2026, driven by increased research and development expenses totaling $44.1 million as the company advances its lead candidate rezpegaldesleukin into Phase 3 trials for atopic dermatitis and alopecia areata. Revenue for the quarter declined to $9.4 million from $11.8 million in the same period the previous year, while cash and investments rose significantly to $952.9 million. The company has initiated all three global registrational trials for the ZENITH AD program and expects topline data in mid-2028, with a target Biologics License Application submission in 2029.Healthcare
- ARMPNov 12, 4:24 PMArmata Pharmaceuticals reported a net income of $54.9 million for the third quarter of 2026, driven primarily by a $69.6 million gain from changes in the fair value of its convertible loan. The company advanced preparations for its pivotal Phase 3 superiority study of AP-SA02, receiving FDA Breakthrough Therapy designation and securing an additional $3.7 million in non-dilutive funding from the U.S. Department of War. Operating expenses for the quarter totaled $10.5 million, while the company held $18.3 million in unrestricted cash and cash equivalents as of September 30, 2026.Healthcare
- FGINov 12, 4:24 PMFGI Industries reported third-quarter 2026 total revenue of $31.7 million, an 11.6% decrease from the prior year, driven by softness in housing and remodeling activity. The company posted a gross profit of $8.7 million with an expanded gross margin of 27.6%, while operating and net losses were recorded at $0.5 million and $0.9 million, respectively. Revenue declined across core categories including sanitaryware and shower systems, though the custom kitchen cabinetry segment grew by 32.8%. Consequently, FGI revised its full-year 2026 net revenue guidance downward to a range of $120-127 million and adjusted its operating and net income forecasts to reflect continued market challenges.Consumer Cyclical
- XOSNov 12, 4:23 PMXos, Inc. reported a third consecutive quarter of positive GAAP gross profit for the period ended September 30, 2026, with the nine-month GAAP gross margin expanding to 26.9% from 13.3% in the prior year. Revenue for the quarter increased 17.0% sequentially to $5.5 million on 33 units delivered, while operating expenses were reduced by 10.0% year-over-year to $25.8 million for the nine-month period. The company delivered its first Xos Hub units internationally to support Waymo's autonomous vehicle operations in London and now has over 1,000 units in the field. Xos revised its full-year 2026 outlook to project revenue between $25 million and $35 million and unit deliveries between 185 and 250 units.Consumer Cyclical
- ENSCNov 12, 4:22 PMEnsysce Biosciences reported a net loss of $82.3 million for the third quarter of 2026, primarily driven by a $79.9 million non-cash charge for acquired in-process research and development related to the Cy Biopharma acquisition. The company completed the acquisition of Cy Biopharma in August, adding the CY200 pipeline asset for Complex Regional Pain Syndrome, and submitted a Phase 2a protocol for this candidate to the UK's MHRA in September. Additionally, Ensysce finished enrollment in the final stage of its PF614-MPAR-102 study for its abuse-deterrent opioid and ended the quarter with $29.7 million in cash and cash equivalents.Healthcare
- INVNov 12, 4:21 PMInnventure, Inc. reported a net loss of $333.8 million for the third quarter of 2026, driven primarily by a $323.5 million goodwill impairment charge. The company is executing a strategic repositioning that includes reducing parent-level headcount from 40 to 15 and transitioning its AeroFlexx and Refinity businesses away from reliance on Innventure capital. During the nine-month period ended September 30, 2026, Innventure generated $3.9 million in revenue while utilizing $74.5 million in operating cash flows. Management aims to preserve and maximize the value of its interest in Accelsius through disciplined capital allocation and cost reductions.Financial Services
- CRDFNov 12, 4:21 PMCardiff Oncology reported a net loss of $30.4 million for the nine months ended September 30, 2026, driven by $32.0 million in operating expenses. The company's Phase 2 trial for onvansertib in first-line RAS-mutated metastatic colorectal cancer remains ongoing, with median progression-free survival not yet reached in the 30 mg onvansertib plus FOLFIRI/bev arm compared to approximately 11 months in standard-of-care arms. As of late September 2026, all patients in the 30 mg onvansertib arm have exceeded 21 months on treatment, with the longest duration surpassing 29 months. Cardiff holds approximately $33.8 million in cash and cash equivalents as of September 30, 2026, and plans to initiate a registrational Phase 3 trial in the first quarter of 2027.Healthcare
- VATENov 12, 4:21 PMINNOVATE Corp. reported third-quarter 2026 consolidated revenue of $495.5 million, a 42.8% increase from the prior year, driven primarily by its Infrastructure segment. The company completed the sale of DBM Global to IES Holdings for approximately $413 million in cash and stock, and sold a controlling interest in HC2 Broadcasting to CONX Corp., retaining a 25% stake. Net income attributable to common stockholders rose to $15.8 million in the quarter, compared to a net loss of $9.4 million in the same period last year, largely due to a $32.9 million gain on the sale of the broadcasting interest. Total Adjusted EBITDA for the quarter reached $40.5 million, more than doubling the $19.8 million reported in the previous year.Industrials
- LVLUNov 12, 4:21 PMLulus reported a 20% year-over-year decline in third-quarter 2026 net revenue to $58.6 million, driven by a 20% drop in total orders placed and higher return rates. The company posted a net loss of $4.3 million and an adjusted EBITDA loss of $1.8 million, while successfully reducing inventory by 17% and improving gross margin by 230 basis points to 44.9%. Management revised its full-year 2026 outlook downward due to the continued impact of historical assortment decisions, though it anticipates revenue decline rates to moderate in fiscal 2027. Additionally, the company expects capital expenditures for 2026 to range between $1.5 million and $2.0 million.Consumer Cyclical
- CDXSNov 12, 4:20 PMCodexis, Inc. reported third-quarter 2026 total revenues of $19.3 million, a significant increase from $8.6 million in the same period of 2025, driven by higher product revenue from newly approved customer products. The company achieved a product gross margin of 74.5% for the quarter and reduced its net loss to $8.1 million, or $0.08 per share, compared to a $19.6 million loss in the prior year period. Financial stability was strengthened through a $25 million equity raise completed in July and a $60 million senior secured loan facility with Trinity Capital, which included a $42.5 million drawdown used to refinance existing debt. Codexis reiterated its full-year 2026 revenue guidance of $72 million to $76 million and expects its cash and investments to fund operations through the end of 2028.Healthcare
- YSSNov 12, 4:20 PMYork Space Systems reported third-quarter 2026 revenue of $84.2 million, a 7% decrease from the prior year, while recording a net loss of $807.4 million largely driven by a $749.7 million non-cash goodwill impairment charge. The company's backlog stood at $581.0 million as of September 30, 2026, supported by new contract wins and modifications, and its identified pipeline expanded by over 30% to $14.9 billion. York announced the permanent appointment of Brian Frantz as Chief Financial Officer and outlined strategic initiatives including the proposed acquisition of Outlook Industries to enter the unmanned systems market. Full-year 2026 revenue guidance was narrowed to a range of $380 million to $400 million, with the company maintaining total liquidity of $459 million.Industrials
- SCTXNov 12, 4:20 PMScribe Therapeutics reported third-quarter 2026 financial results, recording a net loss of $9.9 million and holding $174.2 million in cash, cash equivalents, and marketable securities as of September 30, 2026. The company completed an upsized initial public offering in July 2026, raising approximately $155.5 million in aggregate gross proceeds, which extends its funding runway into the first half of 2029. Clinical progress includes ongoing enrollment in the first-in-human Phase 1 trial for STX-1150, an epigenetic silencing therapy targeting LDL-C lowering, with initial data expected in the first half of 2027. Additionally, Scribe expanded its strategic collaboration with Sanofi to include access to its ELXR epigenetic silencing technology alongside its existing gene-editing platform.Healthcare
- CRWSNov 12, 4:19 PMCrown Crafts, Inc. reported second-quarter fiscal 2027 net sales of $19.0 million, a decrease from $23.7 million in the prior-year period. The company achieved a gross profit margin of 32.0%, an increase from 27.7% in the previous year, driven by $0.4 million in tariff refunds and offset by $0.2 million in severance expenses. Net income for the quarter rose to $1.3 million, or $0.12 per diluted share, compared to $1.2 million, or $0.11 per share, in the prior year. Additionally, the Board of Directors declared a quarterly cash dividend of $0.03 per share on the Series A common stock.Consumer Cyclical
- RMRNov 12, 4:19 PMThe RMR Group Inc. announced its financial results for the fiscal quarter ended September 30, 2026. The company, a leading U.S. alternative asset management firm focused on commercial real estate, manages approximately $37 billion in assets through over 800 professionals across more than 30 offices. A conference call to discuss these results was scheduled for November 13, 2026, at 11:00 a.m. Eastern Time, with a live webcast and replay options available.Real Estate
- GROWNov 12, 4:18 PMU.S. Global Investors reported a 18% increase in operating revenues to $2.7 million for the first quarter of fiscal 2027, ending the period with an operating income of $55,000 compared to a loss in the prior year. Average assets under management grew 14% to $1.6 billion, driven by a 45% surge in gold and precious metals strategies. The company also highlighted growth in its defense-focused WAR ETF and shipping-focused SEA ETF, while maintaining a shareholder yield of 8.33% and a strong liquidity position with $35.4 million in net working capital.Financial Services
- PMNNov 12, 4:17 PMProMIS Neurosciences reported a net loss of $8.2 million for the third quarter of 2026, with cash reserves totaling $44.1 million as of September 30, 2026. The company's lead Alzheimer's candidate, PMN310, remains on track to deliver unblinded 12-month topline data from the PRECISE-AD Phase 1b trial in the first quarter of 2027. Recent interim data showed no amyloid-related imaging abnormalities with edema and a 4.4% rate of hemorrhage, all of which were mild and asymptomatic. Ivana Rubino, Ph.D., a former senior executive at Biogen and Roche, was appointed Chief Commercial Officer effective October 5, 2026, to guide the company's late-stage development and commercial strategy.Healthcare
- PARKNov 12, 4:17 PMPark Dental Partners reported third-quarter 2026 revenue of $64.9 million, representing a 6.0% increase from the prior year, driven by same-practice growth and acquisitions. The company achieved net income of $1.7 million and adjusted EBITDA of $5.0 million for the quarter, while supporting 225 affiliated doctors across 88 practices. Full-year 2026 revenue is now projected to range between $262.0 million and $265.0 million, incorporating the expected contribution from the recently acquired Village Family DSO. Additionally, the company completed the acquisition of Village Family DSO in November 2026, with integration activities commencing immediately.Healthcare
- PROKNov 12, 4:17 PMProKidney Corp. reported third-quarter 2026 financial results, ending the period with $141.9 million in cash and cash equivalents to support operations through mid-2027. The company's pivotal Phase 3 PROACT 1 trial is on track to deliver eGFR slope topline results in the second quarter of 2027, with full enrollment expected to exceed 500 patients by the first quarter of 2027. During the quarter, research and development expenses rose to $40.8 million, driven primarily by increased clinical study and manufacturing costs associated with the ongoing trial. Additionally, the company presented eight new data abstracts at the ASN Kidney Week 2026 to further support the mechanistic and clinical evidence for its lead candidate, rilparencel.Healthcare
- ETRANov 12, 4:17 PMElectra Therapeutics reported a net loss of $23.9 million for the third quarter of 2026, supported by a cash position of $402.5 million following a $350 million IPO. The company is advancing its lead candidate, ipsoprubart, through a global registrational program for secondary hemophagocytic lymphohistiocytosis with enrollment completion expected in the second half of 2027. Additionally, ipsoprubart is being evaluated in a Phase 1 trial for T/NK cell malignancies, while the second candidate, ELA822, has initiated a Phase 1 trial in healthy volunteers with data expected in early 2027.Healthcare
- CTSONov 12, 4:16 PMCytoSorbents Corporation reported third-quarter 2026 revenue of $9.7 million, representing a 3% increase from the prior year, while achieving positive operating cash flow of approximately $43,000 excluding restructuring payments. The company improved its gross margin to 75% and reduced total operating expenses by 11% to $8.5 million, resulting in a net loss of $1.8 million compared to $3.2 million in the same period last year. Management highlighted progress on four strategic value drivers, including sustaining cash flow breakeven, revitalizing the core CytoSorb franchise in Germany, advancing the DrugSorb-ATR submission to the FDA for the U.S. market, and exploring commercial opportunities for the HemoDefend-BGA technology.Healthcare
- DFLINov 12, 4:16 PMDragonfly Energy reported third-quarter 2026 net sales of $12.2 million, a 23.8% decrease year-over-year, driven by softness in the recreational vehicle market despite heavy-duty trucking revenue more than doubling sequentially to $1.3 million. The company recorded a net loss attributable to common stockholders of $6.7 million and an adjusted EBITDA loss of $2.3 million, while completing the acquisition of the Dakota Lithium brand to expand its product portfolio. Management projects fourth-quarter 2026 net sales of approximately $12.5 million with adjusted EBITDA expected to reach breakeven, supported by continued fleet adoption and cost-reduction initiatives.Industrials
- ANABNov 12, 4:16 PMAnaptysBio reported fiscal first quarter 2027 results showing Jemperli global net sales of $1.0 billion for the nine months ended September 30, 2026, representing 29% year-over-year growth. The company received $30.3 million in collaboration revenue for the quarter, driven by Jemperli royalties, while net income from continuing operations was $3.9 million. Regulatory updates include FDA approval for Jemperli in locally advanced rectal cancer and an expected PDUFA decision for Quimilza in December 2026. Additionally, a post-trial hearing in the litigation with GSK and Tesaro was held on October 20, 2026, with a judgment anticipated in late 2026 or early 2027.Healthcare
- MSAINov 12, 4:16 PMMultiSensor AI Holdings, Inc. reported third-quarter 2026 net revenue of $1.5 million, a decrease from $1.6 million in the same period of 2025, driven by lower hardware sales and the discontinuation of inspection services. Software subscriptions now constitute the majority of revenue, accounting for 58% of the total, while the company posted a net loss of $1.9 million for the quarter. The company ended the period with $20.4 million in cash and cash equivalents, having reduced its cash burn rate through disciplined spending and strong collections. Strategic progress included the launch of a 14-site rollout in North America for a major global distributor and the expansion of deployments with Manchester Airports Group and a new pilot in the Asia-Pacific region.Technology
- WATTNov 12, 4:16 PMEnergous Wireless Power Solutions reported third-quarter 2026 revenue of approximately $3.4 million, representing a 167% increase compared to the same period in 2025. Year-to-date revenue for the nine months ended September 30, 2026, reached $9.6 million, a 270% rise over the prior year that exceeded the company's full-year 2025 revenue of $5.6 million. The company achieved a gross margin of 14% in the third quarter, improving from 3% in the second quarter, while shipping over 69,500 transmitters since 2024. Energous maintained a net loss of approximately $2.5 million for the quarter, or $0.45 per share, and held $28.8 million in cash and cash equivalents as of September 30, 2026.Technology
- RNANov 12, 4:16 PMAtrium Therapeutics reported third-quarter 2026 financial results, recording $15.3 million in collaboration revenue primarily from a milestone payment with Bristol Myers Squibb. The company dosed the first patient in its Corventis Phase 1/2 clinical trial for ATR 1072, a treatment targeting the root cause of PRKAG2 syndrome, following nonclinical data showing the drug reversed cardiac glycogen accumulation. A $50 million private placement closed in October, bringing the pro-forma cash balance to $293.6 million and extending the company's operational runway through 2028. For the quarter, the company reported research and development expenses of $13.8 million and general and administrative expenses of $8.2 million.Healthcare
- AMPGNov 12, 4:16 PMAmpliTech Group reported third-quarter 2026 revenue of $6.58 million, an 8.0% increase year-over-year, with gross margin expanding sequentially to 34.2%. The company achieved a nine-month gross profit growth of 41.1% to $7.07 million while narrowing its net loss to $1.89 million for the quarter. Following quarter-end, AmpliTech announced record bookings near $25 million in October, pushing its total backlog to over $52 million. Management revised its full-year 2026 revenue outlook to at least $28 million, citing supply-chain constraints and deployment delays that prevented the achievement of a previously withdrawn $50 million target.Technology
- TNONNov 12, 4:15 PMTenon Medical, Inc. reported third-quarter 2026 revenue of $1.4 million, representing a 22% increase compared to the same period in 2025. The company achieved a gross profit of $1.0 million with a gross margin of 66.3% and ended the quarter with $8.3 million in cash and cash equivalents. During the quarter, Tenon raised approximately $15.6 million in gross proceeds, fully repaid its senior convertible notes, and launched the 3D-printed lateral screw for its SImmetry+ SI Joint Fusion System. Additionally, the company added eight new U.S. patents to its portfolio, bringing the total to 38 issued patents.Healthcare
- VNRXNov 12, 4:15 PMVolitionRx Limited reported third-quarter 2026 revenue of approximately $1.6 million, a 157% increase from the prior year, driven by deferred revenue recognition. The company narrowed its operating loss to $3.3 million and reduced its net loss to $3.8 million while strengthening its balance sheet with $2.4 million in cash and the full repayment of a $7.5 million convertible note. Strategic progress includes the launch of the DETECSEPS program for sepsis detection, active licensing discussions for its Capture-Seq technology targeting a combined market over $36 billion, and a pending reimbursement submission for its lung cancer test in France. Additionally, the CEO and board voluntarily reduced their compensation by 50% to align with the company's cost-reduction efforts and commitment to securing licensing agreements.Healthcare
- RCKTNov 12, 4:15 PMRocket Pharmaceuticals reported a net loss of $49.2 million for the third quarter of 2026, with cash, cash equivalents, and investments totaling $279.4 million as of September 30, 2026. The company received FDA alignment to complete its pivotal Phase 2 trial of RP-A501 for Danon disease, with dosing expected to finish by mid-2027. Additionally, dosing has begun in the Phase 1 trial for RP-A701 targeting BAG3-associated dilated cardiomyopathy, and the commercial product KRESLADI achieved readiness with activated treatment centers on October 1, 2026.Healthcare
- QXONov 12, 4:15 PMQXO, Inc. reported a net loss of $123 million for the third quarter of 2026, with net sales reaching $4.90 billion. Despite the GAAP loss, the company achieved an Adjusted Net Income of $229 million and Adjusted EBITDA of $557 million, driven by a 2.2% year-over-year pricing increase and strong demand in mechanical insulation and data centers. The company serves 194,000 customers across its integrated legacy businesses and has authorized a $500 million share repurchase program. Management projects reaching $4 billion in adjusted EBITDA and $50 billion in annual revenue by 2030 through organic growth and acquisitions.Industrials
- GCTSNov 12, 4:15 PMGCT Semiconductor Holding, Inc. reported third-quarter 2026 net revenues of $1.1 million, representing a 148.6% increase from the prior year period, driven by shipments of over 3,200 5G chipsets. The company achieved a net loss of $7.4 million, a 46.7% decrease year-over-year, which included $6.2 million in gains from changes in the fair value of warrant liabilities. Cash and cash equivalents stood at $17.2 million as of September 30, 2026, while the company extended the maturities of $26.5 million in loans during the quarter. Management expects 5G shipment volumes to ramp significantly into the first half of 2027 as customer integration schedules progress.Technology
- NEOVNov 12, 4:15 PMNeoVolta Inc. reported revenue of $2.8 million for the quarter ended September 30, 2026, a significant increase from the previous quarter driven by initial sales through its third-party ownership residential platform. The company achieved a gross profit of $1.0 million, reversing a prior gross loss, while reporting a GAAP net loss of $7.7 million and adjusted EBITDA of negative $5.5 million. Financial results were supported by a $20 million senior secured term loan, bringing total cash and restricted cash to $28.8 million. Strategic progress included the ramp-up of the Pendergrass, Georgia manufacturing facility, a $116 million master purchase agreement for utility-scale products, and a supply collaboration with SK On for 9 GWh of battery cells.Industrials
- CBIONov 12, 4:15 PMCrescent Biopharma completed dose escalation in its Phase 1/2 ASCEND trial for CR-001, having dosed over 125 patients across the United States, Europe, and South Korea, with initial monotherapy data expected in the first quarter of 2027. The company has also dosed the first patient in the global APOLLO trial for CR-002, a PD-L1-targeted ADC, while multiple Phase 2 studies of CR-001 combinations with sacituzumab tirumotecan are ongoing in China. Financially, Crescent reported a net loss of $37.7 million for the third quarter of 2026, with cash and cash equivalents totaling $289.4 million as of September 30, 2026.Healthcare
- FLONov 12, 4:15 PMFlowers Foods, Inc. reported third-quarter 2026 net sales of $1.169 billion, a 4.7% decrease from the prior year, driven by a 7.0% decline in volume that outweighed a 2.3% favorable price and mix. Net income fell 63.6% to $14.4 million, while adjusted net income decreased 56.0% to $21.4 million, resulting in diluted earnings per share of $0.07. The company cited challenging market conditions, including pressure on household budgets and higher logistics costs, as key factors impacting performance. Consequently, Flowers Foods revised its full-year 2026 guidance downward, projecting net sales between $5.016 billion and $5.063 billion and adjusted diluted EPS between $0.63 and $0.68.Consumer Defensive
- BLSMNov 12, 4:15 PMBlossomHill Therapeutics reported a net loss of $24.0 million for the third quarter of 2026, driven by increased research and development expenses related to its lead candidate BH-30643. The company aligned with the FDA on a recommended Phase 2 dose of 50 mg twice daily for BH-30643 and announced the upcoming SOLARA-2 pivotal trial, which is expected to dose its first patient in the first quarter of 2027. Additionally, BlossomHill plans to submit an Investigational New Drug application for its pan-KRAS inhibitor, BH-501284, in the first quarter of 2027. As of September 30, 2026, the company held $224.9 million in cash and cash equivalents, which is projected to fund operations through the second quarter of 2028.Healthcare
- AZTRNov 12, 4:15 PMAzitra, Inc. reported a net loss of $3.0 million for the quarter ended September 30, 2026, with total operating expenses reaching $2.9 million. The company announced positive ex vivo results for its ATR-COSF program, demonstrating a 50% reduction in fine lines and improved skin elasticity, and plans to initiate a first-in-human cosmetic study with results expected by year-end. Additionally, Azitra completed Cohort 1 of its ATR-04 Phase 1/2 trial and received approval to proceed to Cohort 2, which will expand eligibility to include patients with KRAS and MEK inhibitor-associated rashes. As of September 30, 2026, the company held $3.8 million in cash and cash equivalents.Healthcare
- IMMXNov 12, 4:15 PMImmix Biopharma reported a 89% complete response rate across all 45 patients in its NEXICART-2 clinical trial for NXC-201, with potential for up to 98% complete response. The company appointed David He as Senior Vice President of Technical Operations and Karin McIntosh as Senior Vice President of Regulatory Affairs to advance commercial launch preparations. Immix plans to submit a Biologics License Application in mid-2027 and initiate the NEXICART-3 front-line trial in the first half of 2027. For the third quarter ended September 30, 2026, the company reported $340.9 million in cash and marketable securities, providing an operating runway into mid-2028, alongside $15.9 million in operating expenses.Healthcare
- HKHCNov 12, 4:15 PMHorizon Kinetics Holding Corporation reported a net loss of $18.4 million for the third quarter of 2026, driven by unrealized declines in the fair value of key investment holdings. Management and advisory fees remained flat at $17.8 million for the quarter, while assets under management decreased 7.3% to $10.0 billion. The company declared a $0.13 per share cash dividend and authorized a $25 million share repurchase program. Year-to-date results showed a net income of $35.8 million, reflecting unrealized gains that offset the quarterly losses.
- KLCNov 12, 4:15 PMKinderCare Learning Companies reported a net loss of $85.0 million for the third quarter of 2026, driven by $83.4 million in impairment losses and a 5.9% decline in enrollment at its early childhood education centers. Total revenue for the period decreased 1.7% to $665.3 million, while adjusted EBITDA fell to $42.5 million compared to the prior year quarter. The company closed 20 centers as part of an optimization initiative and updated its full-year 2026 revenue guidance to a range of $2.64 billion to $2.66 billion.Consumer Defensive
- MRLNNov 12, 4:14 PMMerlin, Inc. reported a third quarter 2026 GAAP net income of $73.8 million, a significant turnaround from the $58.4 million loss in the second quarter of 2026. Total revenue for the quarter reached $3.5 million, while the company ended the period with $161.6 million in cash, cash equivalents, and short-term investments and no outstanding debt. The company secured an $8.9 million task order from USSOCOM for its C-130J autonomy program and a $500,000 contract from USAFRICOM for an autonomous casualty evacuation demonstration. Looking ahead, Merlin plans to reduce 2027 operating expenses by focusing investment on funded programs with clear revenue paths to preserve its balance sheet.Industrials
- NTLANov 12, 4:14 PMIntellia Therapeutics has submitted a Biologics License Application for lonvo-z, an investigational one-time in vivo CRISPR gene editing therapy for hereditary angioedema (HAE), with a PDUFA goal date of March 10, 2027. Phase 3 HAELO trial data demonstrated a 62% reduction in mean attack rates and an 87% reduction in attack-free weeks compared to placebo, with benefits sustained for up to four years in long-term follow-up. The treatment permanently inactivates the KLKB1 gene to stop excess kallikrein production, offering a potential cure that eliminates the need for chronic long-term prophylaxis and significantly reduces the disease burden for patients.Healthcare
- TACTNov 12, 4:13 PMTransAct Technologies reported preliminary third-quarter 2026 net sales of $14.4 million, representing a 10% increase year-over-year driven by a 33% rise in Food Service Technology revenue. The company recorded a net loss of $440 thousand for the quarter, with adjusted EBITDA reaching $289 thousand, while revising its full-year 2026 revenue guidance to between $55 million and $56 million. Management highlighted strong growth in FST software revenue and online unit installations, though the Casino and Gaming segment experienced a decline due to cyclicality. Additionally, the Board has initiated a strategic review of the Casino and Gaming business, potentially including a sale of the FST division, to maximize stockholder value.Technology
- SERNov 12, 4:13 PMSerina Therapeutics reported a net loss of $7.9 million for the third quarter of 2026, driven by increased research and development expenses related to clinical activities. The company advanced its investigational Parkinson's disease treatment, SER-252, to Cohort 2 of its registrational study following a positive safety review by an independent committee. Cash and cash equivalents increased to $19.4 million as of September 30, 2026, supported by financing activities. Topline data from the single-ascending-dose portion of the SER-252 trial is expected in the first half of 2027.Healthcare
- SSTINov 12, 4:12 PMSoundThinking, Inc. reported third-quarter 2026 revenues of $25.0 million, a slight decrease from the prior year, while GAAP net loss widened to $8.5 million compared to $2.0 million in the same period of 2025. The company announced a definitive merger agreement with Transom Capital Group to be acquired for $8.00 per share in cash plus contingent value rights, with an expected closing in the fourth quarter of 2026. Due to the pending transaction, SoundThinking will not provide forward-looking guidance or host an earnings conference call for this quarter or future quarters. Adjusted EBITDA for the quarter totaled $2.2 million, down from $3.5 million in the previous year, driven by increased acquisition-related costs and higher operating expenses.Technology
- OFRMNov 12, 4:12 PMOnce Upon a Farm reported third-quarter 2026 net sales of $89.1 million, representing a 34.9% increase from the prior year period. The company posted a net loss of $3.8 million and an adjusted EBITDA loss of $1.0 million, driven by trade investments and cooler placement costs that reduced gross margin to 36.1%. As of September 30, 2026, the company held $106.4 million in cash and cash equivalents with no outstanding debt. Consequently, the company updated its full-year 2026 outlook, lowering net sales guidance to $290–$300 million and adjusting the adjusted EBITDA loss forecast to $4.5–$7 million due to the impact of a voluntary product recall.Consumer Defensive
- SRTSNov 12, 4:12 PMSensus Healthcare reported third-quarter 2026 revenues of $6.0 million, a 13% decrease from the prior year, driven by a shift toward lower-priced SRT-100 systems and the absence of sales to a historically large customer. Despite lower revenue, gross profit increased to $3.3 million as the gross margin improved to 55% due to a favorable product mix and lower cost of sales. The company shipped 26 systems during the quarter, including eight carried over from the previous quarter, and announced the sale of its 1,000th SRT system subsequent to the quarter end. Net loss for the period was $1.5 million, or $0.09 per share, while adjusted EBITDA improved to a negative $1.5 million from negative $2.4 million in the prior year.Healthcare
- BOLTNov 12, 4:11 PMBolt Biotherapeutics completed the acquisition of Prana Therapies in a stock-for-stock reverse merger and secured $120 million in concurrent private placement financing. The company has designated the INSPIRE-built pipeline, led by the Phase 2 bispecific antibody PRA-216, as its primary development focus for treating asthma, atopic dermatitis, and chronic obstructive pulmonary disease. PRA-216 Phase 1 data demonstrated the potential for at-home maintenance dosing every 8 to 12 weeks, with initial Phase 2 proof-of-concept data expected in the second quarter of 2027. For the third quarter of 2026, the company reported a net loss of $4.4 million and operating expenses of $4.7 million, while its cash runway is projected to extend into 2028.Healthcare
- BCDANov 12, 4:11 PMBioCardia, Inc. reported a net loss of $1.8 million for the third quarter of 2026, with total operating expenses reaching $1.8 million. The company successfully completed regulatory interactions with Japan's PMDA regarding its CardiAMP autologous cell therapy and expects to submit for approval in Japan during late 2026 or early 2027. Additionally, the FDA accepted the company's pre-submission minutes for the Helix transendocardial delivery system, with a full De Novo submission targeted for the first quarter of 2027. BioCardia ended the quarter with $2.2 million in cash and cash equivalents, providing an anticipated runway into 2027.Healthcare
- MGNXNov 12, 4:11 PMMacroGenics reported a net loss of $20.1 million for the third quarter of 2026, with total revenue declining to $18.7 million from $53.0 million in the same period last year. The company's cash position increased to $287.7 million as of September 30, 2026, supported by milestone payments from partners and the sale of its GMP manufacturing operations. Clinical progress included the completion of Phase 1 dose escalation for MGC028, the reporting of interim results for MGC026 and lorigerlimab at ESMO 2026, and the dosing of the first patient in the Phase 1 study for MGC030. Additionally, the Board of Directors was strengthened by the appointment of two new independent directors with oncology expertise, and Gilead Sciences exercised an option to license a preclinical bispecific program, triggering a $10 million payment.Healthcare
- FDMTNov 12, 4:11 PM4D Molecular Therapeutics completed enrollment and randomization for the 4FRONT-2 Phase 3 clinical trial of its lead candidate 4D-150 in wet age-related macular degeneration, with topline data expected in the second half of 2027. The company also initiated the global 4SIGHT Phase 3 trial for 4D-150 in diabetic macular edema and presented two-year data from PRISM and SPECTRA trials demonstrating durable clinical activity and a favorable safety profile. Financially, the company reported a net loss of $78.1 million for the third quarter of 2026, driven by increased research and development expenses, while maintaining a cash position of $375 million expected to fund operations through the second half of 2028.Healthcare
- PLRXNov 12, 4:11 PMPliant Therapeutics reported a net loss of $24.4 million for the third quarter of 2026, with research and development expenses remaining flat at $17.9 million despite the termination of its bexotegrast program. The company's lead candidate, PLN-101095, continues to enroll ahead of schedule in the FORTIFY Phase 1b trial for immune checkpoint inhibitor-refractory solid tumors, with interim data expected in 2027. Pliant also announced the appointment of David Raben as Chief Medical Officer and Craig Blanchette as Senior Vice President of Research to lead its RNAi initiatives. The company's proprietary integrin-mediated delivery platform has demonstrated over 75% target gene knockdown in non-human primate studies while avoiding liver exposure, supporting plans to target neuromuscular and cardiac diseases. As of September 30, 2026, Pliant held $142.6 million in cash and short-term investments, which is projected to fund operations through mid-2028.Healthcare
- ALMSNov 12, 4:11 PMAlumis Inc. reported a net loss of $94.9 million for the third quarter of 2026, driven by $80.8 million in research and development expenses and $20.2 million in general and administrative costs. The company highlighted new Phase 3 data for its lead candidate envudeucitinib in plaque psoriasis, which demonstrated rapid and durable improvements in skin clearance and itch resolution, supporting a planned New Drug Application submission in the fourth quarter of 2026. Conversely, the Phase 2b LUMUS trial for envudeucitinib in systemic lupus erythematosus did not meet its primary endpoints in the overall population, though robust responses were observed in a subgroup with high interferon gene signatures. As of September 30, 2026, Alumis held $431.3 million in cash and marketable securities, which is expected to fund operations through the fourth quarter of 2027.Healthcare
- CBUSNov 12, 4:11 PMCibus reported a net loss of $21.9 million for the third quarter of 2026, with cash used in operating activities decreasing by approximately 19% year-over-year to $9.3 million. The company advanced its Rice herbicide-tolerance traits into customer field trials in Ecuador and initiated manufacturing for two biofragrance products, which represent a potential $100 million peak annual revenue opportunity. Regulatory progress included U.S. FDA clearance for an altered-lignin Alfalfa trait and European Union legislation treating precise genomic edits as conventional breeding. Cibus anticipates exiting 2026 with an annualized net cash usage run rate of approximately $35 million, supported by a cash balance of $10.7 million as of September 30, 2026.Healthcare
- INVENov 12, 4:11 PMINVE Technologies reported third-quarter 2026 revenue of $3.1 million, a decrease from $5.0 million in the prior year, driven by lower RFID unit sales and the divestiture of its IoT business to Trackonomy. The company achieved a GAAP net income of $0.6 million, or $0.02 per share, compared to a net loss of $3.5 million in the same period last year, primarily due to gains recognized on the asset sale and the dissolution of a foreign subsidiary. Following the September 15, 2026, sale of its IoT business, INVE Technologies currently has no commercial revenue and has suspended financial guidance. Non-GAAP operating expenses decreased to $4.0 million from $4.5 million in the prior year, reflecting disciplined cost control despite higher strategic transaction-related costs.Technology
- AAWHNov 12, 4:10 PMAscend Wellness Holdings reported third-quarter 2026 net revenue of $130.0 million, representing a 4.2% year-over-year increase and a 3.1% sequential rise. The company generated $31.1 million in Adjusted EBITDA, achieving a margin of 23.9%, while net cash provided by operating activities reached $5.4 million despite a $19.1 million semi-annual interest payment. Retail operations expanded to 61 stores, exceeding the year-end target of 60, and the company maintained its position as the number two brand house across Illinois, New Jersey, and Massachusetts. Additionally, Ascend secured $11 million in non-dilutive mortgage loans and entered a brand licensing agreement to introduce its products to the Canadian market in early 2027.
- LFMDNov 12, 4:10 PMLifeMD reported third-quarter 2026 revenue of $44.6 million, representing a 7% decline from the prior year, while adjusting its full-year revenue guidance downward to a range of $188 million to $191 million. The company achieved an adjusted EBITDA loss of approximately $0.4 million, a significant sequential improvement driven by a 34% reduction in selling and marketing expenses. Total active subscribers grew 13% year-over-year to 350,000, and the pharmacy division saw shipment volume increase by 58.3%. Strategic developments included new dispensing agreements for branded GLP-1 medications with Novo Nordisk and Eli Lilly, as well as an exclusive partnership with AT&T to serve its customer base.Healthcare
- RLMDNov 12, 4:10 PMRelmada Therapeutics reported a net loss of $13.9 million for the third quarter of 2026, with research and development expenses rising to $9.2 million. The company holds approximately $202.1 million in cash and short-term investments as of September 30, 2026, which is projected to fund operations through 2029. Clinical updates indicate that 86% of patients in the NDV-01 Phase 2 study who achieved a complete response at 12 months remained in complete response at 18 months. Relmada remains on track to submit Investigational New Drug applications for both NDV-01 and sepranolone by the end of 2026, with the registrational Phase 3 SPECTRUM program for NDV-01 expected to commence upon clearance.Healthcare
- OPHCNov 12, 4:10 PMOptimumBank Holdings, Inc. reported net income of $7.2 million, or $0.30 per share, for the third quarter of 2026, marking an increase from the previous quarter and the same period last year. The company's gross loan portfolio grew by $150.2 million to $1.37 billion, while total deposits rose by $128.8 million to $1.34 billion during the quarter. Net interest income increased to $16.8 million, driven by higher yields on loans and securities, resulting in a net interest margin of 4.63%. Additionally, the company strengthened its capital position through a $35.0 million subordinated debt offering and maintained strong asset quality with net charge-offs of only $11,000.Financial Services
- UAMYNov 12, 4:10 PMUnited States Antimony Corporation reported third-quarter 2026 revenues of $10.1 million, a 16% increase from the prior year, driven by a 68% rise in antimony pounds sold. The company achieved a gross profit margin of 42%, up from 23% in the previous year, resulting in $4.3 million in gross profit despite a net loss of $9.5 million due to non-cash stock-based compensation and an unrealized loss on an equity investment. Antimony sales included approximately 162,000 pounds of metal ingots accepted by the Defense Logistics Agency, contributing $5.1 million in revenue, while industrial sales volumes increased 10% year-over-year. The company provided full-year 2026 guidance for antimony sales volumes between 1.68 million and 1.81 million pounds, representing a 24% increase over 2025, and maintained significant liquidity with $51.0 million in cash and U.S. Treasury securities.Basic Materials
- PEWNov 12, 4:10 PMGrabAGun Digital Holdings reported third-quarter 2026 net revenues of $21.2 million, a 4.7% decrease from the prior year, driven by lower firearms and non-firearms sales. Despite the revenue decline, the company achieved a 44% increase in gross profit and expanded its gross margin by 480 basis points to 14.4%, supported by improved average selling prices and sourcing. The company posted a net loss of $3.0 million for the quarter and $6.7 million for the first nine months, while maintaining $96.0 million in cash and minimal debt. Subsequent to the quarter, GrabAGun completed the acquisition of Camfour, a New England-based wholesale distributor, to broaden its distribution capabilities.Industrials
- FLNTNov 12, 4:10 PMFluent, Inc. reported third-quarter 2026 revenue of $53.6 million, a 14% increase year-over-year, driven by Commerce Media Solutions revenue doubling to $37.5 million. The company's Commerce Media Solutions segment now accounts for 70% of total revenue with an annual run rate exceeding $145 million and a gross margin of 30%. Net loss for the quarter narrowed to $3.1 million from $7.6 million in the prior year period, while adjusted EBITDA reached near-breakeven at $0.0 million. Fluent expects full-year 2026 to deliver double-digit revenue growth on aggregate continuing businesses and improved adjusted EBITDA.Communication Services
- SMTINov 12, 4:10 PMSanara MedTech Inc. reported third-quarter 2026 net revenue of $28.4 million, an 8% increase from the prior year, driven by growth in soft tissue repair products. The company posted a net loss from continuing operations of $1.3 million, or $0.15 per diluted share, compared to a net income of $0.8 million in the same period last year. Adjusted EBITDA for the quarter rose to $5.6 million, while the company updated its full-year 2026 revenue guidance to a range of $110 million to $115 million. Additionally, Sanara continues to advance its pending merger with MiMedx Group, Inc., which received shareholder approval in September.Healthcare
- SNALNov 12, 4:10 PMSnail, Inc. reported third-quarter 2026 net revenues of $33.1 million, representing a 139.2% increase from the prior year period, driven primarily by strong sales of ARK: Survival Ascended and its downloadable content. The company achieved a net income of $6.7 million for the quarter, a significant turnaround from a net loss of $7.9 million in the same period last year, while total units sold rose 73.3% to 2.0 million. Key operational highlights included the launch of new ARK content updates, the release of titles such as Bellwright and Honeycomb: The World Beyond, and the unveiling of upcoming AAA projects like 9 Yin Sutra and For The Stars. Looking ahead, Snail expects continued momentum from its established ARK content pipeline extending through 2027 and the anticipated release of ARK: Dragontopia in December 2026.Communication Services
- EQNov 12, 4:10 PMEquillium, Inc. initiated a Phase 1 clinical trial for its investigational drug EQ504 in October 2026, with proof-of-mechanism data expected in the second quarter of 2027. The company reported cash and cash equivalents of $53.3 million as of September 30, 2026, and secured an additional $20 million in financing later that month, extending its cash runway into 2029. For the third quarter of 2026, Equillium recorded a net loss of $4.6 million, driven by research and development expenses of $2.5 million and general and administrative expenses of $2.6 million. EQ504 is a selective aryl hydrocarbon receptor modulator designed to treat ulcerative colitis and other inflammatory disorders through a non-immunosuppressive mechanism.Healthcare
- LCTXNov 12, 4:10 PMLineage Cell Therapeutics reported a net income of $4.2 million for the third quarter of 2026, driven primarily by a non-cash gain from the fair value remeasurement of warrant liabilities. The company acquired NeuroAirmid Therapeutics, adding the HUNT1 clinical-stage cell therapy candidate for Huntington's Disease to its pipeline, and secured a U.S. patent for its AlloSCOPE 5D manufacturing technology. Financial results showed total revenues of $1.4 million and operating expenses of $8.8 million, with cash and marketable securities totaling $45.2 million expected to fund operations through the second quarter of 2028. Key program updates include the advancement of the ReSonance hearing loss therapy into the second year of its collaboration with William Demant Invest and the initiation of preclinical testing for the COR1 corneal endothelial disease program.Healthcare
- ELDNNov 12, 4:10 PMEledon Pharmaceuticals reported a net loss of $3.9 million for the third quarter of 2026, driven by $17.8 million in research and development expenses, while maintaining $69.7 million in cash and short-term investments sufficient to fund operations into the second quarter of 2027. The company received FDA Fast Track designation for tegoprubart in kidney transplantation and cleared an IND application for a registrational study in islet cell transplantation for type 1 diabetes. Clinical updates included new patient-reported outcome data showing improved quality of life and symptom burden for tegoprubart compared to tacrolimus in kidney transplant recipients, alongside long-term data demonstrating sustained eGFR advantages. Upcoming milestones include the initiation of the global Phase 3 LEGACY trial for kidney transplantation in the fourth quarter of 2026 and the start of a registrational path study for islet cell transplantation.Healthcare
- RKDANov 12, 4:09 PMArcadia Biosciences reported third-quarter 2026 total revenues of $1.619 million, representing a 24% year-over-year increase driven by strong summer program volumes. The company achieved net income of $1.755 million for the quarter, a significant improvement from the $856,000 net income recorded in the same period of 2025, largely due to a $2.6 million gain from changes in the fair value of warrant and option liabilities. Zola brand revenues reached their highest quarterly sales ever, with a new 1-liter espresso formulation beginning shipments and slim can variants scheduled for launch in early 2027. Operating expenses for the nine-month period decreased by 23% compared to the prior year, offset by a $2.7 million reduction in other operating income related to the absence of prior-year patent transfer gains.Consumer Defensive
- ACCVNov 12, 4:08 PMAccelevation Holdings Corp. reported third-quarter 2026 revenue of $202.2 million, representing a 65.9% year-over-year increase, while bookings surged 364% to $768.9 million. The company achieved a backlog of $1.7 billion and an adjusted EBITDA of $37.7 million, with operating cash flow turning positive to $62.5 million. Following its initial public offering in October 2026, the company entered into a new $650 million senior secured credit agreement to reduce leverage. Management has issued full-year 2026 guidance projecting revenue between $905 million and $915 million and adjusted EBITDA between $155 million and $165 million.Industrials
- REKRNov 12, 4:08 PMRekor Systems reported a net loss of $2.9 million for the third quarter of 2026, narrowing from $4.1 million in the prior year period, while recurring revenue grew 16% to $7.5 million. The company reduced its nine-month operating cash use by 49% to $10.6 million following a major rightsizing initiative that eliminated approximately $9.7 million in lease liabilities. Recent business developments include a potential $1.4 million five-year contract with the Oregon Department of Transportation and a 94% increase in the contract ceiling with the Florida Department of Transportation. Additionally, Rekor expanded its Born Authentic product line to include audio authentication and is actively pursuing refinancing for its $15 million Series A Prime Revenue Sharing Notes due in December 2026.Technology
- ERASNov 12, 4:08 PMErasca, Inc. reported a net loss of $51.3 million for the third quarter ended September 30, 2026, while maintaining a cash position of $947.8 million. The company's lead candidate, ERAS-0015, received FDA Fast Track Designation for metastatic pancreatic adenocarcinoma in August 2026. Erasca is advancing toward three potentially registration-enabling trials in pancreatic and lung cancers, with preliminary data for ERAS-4001 expected in the second half of 2026. Additionally, the firm completed an upsized public offering in July 2026 that raised approximately $632.5 million to fund its development pipeline.Healthcare
- OBXNov 12, 4:07 PMObsidian Therapeutics reported third-quarter 2026 financial results showing a net loss of $50.7 million and cash reserves of $324.4 million as of September 30, 2026. The company presented updated efficacy data for its lead candidate amsoki-cel in advanced melanoma, demonstrating a 67% objective response rate and a median progression-free survival of 8.3 months in the registration-enabling cohort of the Agni-01 study. Enrollment in this cohort is expected to conclude by the end of the first quarter of 2027, with topline data anticipated by the end of 2027. Corporate updates include the completion of a $350 million financing round, the closing of a transaction with Galera Therapeutics, and the appointment of Mark Reisenauer to the Board of Directors.Healthcare
- SHIMNov 12, 4:07 PMShimmick Corporation reported a net income of $1 million for the third quarter ended October 2, 2026, marking its first positive net income since the third quarter of 2023. Revenue for the quarter reached $136 million, driven entirely by Shimmick Projects which saw a 28% increase quarter-over-quarter, while Adjusted EBITDA rose 106% to $9 million. The company's liquidity increased by $20 million to $53 million, and its backlog stands at approximately $907 million with Shimmick Projects representing 98% of the total. Management reaffirmed full-year 2026 Adjusted EBITDA guidance between $20 million and $25 million and raised revenue expectations to a range of $500 million to $525 million.Industrials
- IDNNov 12, 4:07 PMIntellicheck reported a net income of $0.5 million for the third quarter of 2026, marking its fifth consecutive quarter of profitability. Revenue for the period totaled $5.7 million, while Adjusted EBITDA increased to $0.9 million, representing the sixth consecutive quarter of positive performance. The company ended the quarter with $13.2 million in cash and no debt, its highest cash balance since the end of 2021. Banking and lending remained the fastest-growing vertical, with momentum also observed in emerging sectors such as cargo, freight, and automotive credit.Technology
- TMCNov 12, 4:07 PMThe Metals Company reported a net loss of $28.4 million for the third quarter of 2026, with liquidity of approximately $123 million available as of September 30. The company's subsidiary, TMC USA, received an updated timeline from NOAA expecting a final certification determination by mid-December 2026 for its USA-A commercial recovery permit application. TMC is advancing a capital-light production strategy with Allseas to initiate operations upon permit grant, while simultaneously pursuing U.S. government funding for a processing facility in Brownsville, Texas. Additionally, the company appointed Liam Mallon, former President of ExxonMobil Upstream, to its Board of Directors to leverage his extensive energy and offshore experience.Basic Materials
- NPCENov 12, 4:07 PMNeuroPace reported third-quarter 2026 total revenue of $23.1 million, with RNS System revenue reaching $22.9 million, representing a 1.4% year-over-year growth. The company revised its full-year 2026 revenue guidance downward to a range of $91 million to $92 million, citing the need to improve commercial execution following isolated account-level issues. Despite a net loss of $3.3 million for the quarter, the company achieved a positive adjusted EBITDA of $0.4 million and increased its non-GAAP gross margin to 84.8%. Strategic advancements include an FDA submission for the NeuroPace Remote Care system and the initiation of the AURORA study to support indication expansion for adolescents.Healthcare
- SLSNov 12, 4:07 PMSELLAS Life Sciences reported a net loss of $10.1 million for the third quarter of 2026, with research and development expenses rising to $7.0 million due to costs associated with the Phase 3 REGAL trial and potential Biologics License Application for GPS. The company holds $134.7 million in cash and cash equivalents as of September 30, 2026, providing capital to advance its clinical programs. Topline primary endpoint results for the Phase 3 REGAL trial of Galinpepimut-S in acute myeloid leukemia are expected to be announced following the 80th event milestone. Additionally, 40 patients have been enrolled in the Phase 2 trial of tambiciclib (SLS009) for newly diagnosed AML, with preliminary data anticipated in the fourth quarter.Healthcare
- LFTONov 12, 4:07 PMLiftoff Mobile reported third-quarter 2026 revenue of $238 million, representing an 8% increase from the previous quarter and a 32% year-over-year growth. The company achieved a net income of $87 million and an adjusted EBITDA of $145 million, with margins of 37% and 61% respectively. Trailing twelve-month free cash flow rose 158% to $249 million, driven by strong performance across key app categories. Management provided fourth-quarter revenue guidance between $244 million and $249 million and full-year revenue guidance between $907 million and $912 million.Communication Services
- KSCPNov 12, 4:06 PMKnightscope reported third-quarter 2026 revenue of $8.7 million, representing a 177% increase year over year and marking the third consecutive quarter of triple-digit growth. The company achieved a positive gross margin of $0.4 million, driven by a 349% surge in service revenue to $8.6 million, while operating expenses rose to $12.0 million. Knightscope unveiled its Autonomous Security Force at GSX 2026 and secured approximately $27 million in renewals and bookings since May 2026, though the company reported a net loss of $11.8 million for the quarter.Industrials
- AZRNov 12, 4:06 PMAzora Therapeutics, Inc. reported a net loss of $64.6 million for the third quarter ended September 30, 2026, driven primarily by a $57.1 million non-cash charge related to the change in fair value of milestone warrant rights liability. The company's cash and cash equivalents stood at $22.0 million as of the quarter's end, which is expected to fund operations through the initiation of a Phase 1a clinical trial. Azora advanced its lead candidate, AT177, an oral AhR agonist for ulcerative colitis, through IND-enabling studies with a planned IND submission and Phase 1a trial initiation in the first half of 2027. Corporate updates include a name change from Adial Pharmaceuticals, a new Nasdaq ticker symbol (AZR), and the appointment of a new executive team and Board of Directors effective late October 2026.Healthcare
- STEXNov 12, 4:06 PMStreamex Corp. reported a net loss of $17.5 million for the third quarter of 2026, driven primarily by $9.3 million in non-cash stock-based compensation. The company's gold-backed token, GLDY, grew by 240 net ounces to reach 3,351 ounces, while external ownership of the token doubled to 17.7% of the outstanding supply. Streamex ended the quarter debt-free with a total liquidity position of $36.5 million, including $13.2 million in cash and investments, and announced that GLDY will soon launch on Equity Trust's IRA platform.Healthcare
- CSCONov 12, 4:06 PMCisco reported record first-quarter revenue of $18.5 billion, representing a 24% year-over-year increase, alongside record non-GAAP earnings per share of $1.40. The company raised its full-year fiscal 2027 revenue guidance to a range of $74.8 billion to $75.8 billion and increased its AI infrastructure revenue expectation from hyperscalers to $9 billion for the year. Operating performance was driven by broad-based demand, with product revenue growing 32% and double-digit growth observed across all geographic regions and customer markets.Technology
- EVMNNov 12, 4:06 PMEvommune, Inc. reported a net loss of $30.9 million for the third quarter of 2026, with cash and investments totaling $262.3 million as of September 30, 2026. The company in-licensed EVO570, an oral VAV-1 molecular glue degrader, for $30 million and concurrently raised $30 million through a private placement of common stock. Clinical updates include positive Phase 2a data for EVO301 in atopic dermatitis, which supports a Phase 2b trial expected to initiate in mid-2027, alongside plans to begin Phase 1 trials for EVO570 and EVO646 in early 2027.Healthcare
- HQINov 12, 4:06 PMHireQuest reported third-quarter 2026 net income of $1.7 million, or $0.12 per diluted share, a decrease from $2.3 million in the same period of 2025. Total revenue for the quarter reached $8.8 million, representing a 4.0% increase year-over-year, while adjusted EBITDA remained consistent at $4.5 million. The decline in net income was primarily driven by a $1.3 million write-down of notes receivable related to a franchised location repossession and higher workers' compensation expenses. System-wide sales for the quarter totaled $131.2 million, with pro forma growth of 11.4% after accounting for the MRINetwork Assets Divestiture.Industrials
- SLSNNov 12, 4:06 PMSolésence, Inc. reported record third-quarter 2026 financial results with revenue increasing 38% year-over-year to $20.2 million. The company achieved its highest-ever net income of $3.7 million, a significant turnaround from a $1.0 million net loss in the same period of 2025. Gross margin expanded substantially to 39.3% from 23.8% in the prior year, driven by operational improvements and capacity enhancements. These results position the company for sustained growth as it continues to scale its manufacturing and innovation capabilities.Consumer Defensive
- OPNWNov 12, 4:05 PMOpenWorld, Inc. reported third-quarter 2026 revenue of $7.4 million, driven by a $6.4 million contribution from its new real-world asset (RWA) platform which achieved an 80% gross margin. The company recorded a GAAP net loss of $10.2 million for the quarter, primarily due to $6.4 million in non-recurring stock-based compensation and $6.0 million in merger-related professional fees. Subsequent to the quarter, OpenWorld secured $1.1 billion in non-binding letters of intent for tokenized financing programs involving AI infrastructure and intellectual property. The company also completed a $3.5 million registered direct offering and the acquisition of Blocksight Holdings to enhance its platform capabilities.Technology
- DERMNov 12, 4:05 PMJourney Medical Corporation reported total revenues of $19.0 million for the third quarter of 2026, representing an 8% increase from the prior year period. The company's flagship product, Emrosi, generated $9.0 million in revenue, marking an 84% year-over-year growth driven by increased prescription demand and improved reimbursement mixes. Gross margin improved to 69% for the quarter, while the GAAP net loss narrowed to $1.3 million compared to $2.3 million in the same period of 2025. The company ended the quarter with $22.3 million in cash and cash equivalents and achieved positive non-GAAP EBITDA of $3.5 million.Healthcare
- JCAPNov 12, 4:05 PMJefferson Capital reported record third-quarter 2026 results with collections growing 35% to $319.2 million and deployments surging 111% to $318.0 million. The company achieved a record Estimated Remaining Collections (ERC) of $3.6 billion, representing a 23% increase from the prior year period. Financial performance included pre-tax income of $58.9 million and net income of $46.9 million, resulting in earnings per share of $0.76. Additionally, the Board of Directors declared a quarterly cash dividend of $0.24 per share, payable in December 2026.Financial Services
- ADRXNov 12, 4:05 PMADARx Pharmaceuticals completed its initial public offering and a concurrent private placement, generating approximately $602.5 million in aggregate gross proceeds. The company advanced three Phase 2 clinical trials for its lead candidate agazisiran to treat complement-mediated diseases and received Fast Track designation from the FDA for onvuzosiran in hereditary angioedema. For the third quarter ended September 30, 2026, the company reported collaboration revenue of $2.2 million, research and development expenses of $26.7 million, and a net loss of $28.1 million. As of the end of the quarter, ADARx held $901.0 million in cash, cash equivalents, and short-term investments, which is expected to fund operations into 2030.Healthcare
- NMAXNov 12, 4:05 PMNewsmax Inc. reported record third-quarter 2026 revenues of $69.0 million, representing a 52.5% year-over-year increase, driven by a $14.0 million non-recurring service revenue termination fee. Excluding this one-time item, the company achieved a record $55.0 million in revenue, a 21.6% increase, alongside a net income of $15.2 million and adjusted EBITDA of $19.0 million. The broadcaster expanded its audience reach to 22.5 million total viewers and grew social media followers by 13% to 26.8 million while launching international services including Newsmax Ukraine. Newsmax maintained its full-year 2026 revenue guidance of $212 million to $216 million, excluding the one-time payment, which reflects 13% year-over-year growth at the midpoint.Communication Services
- DMRCNov 12, 4:05 PMDigimarc Corporation reported third-quarter 2026 total revenue of $6.4 million, a decrease from $7.6 million in the same period of 2025, driven by the expiration and step-down of major commercial contracts. The company's ending Annual Recurring Revenue (ARR) declined to $10.8 million from $15.8 million the prior year, though service revenue increased to $3.3 million. Net loss attributable to Digimarc Corporation for the quarter was $8.1 million, or $0.36 per diluted share, while non-GAAP net loss was $2.9 million. At the end of the quarter, the company held $22.1 million in cash, cash equivalents, and marketable securities, with free cash flow usage totaling $4.3 million.Technology
- PRMENov 12, 4:05 PMPrime Medicine dosed the first patient in its global Phase 1/2 clinical trial for PM577a, an in vivo Prime Editing therapy for Wilson disease, with initial data expected in 2027. The company received FDA clearance for its Investigational New Drug application for PM647 to treat Alpha-1 Antitrypsin Deficiency, also anticipating initial clinical data in 2027. Prime Medicine plans to submit a Biologics License Application for PM359 in Chronic Granulomatous Disease during the first half of 2027. In November 2026, the company raised $143.7 million in gross proceeds from a public offering, bringing its pro-forma cash position to approximately $209.5 million to fund operations through 2027.Healthcare
- SSTNov 12, 4:05 PMSystem1, Inc. reported third-quarter 2026 revenue of $26.0 million, a significant decline from the $61.6 million recorded in the same period of 2025. The company posted a GAAP net loss of $61.5 million and an adjusted EBITDA of negative $0.7 million, driven by substantial impairment charges and reduced monetization from Google's AI overviews. Key operational highlights included the MapQuest app reaching number one on major app stores and Startpage integrating into Mozilla's Firefox browser. In response to these financial pressures and strategic shifts, System1 announced its intention to voluntarily delist from the New York Stock Exchange and move to the OTC Venture Market.Industrials
- INTZNov 12, 4:05 PMIntrusion Inc. reported third-quarter 2026 revenue of $2.7 million, marking an 84% sequential increase and a 36% year-over-year rise driven by the first full quarter of contributions from the VigilAigent acquisition and a contract with the State of Texas. The company recorded a net loss of $2.9 million for the quarter, with operating expenses rising to $4.3 million due to integration costs, while gross profit margin decreased to 55% from 66% in the prior quarter. On October 29, 2026, Intrusion completed a $4.0 million debt-for-equity exchange, which increased stockholders' equity to over $5.0 million and secured an additional 180-day extension from Nasdaq to regain compliance with minimum bid price requirements.Technology
- TLPHNov 12, 4:05 PMTalphera reported a net loss of $4.0 million for the third quarter of 2026, with cash and investments totaling $14.2 million as of September 30, 2026. The company submitted a briefing document to the FDA seeking approval to close enrollment in its NEPHRO CRRT study by December 31, 2026, citing that the current enrollment of over 75% of the target provides more than 80% statistical power for the primary endpoint. Updated market research has raised the estimated peak sales for nafamostat in the CRRT market to over $200 million. Talphera plans to file a Form S-3 Shelf Registration Statement to replace its existing registration that expires in November 2026.Healthcare
- HOURNov 12, 4:05 PMHour Loop, Inc. reported net revenues of $32.1 million for the third quarter of 2026, a 4% decrease from the prior year, while nine-month revenues rose 11% to $95.9 million. Net income for the third quarter was $0.4 million, down from $0.5 million in the same period last year, and totaled $2.3 million for the first nine months of 2026. The company narrowed its full-year 2026 revenue guidance to a range of $147.0 million to $152.0 million, anticipating 3% to 6% year-over-year growth. Cash and cash equivalents decreased to $1.1 million as of September 30, 2026, primarily due to increased inventory investments ahead of the holiday season.Consumer Cyclical
- CADLNov 12, 4:05 PMCandel Therapeutics reported a net loss of $21.9 million for the third quarter of 2026, driven by increased research and development expenses related to clinical trials and manufacturing. The company holds $203.1 million in cash and cash equivalents as of September 30, 2026, which is projected to fund operations through the second quarter of 2028. Clinical updates include the acceptance of three poster presentations at the SITC 2026 Annual Meeting and the announcement of a planned Biologics License Application submission for aglatimagene in prostate cancer in mid-2027. Recent corporate developments include the appointment of Martine Zimmermann to the Board of Directors and Maria Ostrovsky as General Counsel to support regulatory and commercial readiness.Healthcare
- GUTSNov 12, 4:05 PMFractyl Health reported positive six-month results from its REMAIN-1 Pivotal Cohort, demonstrating that the Revita procedure maintained approximately 80% of GLP-1-induced weight loss compared to 67% for the sham group with high statistical significance (p=0.0023). The company announced a strategic shift to focus exclusively on Revita, resulting in a 45% workforce reduction and the discontinuation of its Rejuva gene therapy program. Financially, Fractyl reported a net loss of $14.2 million for the third quarter of 2026 and expects its cash runway to extend into the second quarter of 2027. The company plans to submit a De Novo marketing application to the FDA in late 2026 and anticipates topline 12-month data in the first quarter of 2027.Healthcare
- ASMBNov 12, 4:05 PMAssembly Biosciences initiated a Phase 2 clinical study for its drug ABI-6250 in patients with chronic hepatitis delta virus infection and received FDA approval to proceed with a Phase 2 study for cholestatic liver diseases. The company exercised its option to share 40% of U.S. development costs and profits for the HSV helicase primase inhibitor program under its collaboration with Gilead Sciences. Assembly Biosciences received a $75 million collaboration extension fee from Gilead, bringing its total cash, cash equivalents, and marketable securities to $314.3 million as of September 30, 2026, which is projected to fund operations into 2029. For the third quarter of 2026, the company reported revenue of $3.0 million from collaborative research and a net loss of $20.3 million.Healthcare
- BLNENov 12, 4:05 PMBeeline Holdings reported a 30% year-over-year increase in Q3 2026 net revenues to $3.0 million, while its net loss decreased to $3.8 million. The company originated 268 loans during the quarter, achieving an overall margin of 3.56% and narrowing its adjusted EBITDA loss by 33% sequentially to $1.8 million. Management is advancing a proposed acquisition of TYTL, which is expected to finalize definitive agreements soon, and has initiated a $3 million annualized cost reduction plan. Additionally, the CEO will cancel 3 million merger shares upon closing to reduce dilution for existing shareholders.Financial Services
- BSEMNov 12, 4:05 PMBioStem Technologies reported third-quarter 2026 net revenue of $7.6 million, with hospital revenue rising sequentially to $6.8 million. The company raised its full-year 2026 revenue guidance to a range of $28 million to $29 million, up from the previous outlook. In-house production of Neox and Clarix products is scheduled to commence in the first half of 2027, marking progress toward vertical integration. The company also closed a private placement generating approximately $3 million in gross proceeds and established a $40 million committed equity facility.Healthcare
- LINKNov 12, 4:04 PMInterlink Electronics reported third-quarter 2026 revenue of $3.06 million, a 3.4% increase from the prior year, driven by higher shipments of force-sensing and gas-sensor products. The company posted a net loss of $316,000 for the quarter and $406,000 for the first nine months, while Adjusted EBITDA improved to a positive $79,000 for the nine-month period. Strategic expansions included opening a new 4,000-square-foot R&D center in Rotherham, UK, and adding a 10,000-square-foot facility in Irvine, Scotland, to support smart textiles and medical applications. Management anticipates closing a transformative acquisition before year-end, which is projected to generate combined pro forma revenue of $50 million and over $4 million in Adjusted EBITDA for 2026.Technology
- HAWKNov 12, 4:04 PMHawkEye 360 reported third-quarter 2026 revenue of $59.3 million, representing an 84% increase from the prior-year period, driven by a record international revenue of $23.3 million. The company raised its full-year 2026 revenue guidance to a range of $225 million to $227 million and non-GAAP Adjusted EBITDA guidance to $38 million to $40 million. As of September 30, 2026, the company's backlog stood at $300.3 million, supported by new multi-year contracts with allied partners and the recent launch of Clusters 15 and 16.Industrials
- IZEANov 12, 4:03 PMIZEA Worldwide, Inc. reported third-quarter 2026 revenue of $6.2 million, representing a 23% decrease from the prior-year period, driven by the strategic shift away from non-core small and mid-sized business accounts. Despite the revenue decline, Managed Services bookings surged 94% to $7.0 million, reflecting strong demand from enterprise clients including Disney-ABC, HBO Max, and Hulu. The company recorded a net loss of $0.4 million for the quarter while maintaining a cash position of $46.4 million with no long-term debt. Management projects fourth-quarter revenue to range between $7.5 million and $8.1 million, anticipating a 24% to 34% year-over-year growth.Communication Services
- CBRSNov 12, 4:03 PMCerebras Systems reported record third-quarter 2026 GAAP revenue of $210.8 million, representing a 55% year-over-year increase, while core non-GAAP revenue reached $230.9 million, up 70%. The company secured 700 megawatts of data center capacity under contract and announced new commercial wins with two hyperscalers, including an integration with Oracle Cloud Infrastructure. Looking ahead, Cerebras raised its full-year 2026 core revenue outlook to a range of $940 to $960 million and projects tripling revenue in 2027.Technology
- ENHANov 12, 4:03 PMEnhanced Group Inc. reported a third-quarter 2026 net loss of $13.5 million and revenue of $3.3 million, driven by telehealth sales and sponsorship recognition. The company signed a definitive agreement to acquire a 77% controlling interest in DEAG Deutsche Entertainment AG through an all-stock transaction valued at 5.3 times DEAG's FY2027E Adjusted EBITDA. Concurrently, Enhanced secured a $15 million private investment in public equity (PIPE) to support the acquisition and future growth. Following the expected closing in the first quarter of 2027, the combined entity projects approximately $670 million in revenue and $26 million in Adjusted EBITDA for the full year 2027.Consumer Defensive
- MTEXNov 12, 4:03 PMMannatech reported net sales of $24.9 million for the third quarter of 2026, representing a 14.6% decrease compared to the same period in 2025. The company recorded a net income of $8.9 million, or $4.61 per diluted share, driven primarily by a $10.9 million non-cash income tax benefit related to the remeasurement of deferred tax liabilities on unremitted foreign earnings. Operating performance showed a decline, with income from operations dropping to $0.3 million from $2.0 million in the prior year, while the number of independent associates and preferred customers fell to approximately 111,000. Additionally, the company's cash and cash equivalents decreased by 12.4% to $5.4 million as of September 30, 2026.Consumer Defensive
- CVSINov 12, 4:03 PMCV Sciences, Inc. reported third-quarter 2026 revenue of $3.0 million, a 7.0% decrease from the same period in 2025, driven by lower sales volume and average prices due to restrictive federal and state regulations. The company achieved a gross margin of 50.0% and recorded a positive adjusted EBITDA of $32,000, marking a significant improvement over the adjusted EBITDA losses in the prior year and the second quarter of 2026. Operating expenses were reduced by 11.6% year-over-year to $1.6 million, excluding the benefit from a $500,000 gain on a legal settlement. At the end of the quarter, the company held a cash balance of $0.3 million and strengthened its working capital position to $0.7 million.
- LWAYNov 12, 4:03 PMLifeway Foods reported record third-quarter 2026 net sales of $67.8 million, representing an 18.6% year-over-year increase driven by higher volumes of branded drinkable kefir. Despite this top-line growth, net income for the quarter declined to $0.3 million due to elevated input costs for milk, packaging, and transportation, which reduced gross profit margins to 18.0%. Year-to-date 2026 net sales reached $197.7 million, a 25.8% increase, while the company anticipates margin expansion in 2027 following planned price increases and the completion of its Waukesha facility.Consumer Defensive
- NUWENov 12, 4:03 PMNuwellis reported a 24% year-over-year improvement in its third-quarter 2026 operating loss to $2.1 million, driven by a 430 basis point expansion in gross margin to 69.5% and a 13% reduction in operating expenses. Net sales for the quarter remained flat at $2.2 million due to a prior-year backorder comparison, though sales grew 12% sequentially and 13% for the first nine months to $6.6 million. The company sold 32 Aquadex consoles in the first nine months of 2026, an 88% increase from the prior period, while strengthening its balance sheet to $8.3 million in cash and cash equivalents. Strategic initiatives included an FDA 510(k) submission to expand Aquadex indications for pediatric patients and new distribution agreements for the AtriAmp and Zorro-Flow products.Healthcare
- AMATNov 12, 4:02 PMApplied Materials reported record fourth-quarter revenue of $10.41 billion, representing a 53% year-over-year increase, driven by strong demand for semiconductor equipment. The company achieved a non-GAAP gross margin of 50.6% and non-GAAP earnings per share of $4.16, marking a 92% increase from the prior year. For the full fiscal year 2026, revenue reached a record $34.45 billion with non-GAAP EPS of $12.89, while generating $8.87 billion in operating cash flow. Additionally, the company unveiled the EPIC Center in Silicon Valley to accelerate collaborative R&D and announced new partnerships with Intel, KIOXIA, Besi, and UCLA.Technology
Earnings Call Transcripts
More →- AMLXAMYLYX-HOSTED KOL EVENT AT OBESITYWEEK 2026 - AMYLYX PHARMACEUTICALS INC 1d ago
- NVDAFROM AI FACTORIES TO INTELLIGENT CITIES - NVIDIA CORP 2d ago
- NVDAEarnings Call - NVIDIA CORP 2d ago
- NBISNebius Q3 2026 Earnings Call - NEBIUS GROUP NV 3d ago
- ALLNAll-In Podcast: Jensen OUT as Nvidia CEO: "Spy" Scandal, Export Restrictions, Market Impact - All-In Podcast 3d ago
- DEFTAutoCanada Inc. - Third Quarter 2026 Results - DEFI TECHNOLOGIES INC 3d ago
- PYRGFThird Quarter 2026 Business Update Conference Call - PYROGENESIS CANADA INC 3d ago
- USASAmericas Gold and Silver Third Quarter 2026 Webcast - AMERICAS GOLD & SILVER CORP 3d ago
- WPRTAetherion Technologies Q3 2026 Conference Call - AETHERION TECHNOLOGIES INC 3d ago
- PHXWhiteHawk Minerals 3Q26 Earnings Call - PHX MINERALS INC 3d ago
- DEFTK-Bro Linen Inc. - Third Quarter 2026 Results - DEFI TECHNOLOGIES INC 3d ago
- DEFTK-Bro Linen Inc. - Third Quarter 2026 Results - DEFI TECHNOLOGIES INC 3d ago
- PHXWhiteHawk Minerals 3Q26 Earnings Call - PHX MINERALS INC 3d ago
- BRAGBragg Gaming Group 3Q26 Earnings Conference Call - BRAGG GAMING GROUP INC 3d ago
- DEFTCorby Q1 2027 Earnings Call - DEFI TECHNOLOGIES INC 3d ago
- LFTLument Finance Trust, Inc. - Q3 2026 Earnings and Investor Call - LUMENT FINANCE TRUST INC 3d ago
- LMFAPowerCompute's 3Q 2026 Earnings Call - POWERCOMPUTE INC 3d ago
- GEMIGemini Third Quarter 2026 Earnings Call - GEMINI SPACE STATION INC 3d ago
- CNVSCineverse Corp Reports Second Quarter Fiscal 2027 Results - CINEVERSE CORP 3d ago
- OWLTOwlet Q3'26 Earnings Conference Call - OWLET INC 3d ago
- DEFTCipher Pharmaceuticals Inc. - Third Quarter 2026 Financial Results Call - DEFI TECHNOLOGIES INC 3d ago
- CPHRCipher Pharmaceuticals Inc. - Third Quarter 2026 Financial Results Call - CIPHER PHARMACEUTICALS INC 3d ago
- RPMSYSCO CORPORATION ANNUAL MEETING OF STOCKHOLDERS - RPM INTERNATIONAL INC 3d ago
- YTRAYatra 2Q27 Earnings Conference Call - YATRA ONLINE INC 3d ago
- YTRAYatra 2Q27 Earnings Conference Call - YATRA ONLINE INC 3d ago
- DMACDiaMedica Therapeutics Third Quarter 2026 Financial Results and Business Update Conference Call - DIAMEDICA THERAPEUTICS INC 3d ago
- PARKPark Dental Partners Reports 2026 Third-Quarter Results - PARK DENTAL PARTNERS INC 3d ago
- LMFAPowerCompute's 3Q 2026 Earnings Call - POWERCOMPUTE INC 3d ago
- DLODLOCAL Third Quarter 2026 Results - DLOCAL LTD 4d ago
- KLCKinderCare Third Quarter 2026 Earnings Call - KINDERCARE LEARNING COMPANIES INC 4d ago
Research Reports
Technology →Oct 2, 2026 to Nov 16, 2026 · 407 companies
Technology Earnings Report — 2026-10-02 to 2026-11-16
Report generated: 2026-11-16 18:35:39 EST
Overview
Companies reported: 407 (2026-10-02 - 2026-11-16). The technology sector delivered broadly positive results driven primarily by surging demand for AI infrastructure and data center capabilities, which fueled record revenues and earnings for hyperscalers and semiconductor equipment makers. While AI-exposed leaders such as Super Micro Computer (SMCI), CoreWeave (CRWV), and Applied Materials (AMAT) reported double-digit growth and margin expansion, the sector exhibited significant bifurcation with traditional hardware and legacy software firms facing headwinds from inventory corrections and slower adoption rates. Strategic shifts toward recurring revenue models, aggressive capital allocation via share buybacks, and accelerated M&A activity further characterized the period, though supply chain constraints and liquidity risks continued to impact specific smaller-cap participants.
Leaderboard
Top 5 by Revenue Growth (YoY)
| # | Company | Ticker | Revenue Growth YoY | Revenue |
|---|---|---|---|---|
| 1 | Ainos Inc. | AIMD | 29,567% | $642,889 |
| 2 | Boost Run Inc. | BRUN | 496% | $39.9 million |
| 3 | FiEE, Inc. | FIEE | 382.1% | $9.6 million |
| 4 | Sandisk Corp. | SNDK | 378% | $11.031 billion |
| 5 | QumulusAI Inc. | QMLS | 376% | $14.8 million |
AIMD growth rate is derived from a surge to $642,889 from a negligible prior-year base; SNDK growth reflects a 378% increase to $11.031 billion.
Top 5 by Net Income Growth (YoY)
| # | Company | Ticker | Net Income Growth YoY | Net Income |
|---|---|---|---|---|
| 1 | Strategy Inc | MSTR | 599.6% | $19.53 billion |
| 2 | M-tron Industries | MPTI | 66.4% | $3.0 million |
| 3 | Core Scientific | CORZ | n/a | $1.2 billion (non-cash warrant gain) |
| 4 | Netlist | NLST | n/a | $85.4 million |
| 5 | KULR Technology Group | KULR | n/a | $4.47 million |
Net income growth for Core Scientific, Netlist, and KULR Technology Group is not explicitly stated as a percentage in the summaries; values are derived from reported current and prior period figures or noted as non-cash adjustments.
Themes
- AI infrastructure and data center demand are primary growth drivers, with hyperscalers and cloud providers fueling record revenue for companies like CoreWeave (CRWV), Cerebras (CBRS), Super Micro Computer (SMCI), and Marvell (MRVL), while semiconductor equipment makers like Applied Materials (AMAT) and KLA (KLAC) report surging bookings tied to AI chip manufacturing.
- A significant portion of the sector is pivoting toward AI-integrated products and services, evidenced by revenue growth in AI-specific segments for companies such as SoundHound AI (SOUN), Palantir (PLTR), and Adobe (ADBE), alongside strategic acquisitions of AI-focused firms like Level AI (FIVN) and Arize (DT).
- Recurring revenue models and subscription-based growth remain a key strategic focus, with many software and infrastructure firms reporting strong Annual Recurring Revenue (ARR) expansion, including ServiceNow (NOW), Shopify (SHOP), and Fortinet (FTNT), as they transition from one-time license sales to hosted, high-margin SaaS structures.
- Cost discipline and margin expansion are prevalent themes, with numerous companies achieving record operating margins or narrowing losses through operational efficiency, such as Datadog (DDOG), AppLovin (APP), and Cisco (CSCO), while others like Netlist (NLST) and QumulusAI (QMLS) have turned profitable due to AI-driven demand.
- Mergers and acquisitions are accelerating as firms seek to integrate AI capabilities or expand market reach, with notable transactions including Microsoft's OpenAI partnership, Broadcom's acquisition of VMware (implied context), and various smaller deals by companies like Fortive (FTV) and Flex (FLEX).
- Capital allocation strategies are shifting toward aggressive share repurchases and dividends, particularly among cash-rich technology leaders like Apple (AAPL), Microsoft (MSFT), and Broadcom (AVGO), reflecting confidence in future cash flows despite high capital expenditure requirements for AI infrastructure.
- Supply chain constraints and component availability remain a critical operational challenge, impacting revenue recognition and production schedules for semiconductor and hardware firms like Intel (INTC), NVIDIA (NVDA), and various electronics distributors, though some companies like Diodes (DIOD) report easing constraints.
- Geopolitical risks and regulatory uncertainties, including export controls and trade tariffs, are influencing strategic decisions, with companies like AMD (AMD) and Micron (MU) navigating complex global markets while maintaining growth in specific regions like the U.S. and Europe.
- The transition to next-generation technologies, such as quantum computing (IonQ, D-Wave), advanced packaging (TSMC, Amkor), and autonomous systems (Waymo, Aurora), is driving early-stage investment and revenue potential, though many of these segments remain in pre-commercial or pilot phases.
- Financial performance is increasingly bifurcated, with AI-exposed companies delivering double-digit growth and profitability, while traditional hardware and legacy software firms face headwinds from macroeconomic softness, inventory corrections, and slower adoption rates in non-AI sectors.
Market Outlook & Trends
- Revenue growth is being driven by AI infrastructure demand, with companies like CoreWeave (CRWV), Cerebras (CBRS), and Super Micro Computer (SMCI) reporting record revenues and raised guidance, while others such as Applied Materials (AMAT) and AMD (AMD) cite strong data center and AI segment performance as primary catalysts.
- Demand for semiconductor equipment and components remains robust, evidenced by record backlogs at KLA (KLAC), Onto Innovation (ONTO), and Applied Materials (AMAT), though supply chain constraints and extended lead times persist for some manufacturers like Diodes Inc (DIOD) and Micron.
- Backlog levels are reaching historic highs across the sector, with companies like Onsemi (ON), TE Connectivity (TEL), and Fortive (FTV) reporting significant increases, indicating strong visibility for future revenue, particularly in AI, automotive, and industrial applications.
- Pricing power and margin expansion are evident in several segments, with firms like Marvell (MRVL), Marvell Technology (MRVL), and Marvell (MRVL) benefiting from high-value AI product mixes, while others like Netgear (NTGR) and Netgear (NTGR) face margin pressure from rising component costs and inventory adjustments.
- Cost management and operational efficiency are key themes, with companies such as Veritone (VERI), Latch (LTCH), and Latch (LTCH) implementing restructuring plans and headcount reductions to improve adjusted EBITDA margins and achieve profitability targets.
- Strategic pivots toward recurring revenue models and software-as-a-service are accelerating, with firms like Research Solutions (RSSS), Phunware (PHUN), and Workiva (WK) highlighting growth in ARR and subscription revenue as a path to higher valuations and stability.
- Capital allocation strategies are shifting, with many profitable companies like Apple (AAPL), Microsoft (MSFT), and Cisco (CSCO) returning significant cash to shareholders via buybacks and dividends, while growth-stage firms like CoreWeave (CRWV) and CoreWeave (CRWV) are raising substantial debt and equity to fund aggressive capacity expansion.
- Risks identified by management include liquidity constraints for smaller cap firms like AMC Robotics (AMCI) and Veritone (VERI), regulatory uncertainties regarding AI and data privacy, geopolitical tensions affecting supply chains, and potential delays in product ramp-ups or customer acceptance of new technologies.
- M&A activity is active, with companies like Broadcom (AVGO), Marvell (MRVL), and Marvell (MRVL) executing acquisitions to expand capabilities in AI, optical solutions, and specialized markets, while others like CoreWeave (CRWV) and CoreWeave (CRWV) are pursuing strategic partnerships to secure supply and demand.
- The outlook for the coming quarters suggests continued divergence between AI-exposed leaders and traditional hardware players, with the former expected to sustain double-digit growth while the latter navigate cyclical headwinds, inventory corrections, and the need for strategic transformation to capture AI-related opportunities.
Key Numbers
- Super Micro Computer (SMCI) reported record Q1 FY2027 revenue of $19.9 billion, a 298% year-over-year increase, with net income surging to $1.594 billion and non-GAAP diluted EPS reaching $1.81.
- CoreWeave (CRWV) posted Q3 2026 revenue of $3.66 billion, up 168% year-over-year, while Adjusted EBITDA rose 169% to $2.26 billion, though net loss widened to $709 million.
- Cisco Systems (CSCO) achieved record Q1 FY2027 revenue of $18.5 billion, up 24% year-over-year, with GAAP net income rising 59% to $4.6 billion and raising full-year revenue guidance to $74.8–$75.8 billion.
- Applied Materials (AMAT) reported record Q4 FY2026 revenue of $10.41 billion, up 53% year-over-year, with non-GAAP EPS reaching a record $4.16, up 92% from the prior year.
- AMD (AMD) recorded Q3 2026 revenue of $13.4 billion, up 45% year-over-year, driven by a 97% surge in Data Center revenue to $8.5 billion, with non-GAAP net income increasing 77% to $3.5 billion.
- Microsoft (MSFT) reported Q1 FY2027 revenue of $92.3 billion, up 19% year-over-year, with net income growing 32% to $36.6 billion and Azure revenue surging 48%.
- Apple (AAPL) posted Q4 FY2026 revenue of $114.5 billion, up 12% year-over-year, with Services revenue reaching an all-time high of $31.6 billion and iPhone revenue hitting a September quarter record of $57.6 billion.
- Palantir (PLTR) reported Q3 2026 revenue of $2.313 billion, up 96% year-over-year, with GAAP net income of $1.128 billion and raised full-year 2026 revenue guidance to $8.530–$8.534 billion.
- Shopify (SHOP) delivered Q3 2026 revenue of $3.742 billion, up 32% year-over-year, with net income rising to $462 million and free cash flow increasing to $816 million.
- Datadog (DDOG) reported Q3 2026 revenue of $1.20 billion, up 35% year-over-year, with GAAP operating income turning positive at $75 million and free cash flow reaching $251 million.
Outliers
- CoreWeave (CRWV) posted the strongest report with Q3 revenue surging 168% YoY to $3.66 billion and raised full-year guidance to $13.0–$13.3 billion, driven by massive infrastructure expansion and a $132.5 billion revenue backlog.
- Super Micro Computer (SMCI) delivered the most significant revenue growth with Q1 FY27 net sales jumping 298% YoY to $19.9 billion, supported by a 79% sequential increase and record deferred revenue of $5.67 billion.
- Arista Networks (ANET) reported the strongest growth among established hardware peers, with Q3 revenue rising 58.5% YoY to $3.66 billion and raising Q4 guidance to $3.9–$4.0 billion on AI networking demand.
- AMD (AMD) posted the most robust earnings surprise among major chipmakers, with Q3 revenue reaching a record $13.4 billion (up 45% YoY) and Data Center segment revenue surging 97% to $8.5 billion.
- AMC Robotics (AMCI) presented the weakest financial results, with Q3 revenue plummeting 35.5% YoY to $0.97 million, gross margins collapsing to 54.6% from 70.3%, and operating losses widening significantly due to inventory impairments and financing costs.
- Veritone (VERI) reported the most concerning liquidity outlook, with Q3 revenue declining 30.1% YoY to $18.6 million, cash reserves dropping to $7.3 million, and facing immediate repayment risks on $45.5 million in convertible notes due in December 2026.
- GoPro (GPRO) issued the most severe going concern warning, with Q3 net revenue falling 41% YoY to $96 million, gross margins contracting to 12.7%, and the company seeking lender waivers for covenant noncompliance while delaying its 10-Q filing.
- Intel (INTC) showed the most mixed results among major peers, with Client Computing and Physical AI Group revenues declining 5% despite a 78% surge in Data Center and AI revenue, leading to a 33% drop in GAAP EPS.
VC News
More →- 2026 security sees 1990s exploit speed via AI. Worms target API keys & ransomware. Enterprises must accelerate patching & shift to continuous AI red-teaming. New startups will harden legacy stacks. Defense needs AI-native layers & agentic security to counter collapsing vulnerability windows. Andreessen Horowitz · 9h ago
- Eli Lilly hits $1T cap driven by $17B Q3 GLP-1 sales. Pharma relies on top 25% of hits for 85% revenue. AI aims to slash 13-year, $2B development costs. Bio-AI matures to GPT-3 levels with major partnerships. Valuation shifts toward discovery engines over approved portfolios. Andreessen Horowitz · 3d ago
- AI accelerates attacks requiring machine-speed defense. White House plan targets 5 critical sectors: power, banking, water, comms, hospitals. Focus is containment over replacement. CEOs accountable via monthly scorecards & board attestations. Goal: contain top targets in 6 months using AI & digital twins. Andreessen Horowitz · 4d ago
- Gaming archetypes: indie, toolmakers & world-builders. AI accelerates all three by bridging skill gaps & expanding production. New models enable end-to-end design & decompilation. Leaders reorganize for AI-assisted dev. Studios shorten cycles to risk more IP. AI tools foster a new generation of developers. Andreessen Horowitz · 4d ago
- SE3 secures $30M Series A to build sovereign spatial intelligence for EU defense, capitalizing on €800B spending plans & MOSA shift. The Munich-founded firm partners with HENSOLDT, Ukraine, & Germany's forces to enable autonomous ops where GPS fails. Accel · 4d ago
- Taneja warns AI's top risk is a trust-driven prisoner's dilemma. General Catalyst backs both closed & open models, highlighting a resilience premium markets undervalue. Summa Health adoption rose from 20% to 80% post-acquisition. Breaking the cycle requires costly first moves & rules for cooperation. Founders must build at the frontier without relying on one lab to ensure no single entity can switch off the AI economy. General Catalyst · 4d ago
- Fractile secures Series C co-led by Exponential. Its chip-first approach solves AI inference bottlenecks via stacked DRAM, promising 10x speed & lower cost. With 80% of future AI spend targeting inference, Fractile's vertically integrated stack targets a $100B+ market. Lightspeed Venture Partners · 5d ago
- Edelbyte, spun from Microsoft's Kusto team, rethinks data platforms for AI agents. Founders include ex-Microsoft engineers. Like Confluent, it targets B2B with 10x query efficiency. We led their seed round. Sequoia Capital · 5d ago
- Invest in General Translation, a Series A AI localization firm. It integrates into React, GitHub, Figma, Slack to fix brittle workflows. Clients include Cursor, Ramp, Clickhouse. Founder Archie McKenzie, ex-Princeton CS. Martin joins board. Andreessen Horowitz · 6d ago
- AI agents now drive majority web traffic, author half of articles & generate most code. Shopify & Vercel report 8x-28x growth. B2A economy emerging: treat agents as customers or face obsolescence. Andreessen Horowitz · 6d ago
- US infrastructure faces extreme delays & cost overruns, with manufacturing share dropping from 25% to 16%. NEPA is the primary obstacle, not environmental safety. A bipartisan consensus forms around the 2026 Bipartisan American Affordability & Jobs Act to reform permitting through hard deadlines & streamlined reviews. Andreessen Horowitz · 1w ago
- Lightspeed leads Nominal's Series C to modernize hardware testing. Legacy inefficiencies plague engineers, but Nominal unifies sensor data & video on one timeline. AI agents handle debugging, safety, & planning in air-gapped environments. Clients include Hermeus w/ $53M Air Force contract. Targets $100B annual labor savings for aerospace & chemical engineers. Lightspeed Venture Partners · 1w ago
- SoftBank, Grab & PETROS commit $1.85B to AI infrastructure across Sarawak & Peninsular Malaysia. Long-term target: 5GW+ capacity. SoftBank locks up Grab shares for 5 years. Initiative supports Malaysia's AI Nation 2030 ambition to address surging regional demand. SoftBank Group · 1w ago
- SoftBank leads $1B AI infrastructure deal in Sarawak with Grab & PETROS. Target: 5GW compute capacity. Aligned with Malaysia's AI Nation 2030. Aims to become Asia's largest AI site serving gov & multinationals. SoftBank Group · 1w ago
- Exploit costs dropped while patching stalled, creating a widening gap. Remediation times hit 252 days in 2025. AI generates exploits in hours. 94% of ransomware attacks target backups but only 28% recovered data in 2026. Future defense requires removing exposure, virtual patching, memory-safe code, or making patching unnecessary. Andreessen Horowitz · 1w ago
- SoftBank agreed Oct 8, 2025 to buy ABB robotics. Nov 4, 2026, China blocked the deal. Both firms continue dialogue despite the prohibition. SoftBank Group · 1w ago
- AI slashed exploit time to days before disclosure, hitting 395 orgs in hours. Patching lags at 43 days median, leaving schools & critical infrastructure exposed. Ransomware payments dropped as attackers target small victims with destructive attacks. Defenders must shift to isolation & segmentation where updates are impossible. Andreessen Horowitz · 1w ago
- Tech buyouts face structural stress from debt & rates, lacking fixer-uppers. Venture outperforms innovation cycles; 2007-2016 top VC funds hit 5.3x DPI vs 3.5x for buyouts. 70% of recent debt foreclosures stem from 2021-2022 deals. $140B in risky PE loans mature in 2028. Andreessen Horowitz · 1w ago
- Industry practice now favors full desktop access for AI agents. Phaze delivers high-performance remote desktops for OS-specific apps & latency-sensitive workloads. Founded by ex-Parsec creators with backing from prior investors to enable seamless agent access. Andreessen Horowitz · 1w ago
- Accrual co-founders Nicolaescu & Chandrasekaran target accounting with AI automating 90-99% of tax prep. The 20-person team avoids AI wrappers by focusing on complex multiplayer workflows. Strategy includes model-agnostic tech & acquiring a firm for cultural shifts. General Catalyst · 1w ago
- Longevity went mainstream via AI & pandemic. A healthcare home race is underway. Non-toxic product spending surges. Peptides grow but GLP-1s dominate at $44B. Cholesterol management evolves with new drugs. Wearables focus on biomarkers. Neurotech shifts to consumer use. Founders should build tools for actionable behaviors. Andreessen Horowitz · 1w ago
- Cresta, founded 2017 at Stanford, joined Salesforce after Ping Wu led it from stealth to AI agent autonomy. The acquisition transitions Cresta from research to mission-critical business infrastructure, leveraging Salesforce's global platform for enterprise scaling. Sequoia Capital · 1w ago
- Tutor Intelligence leads Series B with robots prioritizing task completion over specific models. Deploying via teleoperators, they target 1,000 units by 2027. Hourly pricing shifts costs to Opex for SMBs, large logistics, & mid-market firms. Co-founders Gruenstein & Kosowsky leverage MIT expertise for ROI-driven adoption. Andreessen Horowitz · 2w ago
- Lower inference costs demand pricing on value units, not tokens. Buyers need 96% adoption & 34% speed gains to justify premiums. 94% expect spending growth in 2026. Vendors must make context cheaper to rent than rebuild while widening app advantages faster than model progress. Andreessen Horowitz · 2w ago
- a16z welcomes Andy Baker as advisor to Global Affairs. Baker, former Deputy NSA to Trump & NSA to VP Vance, brings 10+ years as Foreign Service Officer. Goal: help founders in AI, defense, cybersecurity, energy, & infrastructure navigate geopolitics & government priorities. Andreessen Horowitz · 2w ago
- a16z prioritizes founder backgrounds for its $1M Speedrun checks with an SF residency deadline Nov 1. AI empowers solo founders but teams may still outperform on scaling. Non-technical founders can prototype yet lack technical judgment. Domain experts understand pain points but lack outsider perspective. Young founders leverage AI but lack enterprise experience. Content creators face viral-to-sustainable challenges. Investor preferences shift with tech cycles. Evaluate how AI changes capabilities rather than inverting old rules. Andreessen Horowitz · 2w ago
- SoftBank delays LINE MAN capital increase to Jan 2027 due to coordination needs. Deal involves 12.4M new shares for $130M. Impact on current fiscal results minimal. Post-completion SoftBank will hold 63.7% voting rights in LINE MAN. SoftBank Group · 2w ago
- LLMs treat file systems as native behaviors. Using bash & files as external memory cuts token costs & prevents context rot. Vercel cut agent costs 75% this way. Start local, add DBs only for scale. Files offer audit trails & interface abstraction, but lack concurrency guarantees. Lightspeed Venture Partners · 2w ago
- AI accelerates cyber threats, driving 87% of CISOs to boost 2027 spending. Security headcount rises as AI governance becomes top priority. Only 18% use AI SOC tools now, yet startups lead innovation while incumbents lag in addressing AI-specific gaps. Andreessen Horowitz · 2w ago
- VC shifted to specialized teams applying traditional finance to early-stage tech, often ignoring that tech waves precede business models. Four philosophies: Financial (metrics), Productive (tech as market creator), Frontier (founders), Speculative (perception). Align philosophy with deal stages to avoid the grab bag trap. Andreessen Horowitz · 2w ago
- Databricks hit $7B run rate w/ 80% YoY growth. Its Lakehouse & Lakebase unify data & ops. CEO Ghodsi proposes SORA for agents, shifting humans from execution to strategy. The firm rejected a $6B offer to build the future OS. AI triggers a Second Managerial Revolution. Andreessen Horowitz · 2w ago
- Amjad Khatib notes early AI agent adoption mirrors historical tech chaos like PCs and spreadsheets. This disorder signals deep alignment. Future success depends on Replit's Agent Habitat, which structures chaos to let employees generate code and drive productivity without stifling ownership. Andreessen Horowitz · 3w ago
- SoftBank resolved to pay JPY 5.50 interim dividend per share, record date Sept 30, payable Dec 2. Total cash: JPY 31.3B. FY27 forecast: JPY 16.50 total. FY26 actual: JPY 27.50. Share split effective Jan 1, 2026. SoftBank Group · 3w ago
- SoftBank Group Corp. fully redeemed its EUR 2.875% Senior Notes due Jan 2027. Redemption finalized Oct 21, 2026. All notes are now canceled & no longer outstanding. SoftBank Group · 3w ago
- Zetwerk listed after 8 years, growing from 200 suppliers to 7k across 26 countries. Revenue hit ₹15,913 cr (~$1.68B) with ₹12,370 cr order book. Energy is now the largest segment driven by AI & solar. 80% revenue from returning clients. Accel · 3w ago
- DualEntry founder Santiago Nestares raised $90M Series A to replace legacy ERPs like NetSuite with an AI-native platform. The system automates bookkeeping & lets firms scale past $100M revenue with tiny finance teams. Expanding into real estate, tech & manufacturing. Lightspeed Venture Partners · 3w ago
- Warp launched Series A led by Lightspeed to build AI robotic labs for US drug discovery. The team includes ex-OpenAI & ex-Meta AI leaders. Warp records failures to train models & reduce reliance on offshore partners amid BIOSECURE Act pressures. Lightspeed Venture Partners · 3w ago
- a16z renames Crypto fund to Frontier, expanding scope from crypto to broader frontier tech. Strategy targets AI wave, new devices like autonomous machines & bio tech. Firm defines companies by activities, not tech. Led by authors & founders with focus on full-stack startups & programmable rails. Andreessen Horowitz · 3w ago
- Serval automates IT, HR & finance workflows by generating code from natural language. Co-founded by Jake Stauch & Alex McLeod, it launched April 2024 with customers including Perplexity, Mercor & Ramp. The platform covers 13 departments per customer using proactive agents to resolve issues before tickets are filed. General Catalyst · 3w ago
- Legora doubled revenue quarterly after pausing sales to refine AI. It onboards 1k lawyers daily, uses agentic AI for due diligence, & targets global scale from NY, London, & Stockholm. Users average 90 mins daily. CEO aims to empower lawyers in a supply-constrained market. General Catalyst · 3w ago
- Whop hit $500M run-rate, adding 10k daily businesses. Sequoia leads Series D. AI lowers entry barriers as the team launches a decision engine for merchant profits. Sequoia Capital · 3w ago
- Dev bottlenecks shifted from coding to verification. Anthropic saw 25x CI surge. Blacksmith accelerates CI 2x at 60% less cost. 10k+ firms use it; weekly jobs up 18x to 90M. ARR grew 17x in 2026. Founders from Cockroach Labs. Leading Series C for agent-speed validation. Sequoia Capital · 3w ago
- Frontier AI generates CAD but struggles with physical translation due to lossy digital-physical interfaces. Hardware difficulty spans sourcing to mass production, with AI failing at design for manufacturing amid material variability. Future engineering requires better simulation, raw material shifts, & AI labs acquiring rare process knowledge to solve real-world challenges. Andreessen Horowitz · 3w ago
- U.S. manufacturing share halved in 50 yrs. Arda, led by ex-OpenAI CRO Bob McGrew, raised $230M to align factory production with design speeds. Tech integrated into Anduril's ArsenalOS, accelerating assembly from hours to minutes. Funding supports domestic U.S. manufacturing. Accel · 3w ago
- Eka Robotics leads Series A to automate dexterous tasks using Vision-Force-Action model. Founders Agrawal & Haarnoja leverage 10 years of sim-to-real work. System achieves 1,500 picks/hour, 2.5x faster than humans. Tech handles fragile objects without retuning. Investment expands economically viable automation for variable environments. Andreessen Horowitz · 3w ago
- Baba serves 15k families using AI & human advocates to reduce hospital readmissions. Founded by Connor Sweeney, the company connects Medicare patients with vetted nurses to handle admin tasks. Insurance covers 99% of users. Launched 2024-2025, Baba proves profit & social impact coexist in US healthcare. General Catalyst · 3w ago
- Hypersonica targets 2029 deployment of deep-strike systems for European sovereignty. Leveraging 30 years of research, the firm moved from concept to prototype in 9 months. General Catalyst backed the venture to address defense challenges. Recent Norway tests validated the team's rapid pace. General Catalyst · 1mo ago
- Global construction productivity lags GDP & manufacturing. US contractors face labor shortages & lack automation. Origin builds software & hardware for construction robots using real-world data. Their system completes tasks five times faster via high-level instructions. Founders bring Amazon & robotics experience. The team deployed in US before Series A. Accel · 1mo ago
- a16z incubates SAIF, a nonprofit led by Ben Horowitz, to deploy free AI & cybersecurity tools for under-resourced public institutions. With $25M committed, the five-year pilot targets 5-10 anchor cities & 1,800 rural hospitals to fix vulnerabilities in medical devices & infrastructure. Andreessen Horowitz · 1mo ago
- AI infra is fastest tech sector. Modal unified platform grew 15x YoY to $1B revenue run rate in Sept 2026. Over 3B sandboxes now $300M of that. Co-founders Erik Berhardsson & Akshat Bubna built Python-native workflows. Clients include DoorDash & Ramp. Accel led $750M Series D. Accel · 1mo ago
Press Releases
More →- TUCanada's Telecom Map Could Be Redrawn as a Takeover Approach Goes Public PR Newswire · 2m ago
- TSNUSDA Projects Lower Beef and Higher Chicken Output for the Year Ahead PR Newswire · 3m ago
- CDNLCARDINAL INFRASTRUCTURE GROUP INC. INVESTIGATION: CDNL Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights Business Wire · 6m ago
- AVGONasdaq Drops 2.5% for a Third Straight Loss as AI Hardware Stocks Slide PR Newswire · 13m ago
- FRHCFreedom Holding Corp. Reports 81% Increase in Quarterly Revenue to $910.1 Million GlobeNewswire · 14m ago
- KGCDid You Lose Money Investing in Kinross Gold Corporation? Robbins LLP Urges Investors with Significant Losses to Contact the Firm About Their Rights Against KGC Business Wire · 24m ago
- CGONBiotech's Monday Split: Two Trial Wins, One Trial Miss and an FDA Rejection PR Newswire · 26m ago
- SPGIS&P Global Announces Pricing of Public Offering of $750,000,000 Senior Notes due 2031, $600,000,000 Senior Notes due 2034 and $650,000,000 Senior Notes due 2036 PR Newswire · 29m ago
- VVOSVivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update GlobeNewswire · 29m ago
- CCMCFCore Critical Metals Corp. Announces Upsize of Non-Brokered Critical Mineral Flow-Through Private Placement to $750,000 ACCESS Newswire · 35m ago
- MDIAMediaCo Reports Third Quarter Financial Results Business Wire · 48m ago
- WDCWD to Participate in Upcoming Investor Conferences Business Wire · 56m ago
- XPEVXPENG Reports Q3 2026 Results: Both Deliveries and Revenue Reach Record Highs, Overseas Market 2026 Full-Year Sales Target Exceeds 100,000 Units GlobeNewswire · 57m ago
- OCCIOFS Credit Company Announces Preliminary Estimates of Certain Financial Results for its Fourth Fiscal Quarter 2026 Business Wire · 1h ago
- BIIBNew Five-Year Lecanemab Data from Clarity AD Study Long-Term Extension Presented at CTAD 2026 GlobeNewswire · 1h ago
- BIIBNew Five-Year Lecanemab Data from Clarity AD Study Long-Term Extension Presented at CTAD 2026 PR Newswire · 1h ago
- MTBM&T Bank Corporation Announces Increased Common Stock Dividend PR Newswire · 1h ago
- SITESiteOne Landscape Supply Set to Join S&P SmallCap 600 PR Newswire · 1h ago
- CROXCrocs, Inc. to Attend BNP Paribas Outdoor & Sports Conference and Present at The Morgan Stanley Global Consumer & Retail Conference PR Newswire · 1h ago
- AYAAya Gold & Silver Files Amended Q3-2026 MD&A; Q3-2026 Consolidated Cash Costs Corrected to $14.28 per Silver Equivalent Ounce Sold GlobeNewswire · 1h ago
- SMXTSolarMax Technology Reports Third Quarter 2026 Financial Results GlobeNewswire · 1h ago
- CSAICloudastructure Reports 101% Year-Over-Year Growth in Subscription Revenue for the Third Quarter 2026 GlobeNewswire · 1h ago
- BENFBeneficient Reports Second Quarter Fiscal 2027 Results GlobeNewswire · 1h ago
- NAKNorthern Dynasty Announces Results of Governance Committee Review and Supplemental Director Disclosure ACCESS Newswire · 1h ago
- NKLRTerra Innovatum Reports Third Quarter 2026 Financial Results and Continued Progress Toward First Solo™ Reactor Deployment GlobeNewswire · 1h ago
- RITMKBRA Assigns Preliminary Ratings to New Residential Mortgage Loan Trust 2026-NQM12 (NRMLT 2026-NQM12) Business Wire · 1h ago
- NPTTexxon Holding Limited Announces Financial Results for Fiscal Year 2026 PR Newswire · 1h ago
- XPONExpion Energy Reports Third Quarter 2026 Financial and Operational Results GlobeNewswire · 1h ago
- SKESkeena Gold & Silver Reports Q3 2026 Financial Results; Announces Management Appointment GlobeNewswire · 1h ago
- LUVULuvu Brands (OTCQB: LUVU) Reports First Quarter Fiscal 2027 Results: 10% Net Sales Growth, Wholesale Sales Up 12% ACCESS Newswire · 1h ago
FDA Approvals
More →- CGONBiotech's Monday Split: Two Trial Wins, One Trial Miss and an FDA Rejection PR Newswire · 26m ago
- RHHBYFDA Approves Genentech’s WILSERDLY (Giredestrant), a Next-Generation Oral SERD, for ER-Positive, ESR1-Mutated Advanced Breast Cancer Business Wire · 1h ago
- AEONAEON Biopharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · 2h ago
- IDYAIDEAYA Biosciences Announces Successful US FDA Type C Meeting on Phase 2/3 Registrational Trial Designs to Support Potential Accelerated and Full Approval for IDE849, a Potential Best-in-Class DLL3 TOP1 ADC, in Neuroendocrine Carcinomas PR Newswire · 2h ago
- CADLPRISM MarketView Highlights Seven Small-Cap Lung Cancer Developers for Lung Cancer Awareness Month GlobeNewswire · 7h ago
- MMEDFDA Clears MiniMed Fit™ -- World's First and Only Tubeless Insulin Pump with Up to Seven-Day Wear and Zero Interruptions PR Newswire · 9h ago
- EOCNEocene and Barcode Nanotech Report Progress in the Development of Tumor Microenvironment-Targeted Lipid Nanoparticles Formulation of Aramchol PR Newswire · 11h ago
- OCSOculis Announces FDA IND Clearance Enabling Acceleration of Privosegtor Development Program in Acute Multiple Sclerosis Relapses GlobeNewswire · 17h ago
- OCSOculis Announces FDA IND Clearance Enabling Acceleration of Privosegtor Development Program in Acute Multiple Sclerosis Relapses GlobeNewswire · 17h ago
- RHHBYGenentech’s Gazyva Becomes the First FDA-Approved Treatment for Primary Membranous Nephropathy Business Wire · 18h ago
- SMMTSummit Therapeutics Provides Update Regarding Ivonescimab Biologics License Application Business Wire · 1d ago
- BYSIBeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · 3d ago
- CINGWCingulate Inc. Reports Third Quarter 2026 Financial Results and Provides Regulatory Update on CTx-1301 NDA Resubmission GlobeNewswire · 3d ago
- VTGNVistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update GlobeNewswire · 3d ago
- NTHINeOnc Showcases Two Brain Cancer Drug Programs at SNO as FDA Meetings Approach GlobeNewswire · 3d ago
- TNDMTandem Mobi Now FDA Cleared as World’s First and Only Tubeless AID System with up to Seven Days of Wear Business Wire · 3d ago
- AARDAardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates GlobeNewswire · 3d ago
- RVPHReviva Reports Third Quarter 2026 Financial Results and Recent Business Highlights GlobeNewswire · 3d ago
- YDESYD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease GlobeNewswire · 4d ago
- BLSMBlossomHill Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights GlobeNewswire · 4d ago
- TLPHTalphera Reports Third Quarter 2026 Financial Results and Provides Business Update PR Newswire · 4d ago
- ERASErasca Reports Third Quarter 2026 Business Updates and Financial Results GlobeNewswire · 4d ago
- PRMEPrime Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates GlobeNewswire · 4d ago
- RCKTRocket Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Recent Progress Business Wire · 4d ago
- NTHINeOnc CEO Buys More Shares Below $5 as NTHI Secures FDA Meeting to Discuss Phase 3 Trial GlobeNewswire · 4d ago
- NTHINeOnc Insider Buying Expands Ahead of FDA Discussions and Two Key Brain Cancer Data Presentations GlobeNewswire · 4d ago
- TSHATaysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · 4d ago
- NGENNervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury GlobeNewswire · 4d ago
- BBIOA Run of FDA Target Dates Fills the Biotech Calendar From Late November to Year End PR Newswire · 4d ago
- NTHIFDA Meeting Could Put NeOnc's NEO100 Experimental Brain Cancer Drug on Faster Track GlobeNewswire · 5d ago
BNN Bloomberg
More →- CFIA recalls Tree of Life brown rice (insects), Cold Grind turmeric (Sudan I), & Archibald IPA (metal). Recalls are Class 3, indicating low health risk. No illnesses reported yet. 32m ago
- United resolved a tech issue delaying 418 flights Monday; pilots cited a weight-calculation system glitch. No cybersecurity link & in-air flights unaffected. Incident follows recent major disruptions including FAA, JPMorgan & Microsoft outages. 42m ago
- United Airlines systemwide outage delayed 418 flights. Pilot in Houston requested gate stay. FAA ordered nationwide ground stop. Incident follows JPMorgan & Microsoft tech failures. United apologized via social media. 56m ago
- United Airlines confirmed systemwide outage Monday, following FAA network failure days prior. Specific systems unknown. Apology issued. Pilot in Houston requested gate stay until restoration. 1h ago
- Alberta's UCP advances Bill 40 to shift from 87 to 91 ridings, rejecting an independent commission's advice. NDP Leader Nenshi vows legal action citing political manipulation, while experts warn potential Charter breaches. New boundaries take effect for the Oct. 2027 election. 2h ago
- Poilievre staff depart for BC's Doerkson govt amid byelection pressure. Carney's election saw 8 Conservative MPs leave, 4 joining Liberals. Polls show toss-up in Brantford-Brant South on Dec 7. Leadership faces scrutiny if loss occurs. 2h ago
- Health Canada warns inaccurate radon detectors cause lung cancer risk. Use only Canadian National Radon Proficiency Program approved devices. Avoid recalled brands like InkBird sold on Amazon.ca. Test in winter for at least 3 months. Dispose of faulty units per e-waste rules. 2h ago
- 25 former Ecuadorian officials warn Canada-Ecuador trade deal risks relations. They urge removing ISDS clauses from July agreement, citing constitutional bans & human rights concerns. Canadian groups note mining lobby pushed provisions. Shared interests exist, but instrument faces lifespan challenges. 3h ago
- Million stranded Nov 13 after FAA ground stop during L3Harris fiber upgrade. Faulty routers or error unclear. Sec Duffy seeks $50B more funding, may cancel contract. Ops to resume Sunday, but 3M Thanksgiving travelers face week of delays. 3h ago
- Carney & Quebec Premier St-Pierre Plamondon agreed on homelessness & infrastructure priorities but maintain divisions over trade & international representation. They plan a 2027 Francophone gathering while federal control on trade negotiations remains unchanged. 4h ago
- Health Canada warns inaccurate online radon detectors risk lung cancer exposure. Recalled brands include InkBird, Life Basis, Hanchen & Spolehli. Radon is Canada's 2nd leading cause of lung cancer. Use approved monitors from the Canadian National Radon Proficiency Program. Test during winter for 3+ months. Stop using recalled devices immediately. 4h ago
- Cohen says US-Canada deal near but warns Dems can't override Trump tariffs without supermajority. MacNaughton notes current talks differ from past era; advises Canada to pursue deal while diversifying trade & boosting productivity. Report published Nov 16, 2026. 4h ago
- Experts warn algorithmic pricing raises costs for restricted diets. Canada's ethics committee studies the practice, distinguishing it from market pricing. Privacy bills may address surveillance pricing without explicit mentions. 4h ago
- Major U.S. banks including Bank of America, Chase, J.P. Morgan, U.S. Bank, & Wells Fargo faced login issues Monday per Downdetector. Reports follow a Microsoft outage impacting Outlook, Teams, & Copilot. Chase users noted service unavailability during repairs. 5h ago
- Fed Chair Warsh warns AI could drive growth but risks job losses & market plunges if returns fail. He omitted inflation links from chip demand, while VP Jefferson notes higher AI productivity may raise rates. The Fed is now assessing super intelligence scenarios. 5h ago
- Canada's Oct inflation held steady at 3.1% vs 3.2% expected. Underlying rate slowed to 1.8% as cellphone prices fell 6.2% & rent growth eased. Despite 30.9% gas spike, Bank of Canada's Oct 28 hike to 2.5% likely sufficient; economists see no need for Dec rate increase. 5h ago
- DLRGlobal real estate 2026: strong performance in data centres, senior housing, hotels & select retail; residential & rate-sensitive sectors lag. Supply falling due to higher costs improves pricing power. Secular drivers include AI, 75+ demographic boom & e-commerce. Listed REITs show accelerating NOI & FFO growth. Headwinds: higher yields, slowing leasing & power constraints. Top picks: Chartwell Retirement Residences, Digital Realty Trust & Granite REIT. 5h ago
- Bank of Canada Governor Tiff Macklem leaves June 2027. Potential successors include Carolyn Rogers, Jean Boivin, Carolyn Wilkins, Nicolas Vincent, & Jean-François Perrault. 6h ago
- Carney meets Xi in Shenzhen to expand trade in energy & finance while guarding auto sector investments. A trilateral with Trump & Putin is set for Thursday amid Ukraine concerns. Canada seeks to diversify trade & raise human rights issues privately despite Beijing's welcome. 6h ago
- Green Party elected ex-MP Mike Morrice as sole leadership candidate Nov 14. He targets affordability & challenges oil giants while Elizabeth May remains sole Green MP. Morrice aims to reclaim Kitchener Centre seat but won't run in byelections. 6h ago
- Canaccord Genuity sells UK wealth unit to Centerbridge & Mubadala for 1.17B pounds. CEO Dan Daviau leads go-private buyout. Shareholders get $7.45 cash plus 4.15 pounds per share, totaling $15.27 offer. Deal proceeds regardless of privatization completion. 6h ago
- TC Energy plans 370km Alberta Growth Connector pipeline to boost oilsands supply. Project adds 1B cf/d capacity & supports NGTL system. CEO targets 25% demand rise by 2031, driven by oilsands, power, data centers. Strategy leverages existing infrastructure. 7h ago
- Canada's S&P/TSX fell 131 pts to 35,974.53 on energy & base metal losses. US markets dropped: Dow -324, S&P -78, Nasdaq -396. CAD at 69.88c USD. Dec crude down $1.88 to $86.68. Dec gold down $22 to $3,864.30. 7h ago
- Nvidia earnings without Huang & Anthropic IPO valuation at $965B drive strategy. Selling naked puts on NVDA to buy shares at lower costs. Bullish on AI but expect time for earnings growth or political clarity. Limiting IPO allocation to 1% at $820B val. 7h ago
- Trump says he supports Jensen Huang's return as Nvidia CEO, noting Huang is considering it. Trump claims no national security risk & may discuss with Xi. He remains skeptical of spy accusations against Chinese women. 8h ago
- Bank of Canada governor Tiff Macklem steps down June 2, 2027, ending his term that began June 2020. Board has launched successor search, expected to conclude by spring 2027. Final choice requires approval from finance minister & federal cabinet. 8h ago
- Canadian Natural acquires Advantage Energy for $2.53B including debt, paying $13.55 per share. Deal adds 79k boe/day from Montney & Charlie Lake. Strategic fit targeting Q1 2027 close pending approvals. 8h ago
- Conavi Medical launched FDA-cleared OCTIV, a hybrid IVUS-OCT catheter, Nov 2, 2026. First U.S. cases completed at launch. System aligns with 2025 guidelines recommending intravascular imaging, which may reduce cardiac death by 45%. Company raised $10M for U.S. rollout. 9h ago
- Young immigrants often sacrifice goals for family. Plan first: emergency fund, debt payoff, sustainable gift, TFSA. Avoid credit, guilt, & impulsive transfers. Replace yes/no with fixed budgets. Protect your future to truly help loved ones. 9h ago
- Carrier Connect secured a 5-year, 4MW Alpharetta deal worth $24M annually. Now running 7 global sites, it targets 15 by 2027. CEO Binns cites strong demand for its AI-ready Tier II/III facilities. The firm owns all systems & plans to replicate this success internationally. 9h ago
- Canada's Oct inflation held at 3.1%. Core inflation fell to 2%. Gasoline surged 30.9% on Middle East & Ukraine tensions. Rent growth slowed. Grocery prices rose 2% after four months of slower growth. 10h ago
- Quebecor proposed $31B cash-stock deal for Telus. Offer: $6.35 cash + 0.17 Quebecor Class B shares per Telus share. Quebecor values bid at $19.45/share vs Telus close of $12.14. Deal aims to merge networks & spectrum. 10h ago
- Quebecor proposes strategic combo with Telus valued at $31B via cash & stock mix. 10h ago
- Shareholders sue Intel over alleged concealment of PC slowdown & inventory glut causing 28.6% plunge. Suit claims AI gains were outweighed by core issues & alleges motive to defraud during $23B raise. CEO Tan & CFO Zinsner named defendants. 11h ago
- Global shares mixed as Asia tumbled on Nvidia CEO resignation fears & AI slowdown worries. Japan, Korea, Taiwan down sharply while Europe rose. US futures lower ahead of earnings. Oil stable near $95.55. Fed minutes due Wednesday. Dollar at 159.61 yen. 12h ago
- Democrats won Texas Senate seats citing tariff-driven costs, averaging $900/household as rates hit 11.2%. Repeal is hard: Trump holds veto power & $370B revenue complicates $40T debt. Dems lack veto-proof majority & face internal trade divisions. Bipartisan focus may target unpopular 50% Canadian tariffs. 12h ago
- Christopher Liew notes 40s/50s decisions drive early retirement success more than income. Stats Canada reports avg retirement age hit 65.4 in 2025. Budget 2026 proposes RRSP-for-life. BMO survey finds 36% won't reach $1.7M needed. Use TFSA for bridge income. Clear mortgage before stopping work. Delay CPP to age 70 for 42% boost. Sequence income to preserve CPP growth. Finalize plan in 50s. 12h ago
- Roshel acquires Stellantis Brampton plant to close 2026. Deal aims to boost capacity as Canada targets 4% GDP defense spending by 2030. CEO Shimonov notes potential automotive expansion. Critics cite job risks & ICE ties. Roshel expanded via Centigon acquisition 2025 & Daimler MoU 2026. 12h ago
- Canadian exports to China surged 40% to $33.5B in first 9 months of 2026, driven by trade barrier reductions & market access extension to 2028. Oil & canola drove gains, though experts warn against strategic dependence. PM Carney seeks 50% growth by 2030 while meeting Xi in Shenzhen. 13h ago
- StatsCan releases Oct inflation data today; Reuters polls expect rise to 3.2%. Elevated energy prices drive costs, with debate on pass-through risks. Bank of Canada raised rates in Oct & signals further hikes. Report released Nov 16, 2026. 13h ago
- PM Carney travels to China for APEC to expand trade in energy & finance while demanding local jobs in auto investments. Discussions aim to diversify Canada's trade amidst US dynamics & regional security concerns, including private human rights talks on Hong Kong. 13h ago
- Retirement success hinges on 40s & 50s decisions, not earnings. Stats Canada notes avg age hit 65.4 in 2025. Budget 2026 proposes RRSP-for-life but ignores 58-65 gap. Calculate your number, use TFSA for bridging, & aim for mortgage-free status by 58. Delay CPP until 65+. Plan year-by-year income to avoid regrets. 14h ago
- Carney warns Canada may turn to Chinese automakers if US trade talks fail, insisting on local manufacturing. Ontario Premier Ford criticizes the deal, citing job risks. US tariff disruptions already hit the sector, with Stellantis moving Jeep Compass production to Illinois. 20h ago
- Jensen Huang considering return as Nvidia CEO with ally building war room for lobby & seeking White House support. Efforts backed by major tech figures & Huang himself. Board previously approached Arm CEO Rene Haas as potential successor. 1d ago
- Alberta aims to double oilsands output in 10 years driven by policy shifts & Pacific Link funding. Top producers like Cenovus, Suncor & Imperial prioritize disciplined capital allocation, debt reduction & carbon storage negotiations over rapid expansion due to shareholder expectations. 1d ago
- Stellantis faces funding cuts if it sells Brampton plant to Roshel. PM Carney & Industry Minister Joly call sale a betrayal. Sources say officials knew months prior but did not block it. Funding contingent on keeping plant open & protecting workers. Conservatives demand guarantees before supporting package. 1d ago
- FAA grounded US flights 4hrs Friday after tech upgrade overloaded legacy ATC systems. Microsoft services restored Saturday following network capacity issue. No malicious activity found despite public speculation. FAA modernization includes $12.5B in funding, White House seeks $30B more. Schedules to normalize by Sunday. 1d ago
- CAD CPI Monday 8:30 am. TSX: Ballard, Canaccord. US: Tyson, Home Depot, Disney, Nvidia, TJX, Lowe's, Palo Alto, Target, Walmart, Alibaba, Gap, Ross, Intuit. CAD Home Sales/MLS Tuesday. US Retail Sales. FOMC Minutes Wednesday 2 pm. CAD Retail Sales Friday. 1d ago
- Stellantis sold Brampton plant to Roshel, leaving 2k workers in limbo after tariff-driven shutdown. Roshel pledges 2k jobs w/ hiring priority, but union warns no guarantee. Govt may fund Stellantis to keep plant open. Workers fear wage cuts & oppose Roshel's arms/ICE contracts. 1d ago
- Nanos poll shows Canadian support for US deal with tariffs dropped to 33.3% from 41%. PM Carney confirms talks with Trump, but tariffs likely rise to 5%. Experts warn prolonged uncertainty harms jobs. Deal possible before year-end despite public skepticism. 1d ago
Earnings Reports
More →- AYAAya Gold & Silver amended Q3 2026 filings to correct silver ounces sold at Zgounder to 1.4M oz due to inventory error. Revenue & net income unchanged. Consolidated silver eq. sales rose to 1.89M oz. Cash costs per oz fell to $14.28. Morocco operations continue with Boumadine feasibility ongoing. 1h ago
- DISDisney releases FY2026 & Q4 2026 results Nov 17 at 6:30 a.m. ET. Webcast follows at 8:30 a.m. ET. Materials & replay at disney.com/investors. Forward-looking info included. 2h ago
- CURBCurbline (CURB) bought 82 convenience centers for $888.9M YTD, incl. 15 for $138.5M in Q4. Pipeline spans top markets with closings visible into Q1 2027. CEO cites adjacency opportunities & self-managed REIT model. 2h ago
- RDIReading International Q3 2026 rev up 25% to $65.3M; net income $0.5M vs $4.3M loss prior year. 9-mo rev +16% to $177.3M. Sold NYC bldg for $41M to repay debt; net debt $153.4M lowest since 2018. Growth driven by Spider-Man, The Odyssey; future outlook strong with Avengers, Dune 3, Jumanji 3. 9h ago
- SQFTPresidio Property Trust Q3 2026 net loss narrowed to $1.1M ($0.84/share) from $1.9M prior year. Rev fell to $3.0M on asset sales. Model home count dropped to 66. Debt reduced to $62.5M. No new acquisitions. FFO at ($1.0)M. 10h ago
- IFABFiFabric reported record 9mo revenue of $48.4M (+121% YoY) & net earnings of $5M. Q3 revenue rose 26% driven by recurring business. EBITDA margin expanded to 16%. Strong balance sheet with $20.7M cash. CEO cites confidence entering 2027. 10h ago
- GLADGladstone Capital (GLAD) Q3 FY2026 earnings call set for Wed Nov 18 at 8:30 AM ET. Join via webcast or phone (866) 424-3437. Replay until Nov 25. GLAD invests in debt & equity securities, primarily secured term loans to lower middle market US businesses. 10h ago
- TSNTSN released Q4 & FY2026 results Nov 16. Earnings release & 8-K available on IR site. Conference call at 9am ET today. Webcast & slides accessible until Dec 16. Call details: US Toll Free 1-855-669-9658, access code 9960604. Audio-only dial 1-844-890-1795. S&P 500 & Russell 1000 member. 11h ago
- IESCIES Holdings reports fiscal 2026 Q4 results before market open Friday Nov 20. The firm designs & installs electrical & tech systems, serves data centers & housing, & employs 16,000+ US staff under CFO Tracy McLauchlin. 11h ago
- VENUAssets up 59% to $587.6M as revenue rose 5% to $14.1M. Heavy construction costs drove a $49.8M net loss. New venues open soon with sales exceeding $300M. Net tangible asset value per share reached $9.74 mark-to-market. 11h ago
- NVDANvidia CEO Huang resigns after 33 years. Interim CEO Kress faces 6-week stock drop, $1.7T market cap loss, & China probe. Earnings expected $109B revenue. Morgan Stanley cuts 2027-28 estimates. Kress must manage capital & culture transition. 12h ago
- WESWES Q3 2026 results interview with CFO Shults tomorrow pre-market. Upcoming conferences: Mizuho Dec 7, Wells Fargo Dec 8-9, IPI Dec 8-9, UBS Jan 12-13. Operates midstream assets across 5 states. Majority cash flows protected from commodity volatility via fee-based contracts. 12h ago
- ARMKAramark fiscal 2026: $20.1B rev, +9% YoY. EPS +33% to $1.62. Free cash flow up 26% to $573M. Leverage ratio 2.7x. New $1B buyback authorized. Dividend +17% to $0.14. FY2027 outlook: 10% organic revenue growth. 12h ago
- OPTXSyntec Optics (OPTX) CFO leads Nov 17 earnings call on first principles & efficiency. Firm bridges volume & nano-precision for defense, space & AI data centers. Next-gen meta-materials launch 2027 with 10x nano-accuracy. HQ in Rochester, NY. 12h ago
- GSGlobal stock markets are projected to extend their rally in 2027 despite slowing earnings growth and artificial intelligence investment. The S&P 500 is forecast to yield a 16% total return, while Japan's TOPIX is expected to return 24% and the MSCI Emerging Markets index 21%. Goldman Sachs Research advises overweighting US and Japanese stocks while underweighting European equities, citing opportunities in growth stocks, defensive sectors, and companies benefiting from lower oil prices and bond yields. 19h ago
- HSTXFHeliostar Q3 2026: Record $66.3M revenue, $10.2M net income. Produced 14,481 oz gold @ $4,243/oz. AISC $1,948. $53.6M cash, no debt. Safety LTIFR down 50%. Ana Paula permitting on track for Q2 2027. La Colorada stripping for late 2027 start. Full-year guidance 50k-55k oz intact. 2d ago
- BYFCBroadway Financial Q3 2026 net income $392k, up from Q2 $218k vs Q3 2025 loss $24.6m. Loans +11.4%, deposits +21% to $1.1b. NPLs 1.20%, leverage ratio 12.83%. Net interest margin stable at 2.64%. Assets $1.557b, equity $255.5m. 3d ago
- HSTXFHeliostar Q3 2026: Record 14.5k oz gold, $66.3M revenue. AISC $1,948/oz. Net income $10.2M. $53.6M cash, zero debt. Safety up, no LTI. Ana Paula on track for Q2 2027 production without dilution. FY guidance 50-55k oz gold unchanged. 3d ago
- BOFBranchOut Food (BOF) hosts Q3 2026 earnings call Nov 16, 4:30 PM ET. CEO Healy & CFO Dalfonsi will present. The firm uses REV dehydration tech holding 17 patents. Replay available post-event. 3d ago
- XGPUReliance Global Group (XGPU) reports Q3 2026 results Nov 16 at 4:30 PM ET. The firm expands AI infrastructure via GPU Exchange after acquiring Oblivus. Risks include integration challenges, capital access, market conditions, GPU availability, & Nasdaq compliance. 3d ago
- KNDIKandi Group (KNDI) reports Q3 2026 results Nov 18 at 8 AM ET. Live webcast at viavid.webcasts.com. Company focuses on intelligent vehicles, battery swapping, & robotics. 3d ago
- ALLREnded Q3 2026 with $24.1M cash. Reported $6.2M net loss vs $2.8M prior year. Settled $4.9M Novartis liability for $1.0M. Expects Q4 EPS $0.01-$0.04. Full year loss per share projected $0.73-$0.76. Phase 2 ovarian & lung cancer trials ongoing. Japan granted patent until 2039. Secured first CLIA lab contract in Oct 2026. No 2027 guidance provided. 3d ago
- RMIXSuncrete Q3 rev $141M +163% YoY. Net income $78k vs $37.1M loss. Raised 2026 rev outlook to $408M-$434M; adj EBITDA $22.4M. High rates impact residential construction. Call Nov 13 at 10AM ET. 3d ago
- CSIQCanadian Solar Q3 2026 call set for Dec 3 at 8AM ET. Dial +1-877-704-4453 or webcast via investor relations. Replay until Dec 17 at +1-844-512-2921. Company holds $3.5B e-STORAGE backlog as of June 2026. 3d ago
- HDLSuper Hi Intl reports Q3 FY26 results Nov 25 at 7am ET. Haidilao runs 129 locations across 14 countries & ranked World's Strongest Restaurant Brand 2024-2026. Live English/Chinese webcast available; phone dial-in requires Chinese registration. 3d ago
- FINVFinVolution Group (NYSE: FINV) reports Q3 2026 results on Nov 25 after market close. Earnings call at 7:30 PM ET. A fintech platform founded in 2007, it had 254.2 million cumulative registered users as of June 30, 2026. Webcast available at ir.finvgroup.com. 3d ago
- GSEuropean listed company earnings are proving more resilient than domestic economic growth would suggest, driven by sector composition and global revenue exposure. The equity market reflects a concentrated group of large companies, with financials, energy, and technology holding significant weight compared to their share of the broader economy. Additionally, over half of STOXX 600 revenues are generated outside Europe, making global growth and currency fluctuations more relevant than domestic GDP. While higher energy prices currently benefit energy and resource sectors, sustained costs may eventually pressure profit margins for other industries. 3d ago
- IORIncome Opportunity Realty Investors (IOR) reported Q3 2026 net income of $0.9M ($0.22/share) vs $1.0M ($0.25) in 2025. Nine-month net income was $2.593M ($0.64/share) vs $3.014M ($0.74). Lower interest income from related parties drove the decline. 4d ago
- STNStantec Q3 2026 net revenue hit $1.9B, up 9.4%. Adjusted EBITDA rose 16.6% to $377.1M. Backlog grew 11.6% to $9.2B. Company raised full-year outlook to 9-11% revenue growth. Acquired Niche in Australia. Dividend set at $0.245/share. 4d ago
- ARLAmerican Realty Investors reported a $0.7M loss vs $0.1M income last year. Q3 revenue rose to $13.9M. Occupancy hit 82%. On Oct 2, it acquired 782 Texas & Alabama units for $12M cash & notes. Alera loan maturity extended to Nov 2027. 4d ago
- TCITranscontinental Realty Investors reported Q3 2026 net loss of $0.1M vs $0.7M income in 2025. Revenues rose $1.1M to $13.9M. Occupancy at 82%. Acquired 782 units in Texas & Alabama for $12M. Extended Alera loan maturity to Nov 2027. 4d ago
- NUNu Holdings Q3 2026 net income up 31% to $1.1B; revenue up 37% to $6.3B. Added 3.7M customers for 143M global total. Nu US & Nu Global launched. Credit portfolio grew 33% to $41.6B. Efficiency ratio 19.3%, revised full-year guidance 19-19.5%. 90+ NPL at 7.3%. 4d ago
- YSSYork Space Q3 2026 rev: $84.2M (-7% YoY). Net loss $807.4M driven by $749.7M goodwill charge. Adj EBITDA loss $27.6M. Pipeline grew 30% to $14.9B. Backlog $581M. Brian Frantz named permanent CFO. Acquired Outlook Industries. Rev guidance narrowed to $380M-$400M. 4d ago
- QXOQXO Q3 net loss $123M, adjusted EPS $0.13 on $4.895B sales. 9M sales $9.87B, adjusted EBITDA $830M. $500M buyback authorized. Long-term targets: $4B EBITDA by 2030, $50B revenue. 4d ago
- CSCOCisco beats Q1 EPS at $1.40 & rev to $18.5B, up 24% YoY. Stock up 35% YTD. Raised AI infra guidance to $9B. Q2 rev forecast $18B-$18.2B vs $17.88B est; EPS $1.34-$1.36 vs $1.23 est. 4d ago
- SSentinelOne releases Q3 FY27 results after market close Dec 3, 2026, with a conference call at 2pm PT. The company presents at Barclays Global Technology Conference on Dec 10. Webcasts \& materials available at investors.sentinelone.com. 4d ago
- CSCOCisco Q1 FY27 revenue hit $18.5B, up 24% YoY, its strongest growth in 15+ years. EPS reached record $1.40 non-GAAP. Raised FY27 revenue guidance to $74.8B-$75.8B. AI infrastructure revenue expected at $9B. Product revenue surged 32%. 4d ago
- WKHSWorkhorse reschedules Q3 call to Nov 16 at 4:30 p.m. ET due to Microsoft outages. Press release available at ir.workhorse.com. Dial-in: (877) 407-0789 US, (201) 689-8562 Int'l. Replay from 9 p.m. ET Nov 16 via (844) 512-2921, ID 13762979. 4d ago
- VINPVinci Compass Q3 '26 earnings Nov 12: record fees & net income. Navi deal done early; AustralRe launch kicked off Permanent Capital Solutions. R$106.8M fees, R$183.6M net income. $0.17/share dividend declared payable Dec 11. AUM hit R$363B as of Sept. 4d ago
- WSEWise FY27 H1: Active customers +21% to 16.2M. Net revenue +23% to $1.45B. Cross-border volume +24% to $141B. Holdings +28% to $43.5B. Net income +6% to $249.2M. Launched products in US, NZ, Canada. $500M buyback started. FY27 revenue guidance 17.5-20%. 4d ago
- SVBTSVB&T Q3 2026 net income rose 30.64% to $3.39M ($3.07 EPS). ROAA reached 2.02%. Net interest income hit $6.25M while noninterest income grew to $3.20M. Total assets climbed $35.16M to $678.64M. Book value per share increased 12.03% to $72.09. YTD earnings were $9.41M. 4d ago
- SMIDSmith-Midland (SMID) files 10-Q Nov 16, 2026. Chairman CEO Ashley Smith & CFO Dominic Hunter present at IDEAS Conf in Dallas Nov 19 at 1:20pm CT. Webcast available at 3partadvisors.com. Company operates 3 facilities in VA, NC, SC. 4d ago
- FBDTFirst Breach Inc (FBDT) Q3 2026 results on Nov 17 at 5pm ET. Form 10-Q filed Nov 16. Call: 888-506-0062, code 568241. Webcast available. Questions to fpogubila@integcom.us. Defense tech firm making ammo & drones in Maryland. Forward-looking statements subject to risks. 4d ago
- VSXYVictoria's Secret & Co. hosts Q3 2026 earnings webcast Dec 3 at 8:30 a.m. ET. Financial release drops one hour prior. Company operates approx 1,430 stores across 70 countries. Details at victoriassecretandco.com/investors. 4d ago
- CAECAE Inc. raised FY adjusted EPS outlook to $1.28-$1.35. Net income dropped 20.7% to $58.6M; revenue slipped 2.6% to $1.20B. Adj. EPS rose to 33 cents. CEO Bromberg confirmed focus on global footprint reduction. 4d ago
- WMTWalmart (WMT) Q3 2026 earnings release at 6 a.m. CST Thursday, Nov 19. CEO John Furner & CFO John David Rainey host call at 7 a.m. CST. FY26 revenue was $713B with 10,900+ stores serving 280M weekly customers. 4d ago
- CMCTCMCT reports Q3 2026 earnings Nov 16 pre-market. Call at 12pm ET w/ CEO Thompson, CFO Hill & oversight Altebrando. Register 15 mins prior at creativemediacommunity.com. Replay for 90 days. 4d ago
- SAILSailPoint reports Q3 2027 results & outlook Dec 8 before US open. Call at 8:30 AM ET. Webcast at investors.sailpoint.com. Participates in Barclays Global Tech Conference Dec 9 in SF. Company offers AI platform unifying identity, security & data intelligence. 4d ago
- SPHSuburban Propane reported FY26 net income of $109M ($1.63/unit) & Adjusted EBITDA of $284M. RNG volumes rose 13%. The Board raised distributions 7.7% to $1.40 annually. The company acquired propane businesses in California & Florida while refinancing $350M in debt. 4d ago
- TWSTTwist Bioscience (TWST) reported Q4 & FY2026 results. Conference call & webcast start at 8 a.m. ET today. Dial-in details & replay available on Investor Relations site. Firm provides biological solutions for diagnostics, therapeutics, industrial, agriculture & research. 4d ago